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ABSTRACT
The basidiomycete Cryptococcus neoformans is is an invasive opportunistic
pathogen of the central nervous system and the most frequent cause of fungal
meningitis. C. neoformans enters the host by inhalation and protects itself from
immune

assault

in

the

lungs

by

producing

hydrolytic

enzymes,

immunosuppressants, and other virulence factors. C. neoformans also adapts to
the environment inside the host, including producing metabolites that may confer
survival advantages. One of these, acetate, can be kept in reserve as a carbon
source or can be used to weaken the immune response by lowering local pH or as
a key part of immunomodulatory molecules. Thus, cryptococcosis could be treated
by targeting acetate production. The Smith laboratory has identified two potential
pathways for acetate production. The xylulose-5-phosphate/fructose-6-phosphate
phosphoketolase (Xfp) - acetate kinase (Ack) pathway, previously thought to be
present only in bacteria, converts phosphoketose sugars to acetate through acetylphosphate. The pyruvate decarboxylase (Pdc) and acetaldehyde dehydrogenase
(Ald) pathway, found in other fungi, converts pyruvate to acetate through
acetaldehyde. The genes encoding enzymes from these pathways have been
shown to be upregulated during infection, suggesting that acetate production may
be a required part of cryptococcal infection. In Saccharomyces cerevisiae, Pdc
works with one or more Alds to produce acetate. Eight of the nine C. neoformans
Alds and the sole Pdc all contributed to the cellular acetate pool, and loss of some
of these enzymes reduced cell survival during growth on various carbon sources,
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under oxidative or nitrosative stress, under pseudo-hypoxia conditions, and when
the cell wall integrity was disrupted. In addition, deletion mutants of of some of
these enzymes affected capsule formation and melanization, two primary
determinants of Cryptococcus, and led to decreased virulence in macrophages
and Galleria mellonella, an invertebrate model of infection.
Metabolic adaptability is an important attribute for fungal pathogens to
successfully infect and cause disease. Carbon metabolism is critical for virulence
in C. neoformans, but little is known about which carbon sources are utilized during
infection. Lung alveolar macrophages, the first line of host defense against C.
neoformans infection, provide a glucose- and amino acid-poor environment, and
nonpreferred carbon sources such as lactate and acetate are likely important early
in establishment of a pulmonary infection. A global screening was undertaken to
identify C. neoformans proteins necessary in acetate utilization, as possible drug
targets. From two libraries, together comprising 3936 gene knockouts, 41 mutants
failed to grow on media with either glucose or acetate as the carbon source, or on
both media. Of the known proteins lacking in these mutants, most function in
gluconeogenesis,

arginine

biosynthesis,

or

mitochondrial

transmembrane

transport. Overall, this work elucidated the roles of C. neoformans acetate
production and utilization pathways in virulence.

iii

DEDICATION
It is with my genuine gratefulness and warmest regard that I dedicate this
dissertation to my family: my beloved mom, who has always been there for me
when I needed emotional support, my dad, whose dream, before he passed away,
was for me to obtain my Ph.D. in the United States, and whose encouraging voice
I still hear whenever I am struggling, my husband, Akram, who always puts me
first, my daughter Mariam, my bright star, and my brothers Mohamed, Adel, Salah,
and Nuri. Without these people in my life, this dissertation would not have been
completed. I love you all!

iv

ACKNOWLEDGMENTS

I would like to thank my advisor and committee chairman, Dr. Kerry Smith,
for his continuous support of my studies and research over the years, as well as
my dissertation committee members, Dr. Julia Frugoli, Dr. Cheryl Ingram-Smith,
and Dr. Lukasz Kozubowski for their patience, motivation, enthusiasm, and
guidance throughout my time in graduate school.
The completion of my project would not have been possible without the
support of everyone, including the professors, staff, and graduate students, of the
Eukaryotic Pathogens Innovation Center and of the Genetics and Biochemistry
Department at large. I would like to especially express my gratitude to Dr. Meredith
Morris, Dr. Lesly Temesvari, and Dr. Kimberly Paul for making my day and life
more cheerful and happier in hard times. I am also extremely grateful to all my
fellow lab members, past and present, who helped me with my experiments and
assisted me in myriad ways throughout my time at Clemson.
I would like to thank my Libyan family: my husband Akram and my sweet
daughter Mariam for their constant love and support, my beloved mother Salma,
and my brothers, who have been my source of inspiration and who have given me
strength and their continuous moral, spiritual, and emotional support when I
thought of giving up.
Finally, last but by no means least, I am also grateful to my American family
and friends: Cheryl Jones, Nicole Clark-Mount, Hollie H. Smith, Sylvia Cole,

v

Sophia Altamirano, and Archana Nalin Mankad for their love and for supporting me
along the way. Julia Frugoli and Cheryl Ingram Smith, who, in addition to agreeing
to be on my committee and giving me technical advice, also acted as a personal
friend and extended family member.

vi

TABLE OF CONTENTS

Page
TITLE PAGE ........................................................................................................ i
ABSTRACT ........................................................................................................ ii
ACKNOWLEDGMENTS. .................................................................................... v
TABLE OF CONTENTS ................................................................................... vii
LIST OF FIGURES ............................................................................................ xi
LIST OF TABLES ............................................................................................. xv

CHAPTER ONE
LITERATURE REVIEW ................................................................................. 1
Cryptococcus neoformans: Epidemiology and Sources of Exposure....... 1
Ecological niche of Cryptococcus ............................................................ 4
Mechanism of infection and host response .............................................. 5
Cryptococcal response to immune attack and dissemination .................. 8
Virulence Factors ................................................................................... 13
Resistance to Hypoxia ........................................................................... 29
Response to Oxidative and Nitrosative stress ....................................... 31
Degradative enzymes involved in Cryptococcus virulence .................... 33
Metabolites important for C. neoformans infection................................. 39

vii

Table of Contents (Continued)
Page
Four eukaryotic acetate production pathways in protists ....................... 44
Acetate production pathways in fungi .................................................... 45
Pyruvate Decarboxylase (PDC) ............................................................. 50
Aldehyde dehydrogenases (ALDs) ........................................................ 56
Aldehyde dehydrogenases in fungi ........................................................ 57
Summary and Study Objective .............................................................. 63
References ............................................................................................ 68

CHAPTER TWO
THE ROLE OF CRYPTOCOCCOUS NEOFORMANS ALDEHYDE
DEHYDROGENASE FAMILY MEMBERS UNDER STRESS AND
IN VIRULENCE ......................................................................................... 109
Abstract................................................................................................ 109
Introduction .......................................................................................... 112
Materials and methods ........................................................................ 116
Results ................................................................................................. 130
Discussion ........................................................................................... 145
Potential future experiments ................................................................ 178
References .......................................................................................... 183

viii

Table of Contents (Continued)
Page
CHAPTER THREE
THE ROLE OF PYRUVATE DECARBOXYLASE IN THE STRESS
RESPONSE AND PATHOGENESIS OF CRYPTOCOCCOUS
NEOFORMANS ........................................................................................ 222
Abstract................................................................................................ 222
Introduction .......................................................................................... 224
Materials and methods ........................................................................ 230
Results ................................................................................................. 243
Discussion ........................................................................................... 253
Potential future experiments ................................................................ 265
References .......................................................................................... 269

CHAPTER FOUR
USE OF A GENETIC SCREEN TO IDENTIFY ACETATE
UTILIZATION GENES IN CRYPTOCOCCUS NEOFORMANS ................ 299
Abstract................................................................................................ 299
Introduction .......................................................................................... 301
Materials and methods ........................................................................ 304
Results ................................................................................................. 306
Discussion ........................................................................................... 309

ix

Table of Contents (Continued)
Page
Summary and Conclusions .................................................................. 331
References .......................................................................................... 332

APPENDIX
This section contains supplementary material for Chapters Two
and Three.................................................................................................. 351
Method: Flow cytometry analysis of oxidative stress and
cellular integrity .............................................................................. 351
Results ................................................................................................. 353
Overall conclusions and future directions ............................................ 354
References .......................................................................................... 358

x

LIST OF FIGURES

Figure

Page

1.1

Global burden of HIV-related cryptococcal meningitis in 2017............. 105

1.2

Cryptococcal infection is the fourth leading cause of death,
excluding HIV, Sub-Saharan Africa ..................................................... 106

1.3

Cryptococcus neoformans pathogenesis cycle .................................... 107

2.1

Various C. neoformans metabolic pathways that utilize pyruvate ........ 203

2.2

Phylogenetic tree analysis showed evolutionary relatedness
between specific aldehyde dehydrogenases (ALDs) of
C. neoformans and Ald6p, Ald4p and Ald5p of S. cerevisiae............... 204

2.3

Verification of the deletion of each ALD gene in the corresponding
mutant.................................................................................................. 206

2.4

Qualitative growth analysis revealed growth defects in ald5Δ,
ald13Δ, and ald69Δ mutants ................................................................ 208

2.5

Quantification of the impact of deletion of ALD genes on growth in
liquid media with various primary carbon sources ............................... 209

2.6

All ald mutants produced significantly less acetate than the wild
type strain after 12 hours ..................................................................... 211

2.7

ALD genes played an important role in capsule formation................... 212

xi

List of Figures (Continued)
Figure
2.8

Page
The ald69Δ mutant produced less and the ald5Δ mutant produced
more melanin relative to the wild type strain ........................................ 213

2.9

The ald29Δ mutant grew poorly under hypoxia-mimicking
conditions............................................................................................. 214

2.10

ald69 was important for the survival of C. neoformans under
oxidative stress .................................................................................... 215

2.11

The ald69 mutant exhibited an adenine production defect under
nitrosative stress .................................................................................. 216

2.12

ald mutants grew normally under high salt conditions ......................... 218

2.13

The ald69Δ mutant had defects in cell wall and/or capsule integrity .... 219

2.14

Percent survival of wild type and ald mutant C. neoformans strains
after engulfment by macrophages ....................................................... 220

2.15

Galleria mellonella survival assay ........................................................ 221

3.1

Various metabolic pathways utilized by C. neoformans to harness
energy and invade the host immune system........................................ 283

3.2

Phylogenetic tree analysis shows evolutionary relatedness of
Cryptococcus neoformans pyruvate decarboxylase enzymes to
those of other fungal species ............................................................... 284

xii

List of Figures (Continued)
Figure

Page

3.3

Verification of the deletion of PDC in the corresponding mutant .......... 286

3.4

No qualitative difference in growth using glucose, acetate, or
ethanol as the carbon source was observed between wild type and
pdcΔ mutant strains ............................................................................. 287

3.5

Quantification of the impact of deletion of PDC on growth in liquid
media with various carbon sources...................................................... 288

3.6

The pdcΔ mutant produced significantly less acetate than the wild
type strain ............................................................................................ 290

3.7

The PDC gene plays an important role in capsule formation ............... 291

3.8

The pdcΔ mutant produces less melanin than the wild type strain ...... 292

3.9

The pdcΔ mutant grew poorly under hypoxic conditions...................... 293

3.10

The pdcΔ mutant grew normally under oxidative and nitrosative
stresses ............................................................................................... 294

3.11

The pdcΔ mutant grew normally under high salt conditions................. 295

3.12

The pdcΔ mutant had abnormal cell wall and capsule integrity ........... 296

3.13

Percent survival of wild type and pdcΔ mutant C. neoformans cells
after engulfment by macrophages in an in vitro assay ......................... 297

xiii

List of Figures (Continued)
Figure

Page

3.15

Galleria mellonella survival assay ........................................................ 298

4.1

Representative plates of Madhani library strains screened for
growth on glucose or acetate as the only carbon source ..................... 341

Appendix Figures
2.1

Effect of hydrogen peroxide treatment on reactive oxygen species
(ROS) content and membrane damage ............................................... 356

3.1

Effect of hydrogen peroxide treatment on reactive oxygen species
content and membrane damage on wild type and pdcΔ mutant
strains of C. neoformans...................................................................... 357

xiv

LIST OF TABLES

Table

Page

2.1

List of genes/enzymes deficient in the mutants used in this study ....... 201

2.2

List of primers used to verify deletion of ALD genes in mutant
strains .................................................................................................. 202

3.1

Information about the gene/enzyme deficient in the pdcΔ mutant
strains used in this study...................................................................... 282

4.1

Mutants from the Madhani laboratory C. neoformans strain libraries
that were unable to grow on media with glucose as the only carbon
source .................................................................................................. 346

4.2

Mutants from the Madhani laboratory C. neoformans strain libraries
that were unable to grow on media with acetate as the only carbon
source .................................................................................................. 347

4.3

Mutants from the Madhani laboratory C. neoformans strain libraries
that failed to grow on media with glucose as the only carbon source
as well as on media with acetate as the only carbon source ............... 348

xv

CHAPTER ONE
LITERATURE REVIEW
Cryptococcus neoformans: Epidemiology and sources of exposure
Cryptococcus neoformans, an opportunistic pathogen that belongs to the
phylum Basidiomycota (Loftus et al., 2005; Sorrell, 2001), has two species that are
most often found to infect humans: Cryptococcus neoformans, consisting of
cryptococcal serotypes A and D, as well as a hybrid serotype AD, and
Cryptococcus gattii, consisting of serotypes B and C (Litvintseva et al., 2011;
Chayakulkeeree and Perfect, 2008). The vast majority of patients with
cryptococcosis have defects in cell-mediated immunity, specifically in CD4+
lymphocytes. AIDS is a major risk factor with mortality rates in AIDS patients
ranging from 15-20% in the US and 55-70% in Latin America and sub-Saharan
Africa (Park et al., 2009). Immunosuppressive therapy for solid organ transplant
patients is another major risk factor (Neofytos et al., 2010).
The current incidence of cryptococcal meningitis is estimated to be
approximately 220,000 cases per year among HIV infected patients (Rajasingham
et al., 2017) and possibly higher overall, leading to almost 150,000-200,000 deaths
annually (Limper et al., 2017). The incidence rate is down from the ~1 million cases
of fungal meningitis and over 600,000 deaths from cryptococcal meningitis
estimated to have occurred in 2006 (Park et al., 2009). This recent decrease may
seem contrary to the disproportionately high number of HIV-associated
Cryptococcus infections, and deaths, in regions like sub-Saharan Africa;
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nevertheless, the reasons for both of these effects are related. The general fate of
HIV infected patients in developed, industrialized nations dramatically improved
during the 1990’s with the introduction of Highly Active Anti-Retroviral Therapy
(HAART); the mortality rate was significantly reduced and the incidence of various
HIV-associated opportunistic infections like cryptococcosis has been decreasing
since in wealthier countries (Kaplan et al., 2000; Mirza et al., 2003; Jahnke et al.,
1999). However, in parts of the world (and even in parts of the U.S.) where this
therapy is still not affordable, HIV-associated opportunistic infection still poses an
immense threat (McQuiston and Williamson, 2012; Kaplan et al., 2000; Mirza et
al., 2003). AIDS-related cryptococcosis cases and deaths due to cryptococcal
meningitis are much more prevalent in developing nations because the HIV
pandemic rate is significantly higher, and/or access to proper medical treatment
and therapeutic measures, including antifungal medications, is limited or entirely
lacking, in these countries (Warnock, 2006; Park et al., 2009; Pyrgos et al., 2013).
The majority of cryptococcal meningitis cases are found in low-income and middleincome countries; almost 73% of the cases up until 2014 have been reported as
occurring in sub-Saharan Africa (Rajasingham et al., 2017). Similarly, the highest
rates of death due to cryptococcal meningitis were and still are observed in subSaharan Africa (Figure 1.1), to a great extent because of the relatively high number
of untreated HIV/AIDS patients there (Mitchell and Perfect, 1995; Park et al., 2009;
Rajasingham et al., 2017). Hence, in the United States, AIDS patients face a
mortality rate of 15-20%, whereas the rate is 55-70% in Latin America and Sub-
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Saharan Africa (Brown et al., 2012). This indicates that greater patient access to
HAART in developing nations may reduce the prevalence of cryptococcosis, fungal
meningitis, and associated death, just as it has in developed ones. However, even
in countries where HAART has reduced the mortality in HIV-infected patients,
cryptococcosis remains a major cause of invasive fungal infection in non-HIV
patients who are immunocompromised or immunosuppressed due to therapies
they are receiving in the form of monoclonal antibodies, corticosteroids, or other
immunosuppressive

agents,

and

cryptococcosis

can

even

occur

in

immunocompetent non-HIV patients (Snydman et al., 2008; Wu et al., 2009;
McQuiston and Williamson, 2012).
Cryptococcosis is the third most common invasive fungal infection in sold
organ transplant recipients after infections by Candida and Aspergillus species
(Neofytos et al., 2010), and, in the U.S. alone, 20-60% of invasive fungal infections
in non-HIV-infected patients have been reported to be cryptococcosis (Vilchez et
al., 2002). With the increasing application of immunosuppressive therapeutic
regimens, cryptococcosis and other fungal infections are suspected to rise
proportionally as the leading symptomatic diseases in non-HIV-infected patients
(Aratani et al., 2006). Furthermore, amongst the most common diseases prevalent
in sub-Saharan Africa excluding HIV/AIDS, cryptococcal infection is the fourth
leading cause of death (Figure 1.2; Park et al., 2009), and it is estimated that the
mortality rate of infections caused by pathogenic fungi such as C. neoformans, C.
albicans, and A. fumigatus is actually much higher than that of malaria and

3

tuberculosis (Denning and Bromley., 2015; Meyer et al., 2016). Therefore, it is of
great importance to better understand the metabolism and virulence-related
pathways of C. neoformans in order to develop drugs that can kill this pathogen.
Ecological niche of Cryptococcus
Outside of the human host, C. neoformans is found in very diverse
ecological niches, depending on the local environment. The first strain of C.
neoformans was isolated in 1894 by Sanfelice from fruit juice (Emmons, 1951).
Moreover, the presence or absence of such ecological habitats can affect the
distribution and virulence of C. neoformans in any given geographic region. C.
neoformans is commonly found in decaying material in the hollows of at least
eighteen different tree species around the world, including eucalyptus, as well as
in avian excreta, particularly the waste of feral pigeons (Chowdhary et al., 2012;
Randhawa et al., 2003; Reimão et al., 2007). Pigeons only develop a latent
infection, not an active one, as their higher body temperature is not suitable for
fungal growth, but they act as good vectors, since their excrement provides the
required nutrients for C. neoformans var. grubii cells to survive until the cells can
enter the human host as basidiospores through inhalation (Littman and Borok,
1968; Hiremath et al., 2008). Furthermore, since C. neoformans can survive in its
saprophyte form in excreta, it can be found on any surface that comes into contact
with bird droppings, including contaminated soil, fruits, and vegetables, as well as
inside homes in regions of the world where birds can enter through open windows;
this is particularly dangerous for HIV seropositive patients in such regions, since
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they can be regularly re-infected in their own homes (Jarvis and Harrison, 2007;
Chowdhary et al., 2012; Swinne et al., 1989, 1994). Cryptococcus species can
reside inside soil nematodes and free-living amoebae and use them as replicative
hosts; both C. neoformans and C. gattii are capable of doing this in the laboratory
(May et al., 2016). However, prevalence of C. neoformans is more widespread
than C. gatti in terms of host tree species that it was isolated from (17 host tree
species for C. neoformans in contrast to 12 for C. gatti) (Chowdhary et al., 2012),
which results in wide arboreal distribution for C. neoformans and therefore
increased chance of host pathogen interaction
Mechanism of infection and host response
Within the human host, Cryptococcus neoformans can gain access to the
respiratory system by inhalation of spores or desiccated airborne yeast cells from
the environment (Taylor-Smith, 2017). Encapsulated fungal cells often measure
around 5-10 μm, and are therefore susceptible to removal from lung epithelia by
mucociliary clearance (Okagaki and Nielsen, 2012). However, basidiospores or
desiccated cells of C. neoformans isolated from soil or from bird droppings
measure around 0.6-3 μm, which is a sufficiently small size for alveolar deposition
following inhalation (Levitz, 1991; Lin and Heitman, 2006), possibly via the
mucociliary movement itself (Sabiiti and May, 2012). Within the lungs, there are
four possible outcomes to the infection (Sabiiti and May, 2012). The two less
harmful outcomes are that the fungi can be controlled and cleared by the host
immune system or that the infection can become latent and remain in the lungs
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symptom-free (Sabiiti and May, 2012; Jarvis and Harrison, 2007; Goldman et al.,
1994). The third outcome is that the latent infection can revive in the lungs upon
weakening of the immune system, such as due to HIV infection or pharmacological
immune suppression, leading to more serious outcomes (Goldman et al., 1994;
Garcia-Hermoso et al., 1999; Lindell et al., 2006; Jarvis and Harrison, 2007) and
cause lung inflammation and pulmonary disease. The fourth outcome and the most
dangerous is dissemination of Cryptococcus from pulmonary site to other organs
such as the urinary tract, the prostate gland, the skin, bones, the liver, the spleen,
lymph nodes, and, especially, the brain (Liu et al., 2009; Jarvis and Harrison, 2007;
Hernandez, 1989; Sabesin et al., 1963). In fact, the organs most commonly
affected when C. neoformans infects a host are the lungs and the brain, and, in
immunocompromised patients, not only can lung infection lead to pneumonia, but
infection of the blood (fungemia) which often leads to the fatal meningoencephalitis
(Goldman et al., 1994; Chrétien et al., 2002; Sabiiti and May, 2012).
In immunocompetent individuals, there are a number of stages of the
immune response to infection. When C. neoformans cells enter the alveoli of the
lungs, alveolar macrophages attempt to phagocytose the fungal cells and either
kill them or sequester them in granulomas (Rohatgi and Pirofski, 2015; Vecchiarelli
et al., 1994a; Mitchell and Friedman, 1972; McQuiston and Williamson, 2012;
Sabiiti and May, 2012). If a macrophage is successful in engulfment, the fungal
cell is sequestered inside the phagolysosome, an organelle formed by the fusion
of a phagosome and a lysosome to produce a local environment of low pH,
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hydrolytic enzymes, antimicrobial peptides, and toxic free radicals that the
macrophage utilizes to try to destroy the pathogen (Hampton et al., 1998; Vieira et
al., 2002; Cox et al., 2003; Tohyama et al., 1996; Ma and May, 2009). Free
radicals, specifically reactive oxygen species (ROS) and reactive nitrogen species
(RNS), are capable of damaging the fungal cell wall and cell membrane and may
attack the DNA and cellular proteins as well (Bergamini et al., 2004; Dedon and
Tannenbaum, 2004; Upadhya et al., 2013), while the hydrolytic enzymes break
apart pathogen proteins into peptides. Optimally, the pathogen is destroyed and
its peptides are presented by the macrophage via the Major Histocompatibility
Complex (MHC) cell surface receptors to activate T-cells, and the macrophage is
also activated to release cytokines that attract neutrophils and other immune cells
(Dong et al., 1997; Del Poeta, 2004). In particular, CD4+ helper T cells are activated
upon binding of their T cell receptors to the cryptococcal peptides, and these helper
T cells, in turn, release cytokines that regulate the attack upon the fungal pathogen
(Campbell et al., 2008). One subset of these helper T cells are Th1 cells, and
overexpression of Th1 cytokines like tumor necrosis factor α (TNFα) and interferon
γ (IFNγ) has been shown to effectively control the fungal burden by increasing the
inflammatory and immune response (Kawakami et al., 1995; Wormley et al., 2007).
Once macrophages and helper T cells recruit the rest of the immune system to the
site of infection, the cell mediated immune response against C. neoformans is
mostly driven by interleukin 2 (IL-2) activated CD8+ cytotoxic T cells and Natural
Killer (NK) cells, which can detect and destroy the pathogen in an MHC dependent
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or independent manner (Levitz et al., 1994). Natural killer cells and cytotoxic T cells
secrete various proteins, including granulysin, perforin, and granzymes, which
induce cryptococcal lysis and permeabilization and also force infected host cells
to undergo apoptosis (Ernst et al., 2000; Voskoboinik et al., 2006).
Cryptococcal response to immune attack and dissemination
C. neoformans is able to survive in the lungs and disseminate to other
organs because of its ability to evade, counteract, or circumvent the immune
response. For example, the pathogen exploits the fact that, after activating T helper
cells, macrophages have essentially opposite responses to feedback regulation
imposed on them by the cytokines secreted by Th1 versus Th2 T helper subsets
(Voelz et al., 2009). This opposing feedback regulation is the reason for the almost
direct correlation, in HIV infected patients, between cryptococcal virulence and the
degree to which the release of Th1 "pro-inflammatory" cytokines is compromised,
and for the similar correlation observed between virulence and the increased
release of "anti-inflammatory" cytokines by Th2 cells in transplant recipients given
immunosuppressive drugs to counter transplant rejection (Voelz and May, 2010).
Th1 cytokines recruit and activate macrophages and neutrophils and make them
release microbicidal oxidative and nitrosative bursts (Shoham and Levitz, 2005;
Voelz et al., 2009). In contrast, macrophages activated by Th2 cytokines have a
lower expulsion probability, and allow a higher intracellular proliferation of the
fungal pathogen, compared with those activated by Th1 cytokines (Voelz et al.,
2009). C. neoformans inhibits the Th1 response by expressing eicosanoids
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(Noverr et al., 2003), uses components of its polysaccharide-based capsule to
decrease the release of Th1 pro-inflammatory cytokines while increasing the
release of anti-inflammatory IL-10 from Th2 cells (Shoham and Levitz, 2005), and
shifts the Th1-Th2 balance more towards Th2 cells (Voelz and May, 2010), thereby
manipulating the host immune system to its own advantage.
C. neoformans utilizes a number of mechanisms to ensure that it can remain
and survive in the host. Immediately after entry into the alveoli of the lungs, C.
neoformans can secrete Phospholipase B, an enzyme that breaks down
dipalmitoyl phosphatidylcholine (DPPC), the major lipid present in the natural,
tension-reducing surfactant coating the epithelial lining, thus allowing the fungal
cells to attach directly to lung epithelial cells (Ganendren et al., 2006). C.
neoformans can grow into extremely large, polyploid cells, called titan cells, that
have ten-fold the diameter of normal C. neoformans in vivo via pheromone
signaling following mating between opposite mating types (a or α) and therefore
resist phagocytosis, as well as block the phagocytosis of nearby normal-sized
fungal cells (Okagaki et al., 2010; Zaragoza et al., 2010; Okagaki and Nielsen,
2012; May et al., 2016). Just like these titan cells, cryptococci that enlarge their
capsules after they reach the lungs resist being engulfed by macrophages (Levitz
and Tabuni, 1991; Xie et al., 2012; May et al., 2016). This permits the cryptococcal
cells to pass into the bloodstream and thereby enter the systemic circulation,
causing fungemia, via direct internalization by the lung epithelial cells to which they
had attached (Sabiiti and May, 2012; May et al., 2016). The polysaccharide
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capsule also prevents phagocytosis by macrophages in other ways, including by
interaction with the surfactant in the host lung. Inside the lungs of
immunocompetent individuals, opsonization of pathogenic microorganisms by
surfactant proteins A and D (SPA and SPD) normally promote engulfment by
alveolar macrophages, but SPA has no effect on phagocytosis of C. neoformans
(Geunes-Boyer et al., 2012; Schelenz et al., 1995; Giles et al., 2007). Similarly, C.
neoformans cells either use the capsule components glucuronoxylomannan
(GXM) and mannoprotein 1 (MP1) to prevent opsonization by SPD, or, if they lack
an effective capsule, can actually use the SPD coating to protect themselves from
the ROS and RNS mediated chemical attack after engulfment by macrophages
(Geunes-Boyer et al., 2012; Schelenz et al., 1995; Levitz and Tabuni, 1991; Van
de Wetering et al., 2004).
If phagocytosed, C. neoformans can use multiple virulence factors,
including but not limited to the capsule and its components, to survive inside and
to parasitize macrophages, thereby giving rise to a dormant infection (Feldmesser
et al., 2001). Upon subsequent immunosuppression of the host, latent cryptococci
in the granulomas initially produced by macrophages to protect the host, or the
cryptococci surviving inside parasitized macrophages, are reactivated and can
enter the systemic circulation by leaving the macrophages through vomocytosis, a
nonlytic exocytosis (Nicola et al., 2011; Alvarez and Casadevall, 2006). Worse, C.
neoformans cells that have parasitized macrophages can use the macrophages
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as "Trojan Horse" vehicles to travel to other parts of the body, effectively hidden
from the immune system (Charlier et al., 2009; Santiago-Tirado et al., 2017).
As mentioned above, among the various tissues and organs to which C.
neoformans can disseminate, the most notable are those of the central nervous
system (CNS), especially the brain. The CNS is both an immune-privileged site,
allowing C. neoformans cells that have traveled there to evade immune
surveillance, and is a highly sterile environment, eliminating competition from other
pathogens (May et al., 2016). Normally, the blood-brain barrier (BBB) prevents
pathogens from reaching the brain, but Cryptococcus neoformans has evolved
methods to traverse the BBB and reside in the meningeal tissues surrounding the
brain or in the neurons of the brain itself (Charlier et al., 2005). There are three
different proposed mechanisms for dissemination of C. neoformans to the CNS
(Figure 1.3). First, the fungal cells can cross the BBB by forcing their way between
the tight junctions of the vascular endothelial cells in a process known as
paracytosis (Chen et al., 2003; Vu et al., 2013; May et al., 2016). In the second
method, called transcytosis, C. neoformans uses hyaluronic acid on its surface to
bind to CD44 on the luminal endothelium, leading to a protein kinase C-dependent
actin remodeling activity in the endothelial cells that drives these cells to engulf the
cryptococcal cells. The fungal cells then exit out the other side, thereby crossing
the BBB by going through the endothelial cells (Chang et al., 2004; Jong et al.,
2008; May et al., 2016). The third mechanism is known as the ‘Trojan Horse’
hypothesis, in which cryptococcal cells cross the BBB by hitchhiking within host
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phagocytes (such as macrophages), which are then able to breach the BBB using
enzymes the same way that they normally cut through extracellular matrix or tight
junctions to reach a site of infection (Sorrell et al., 2016; May et al., 2016; SantiagoTirado et al., 2017).
The physiological changes that C. neoformans goes through after it has
traversed the BBB into the CNS are not very well understood, but it is known that
fungal cells found in the cerebrospinal fluid (CSF) are metabolically very active and
upregulate various genes involved in core metabolic processes and stress
responses (Chen et al., 2014). The transcriptional profile approximately matches
that of cryptococci grown in nutrient-rich media (Chen et al., 2014), which suggests
that CSF provides many of the essential nutrients that are required for the growth
and activity of C. neoformans. In fact, the pathogen can, depending on the location
to which it has disseminated, upregulate a wide variety of metabolic pathways at
the site of the infection, including those involved in energy production, protein
synthesis and degradation, as well as upregulate genes involved in stress
responses, transport of small molecules, and signaling pathways, even under low
nutrient and hypoxic conditions (Steen et al., 2003; Kronstad et al., 2012). This
metabolically active state of C. neoformans and its responsiveness to the
environmental conditions is likely one of the causes of its survival and virulence.
This responsiveness to local environmental conditions may be just as
important as the ability to counteract the immune response in the survival and
virulence of the pathogen. C. neoformans faces a number of environmental
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challenges inside the human host, including a temperature that is higher than the
optimal growth temperature of Cryptococcus species and low oxygen conditions
found in many cells and tissues of the human body. C. neoformans grows optimally
at atmospheric oxygen concentration (~21%), and its growth is significantly
reduced at lower oxygen concentrations (Odds et al., 1995; Ingavale et al., 2008).
Oxygen concentrations in the human body can range widely between 1% and 15%,
with a normal oxygen concentration of ~14% in the lungs, ~5.3% in the venous
blood, and only 1-5% in the brain (Erecinska and Silver, 2001; Carlsson et al.,
2001; Studer et al., 2000). In order for C. neoformans to invade the CNS after
inhalation into the lungs, reach the brain, and cause meningitis, it must be able to
cope with the significantly lower concentrations of oxygen in the brain (Ingavale et
al., 2008). Furthermore, oxygen levels in host tissues can be further reduced by
thrombosis, inflammation and necrosis associated with the infection (Chun et al.,
2007; Nau and Brück, 2002; Sawyer et al., 1991), thus posing a challenge for the
survival of the pathogen.
Virulence factors
Given the number of hurdles that cryptococci must overcome to infect and
spread in a body, it is not surprising that many virulence factors help with the
pathogenesis of C. neoformans by allowing survival and proliferation inside the
host, evasion or escape from the host immune system, and exploitation of damage
to the host to provide nutrients and survival factors to the pathogen. The virulence
of C. neoformans is due to a concert of many factors and cannot be attributed to
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any single one. However, some of the main virulence factors that contribute to the
pathogenicity of C. neoformans (and C. gattii) are polysaccharide capsule
formation, melanin production and deposition along the cell wall, and the ability to
grow at 37°C (Coelho et al., 2014; Casadevall et al., 2000; Kronstad et al., 2011;
Ma and May, 2009). The cryptococcal capsule and melanin, together, are
protective against phagocytosis and the ROS secreted by immune cells (Wang et
al., 1995; Mednick et al., 2005; Shoham and Levitz, 2005; Rohatgi and Pirofski,
2015).
Several proteases, lipases, and other enzymes, as well as many
metabolites produced by C. neoformans after infection, also play a role in its
virulence. For example, C. neoformans Phospholipase B breaks down host cell
lipids to allow fungal cell exit from macrophages or for use as fungal nutrients (Cox
et al., 2001; Chrisman et al., 2011). As mentioned above, this enzyme is also used
by the fungus to cleave one of the lung surfactant lipids, thereby helping with
adherence to alveolar epithelial cells (Ganendren et al., 2006; Sabiiti and May,
2012), and to produce eicosanoids out of macrophage lipids, which are then used
to suppress the Th1 immune response (Noverr et al., 2003; Sabiiti and May, 2012).
Metabolites produced by the fungus that aid in virulence include the
carbohydrate trehalose, which assists in the ability of the fungus to survive at the
host body temperature (Chen and Haddad, 2004; Gancedo and Flores, 2004), and
the lipid prostaglandin E2, which downregulates host antifungal activity (Valdez et
al., 2012).
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Ion acquisition by the pathogen is assisted by the upregulation of
expression of specific fungal genes and their encoded proteins during infection
(e.g. copper or dual copper/iron acquisition is increased via expression of Ctr4 or
Cft1/Cfo proteins, respectively), to facilitate survival (Jung et al., 2009; Ding et al.,
2013). Homeostasis of iron and copper is critical for virulence, including survival in
the high-copper environment of the lungs and low copper environment of the brain,
or for dissemination to the brain, and mutation or deletion of many of the genes
involved in iron or copper transport, redox state, and homeostasis, including CFT1,
CFT2, FRE2, FRE4, and CUF1 reduces virulence (Jung et al., 2008, 2009; Saikia
et al., 2014; Waterman et al., 2012). Some proteins, like Cft1, Cft2, Cfo1, Ctr1,
Ctr4, and Cu-detoxifying metallothionein (CMT) are expressed differently in
response to, or used to counteract, temperature, oxidative, and/or osmotic stress
or variability in iron and copper levels (Jung et al., 2008, 2009; Lee et al., 2014;
Saikia et al., 2014; Zhang et al., 2016; Sun et al., 2014; Ding et al., 2013;
Waterman et al., 2012).
Polysaccharide capsule
One of the most complex and versatile virulence factors is the fungal
capsule. It provides protection from antimicrobial compounds, toxic free radicals,
and various stress conditions (Zaragoza et al., 2008; Zaragoza, 2011). It has been
shown that acapsular mutants of C. neoformans are avirulent (Chang and KwonChung, 1994). During inhalation, the fungal spores are generally unencapsulated
(Velagapudi et al., 2009) as smaller size helps in passage through the airway, but
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capsule size increases dramatically during infection as the spore reaches the
alveoli (Bergman, 1965; Cruickshank et al., 1973). Furthermore, the location of
infection plays an important role in the regulation of capsule biosynthesis. It has
been shown that the environment in the lung is a potent inducer of capsule
formation and enlargement (Zaragoza et al., 2003), while, in the brain, the capsule
is smaller than in the lungs, but larger than that of cells outside the host (Rivera et
al., 1998; Zaragoza et al., 2003). A larger capsule, especially combined with a
large (titan) cell, blocks phagocytosis of the fungal cells by macrophages in the
lungs (Okagaki et al., 2010; Zaragoza et al., 2010; Okagaki and Nielsen, 2012;
May et al., 2016). The ability of the capsule to interfere with phagocytosis has been
demonstrated in vitro, where there is essentially no phagocytosis of encapsulated
C. neoformans in the absence of opsonins (Shoham and Levitz, 2005). If
phagocytosis does occur, capsule polysaccharides are released into vesicles
around the phagosome (or phagolysosome) inside the engulfing macrophages,
and accumulation of these vesicles in the cytoplasm of the host cell leads to
macrophage dysfunction and lysis (Tucker and Casadevall, 2002). Furthermore,
the capsule is also used to counteract attempts by the macrophage to destroy the
fungal cell by neutralizing the reactive oxygen and nitrogen species produced by
the macrophage to attack the cryptococci (Zaragoza et al., 2008). Additionally,
capsule polysaccharides act as a acid-base buffer to maintain a pH that is optimal
for fungal cell growth but non-optimal for the acid hydrolases used by
macrophages to break down pathogen proteins (De Leon-Rodriguez et al., 2018).
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Cryptococcal

capsules

and

their

components

have

very

strong

immunomodulatory properties, (Chang et al., 2006; Chiapello et al., 2008) which
C. neoformans can use to evade or counteract the host immune response,
secondary to preventing phagocytosis. The capsule, or polysaccharides shed from
it, interfere with the ability of macrophages to present cryptococcal peptides via
MHC receptors, including by downregulating the expression of the MHC receptors;
they also make the macrophages express Fas ligand (FasL) that binds to Fas
receptor on the surface of nearby T cells, thereby inducing the T cells to undergo
apoptosis as well as drive the macrophages to undergo apoptosis (Vecchiarelli et
al., 2003; Monari et al., 2005; Villena et al., 2008; Siegemund and Alber, 2008;
Ben-Abdallah et al., 2012). In addition, capsular material is also reported to delay
maturation and activation of, and antigen presentation by, human dendritic cells
(Vecchiarelli et al., 2003). The capsule or its components also function to inhibit
the secretion of pro-inflammatory cytokines by the host immune cells, reduce
complement activation, inhibit antibody production, and reduce leukocyte
migration, thereby conferring a considerable survival advantage to C. neoformans
within the host (Zaragoza, 2011; Siegemund and Alber, 2008; Villena et al., 2008;
Vecchiarelli, 2007; Ellerbroek et al., 2004b, 2004c; Bose et al., 2003; Buchanan
and Murphy, 1998; Vecchiarelli et al., 1994b). Leukocyte migration to the site of
infection is impeded in a number of ways. These include interfering with chemokine
receptor function and reducing the attraction of leukocytes to chemokines, forcing
the leukocytes to shed from their membranes the L-selectins they use to migrate
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along the blood vessel endothelial cell lining, increasing IL-10 production (by antiinflammatory immune cells), and repressing neutrophil expression of C5a and
TNF-α receptors (Ellerbroek et al., 2004b, 2004c). These processes are all
mediated by the abundant polysaccharides shed from the capsule into the host
bloodstream (Ellerbroek et al., 2004b, 2004c) or via the fully formed capsule.
To form a capsule, C. neoformans produces glucuronoxylomannan (GXM),
which

comprises

about

90-95%

of

the

capsule

polysaccharides,

and

galactoxylomannan (GalXM), which makes up another ~5% of the capsule
polysaccharides (Rakesh et al., 2008; Vecchiarelli et al., 2011). GXM is a large
polymer made of repeating units of α-1,3-mannose, with β-D-xylopyranosyl, β-Dglucopyranosyluronic acid, and 6-O-acetyl groups branching off of the mannose
sugars (Cherniak et al., 1998; Rakesh et al., 2008). These three different mannose
modifications vary in number and order within the GXM polymer, leading to the
formation of different serotypes with sharp antigenic heterogeneity (McFadden et
al., 2007). GXM has been found to be associated with lipids of intracellular and
extracellular vesicles (Oliveira et al., 2009). The presence of GXM in C.
neoformans extracellular vesicles suggests that the fungus synthesizes its capsule
from the outside of the cell to allow for the cell to grow (Rodrigues et al., 2007).
The abovementioned induction of apoptosis of nearby T cells via forced
upregulation of FasL in macrophages have been attributed to GXM that is either
released from inside macrophages or secreted into the blood, from where it binds
to Toll-like receptors (e.g. TLR4) on macrophages or other peripheral blood
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mononuclear cells to induce the production of FasL (Shoham et al., 2001; Monari
et al., 2005; Vecchiarelli, 2007). This FasL induction occurs without stimulating the
activation of NF-κB or the production of TNFα (Shoham et al., 2001; Monari et al.,
2005; Vecchiarelli, 2007).
GalXM is an α-1,6-galactan that contains branches of β-1,3-galactose, α1,4-mannose and α-1,3 mannose chains, and therefore is technically a
glucuronoxylomannogalactan (Vaishnav et al., 1998; Heiss et al., 2009;
Vecchiarelli et al., 2011). GalXM is a critically important factor in the suppression
of T cell activation and in the induction of the subsequent FasL-mediated apoptosis
of those T cells, as well as in the indirect induction of B cell and macrophage
apoptosis (Pericolini 2006, 2010; Vecchiarelli et al., 2011). Together, these
polysaccharides interfere with the activation and proliferation of T cells, thereby
reducing the effect of the cell-mediated immune response (Yauch et al., 2006).
These capsule polysaccharides are produced under low iron conditions in the
presence of CO2 (Granger et al., 1985; Vartivarian et al., 1993; Vecchiarelli et al.,
2011). Along with GXM and GalXM, β1,4 N-acetylglucosamine molecules similar
to those polymerized into the chitin layer between the cell membrane and the cell
wall, and several mannoproteins (the latter of which constitute <1% of the capsule
components) are also found to be associated with the capsule and help in
anchoring the GXM polymers to the fungal cell wall (Ramos et al., 2012;
Vecchiarelli et al., 2011; Fonseca et al., 2009; Rodrigues et al., 2008a; Huang et
al., 2002; Levitz, 2001; Van Dyke and Wormley, 2018; Erwig and Gow, 2016).
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Addition of chitinase to C. neoformans cells causes detachment of the capsule
from the cell wall (Rodrigues et al., 2008a). Acetate and its metabolism are
important in capsule formation, stability, and function (Hu et al., 2008), and, once
converted into acetyl CoA, it can be used in the formation of the β1,4 Nacetylglucosamine that links the cell wall to the capsule (Hu et al., 2008).
Additionally, acetate is the source for the acetylation of GXM, and, despite the
surprising hypervirulence of C. neoformans mutants lacking acetyl groups on their
capsule (Janbon et al., 2001), this acetylation is required for the GXM-mediated
reduction of neutrophil migration to the site of infection (Ellerbroek et al., 2004a).
There are several genes that are involved in capsule formation and
synthesis. CAP59 was the first capsule-associated gene to be isolated, and it
encodes a transmembrane protein (Chang and Kwon-Chung, 1994, 1998, 1999;
Chang et al., 1996) that is required in the process of export of GXM out of the cell
and into the capsule (Garcia-Rivera et al., 2004). CAP64 was the second gene
identified in the capsule formation pathway, and deletion of this gene results in an
acapsular phenotype (Chang et al., 1996, 1997). CAP60 and CAP10 must also be
involved in capsule formation, since deletion of these genes results in an acapsular
phenotype, although the biochemical function of their products is still elusive
(Chang and Kwon-Chung, 1998, 1999). UDP glucuronic acid (UDP-GlcA) is a
critical precursor in the biosynthesis of cryptococcal polysaccharides and
mutations in the UGD1 gene, encoding the UDP-glucose dehydrogenase that is
necessary to synthesize UDP-GlcA, or in CAP10, CAP59, CAP60, or CAP64, lead
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to an acapsular phenotype (Moyrand and Janbon, 2004; Griffith et al., 2004). A
deficiency in UDP-glucose dehydrogenase leads to temperature sensitivity and
loss of thermotolerance, preventing growth at the 37°C host temperature, as well
as morphological defects and an overall decreased virulence (Moyrand and
Janbon, 2004; Griffith et al., 2004). The production of UDP-GlcA is also important
because it can be converted into UDP-xylose; about 20% of GalXM molecules
contain xylose, while 40-60% of GXM molecules contain xylose and GlcA (Griffith
et al., 2004).
Proteins required for transporting the products of enzymes encoded by CAP
genes are as important as the synthesizing enzymes themselves. For example,
the UDP-GlcA transporter, Uut1, has a vital role in capsule formation. C.
neoformans with a reduced ability to transport UDP-GlcA exhibit growth defects
and metabolic abnormalities, resulting in greater phagocytosis by macrophages in
vitro and faster clearance of the infection in vivo (Li et al., 2018).
Several other genes and their corresponding proteins play an important but
non-essential role in capsule synthesis. For instance, CAS1 and CAS3 are
required for acetylation of GXM (Janbon et al., 2001; Moyrand and Janbon, 2004).
Other genes, including UXS1, UGD1, CAS31, CAS32, CAS33, CAS34 and
CAS35, are important for xylosylation of GXM (Bar-Peled et al., 2001; Moyrand
and Janbon, 2004). Computational analysis of the approximately 20 megabase
genome of C. neoformans revealed 30 new genes that have potential roles in
capsule synthesis (Loftus et al., 2005). These include seven members of the
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CAP64 capsule associated gene family and a second CAP10 family of six capsule
associated genes (Loftus et al., 2005). Capsule formation is controlled largely by
the Gα protein-cAMP-PKA signaling cascade (Alspaugh et al., 2002; Hicks et al.,
2004), but is also negatively regulated by the high osmolarity glycerol (HOG)
pathway. (Bahn et al., 2005). The HOG pathway, also referred to as the HOG1
pathway based on the major gene of the pathway, has been shown to be involved
in the response to external environmental stress, such as high temperature,
oxidative stress, or osmotic shock (Bahn et al., 2005). Hog1, an upstream MAP
kinase in the HOG pathway, may have distinct functional roles depending on the
cryptococcal serotype. For example, deletion of HOG1 induces the synthesis of
capsule and melanin in C. neoformans var. grubii, which is serotype A, but not in
C. neoformans var. neoformans, which is serotype D (Bahn et al., 2005).
Melanin production and laccase activity
C. neoformans produces melanin for use as a protective molecule. The
exact molecular structure of the cryptococcal melanin pigment is unknown and it
has often been said to be ‘melanin-like’ pigment; regardless, it is a negatively
charged, hydrophobic molecule of high molecular weight, which is synthesized
from phenolic and/or indolic components via oxidative polymerization (Frases et
al., 2007; Steenbergen and Casadevall, 2003; Nosanchuk and Casadevall, 2003;
Hamilton and Gomez, 2002; Jacobson, 2000). Although melanized cryptococcal
cells have been shown to be responsible for the initial human infection, the
environmental sources of melanin production prior to infection of a host are still
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unclear (Williamson, 1997; McFadden and Casadevall, 2001; Steenbergen and
Casadevall 2003; Frases et al., 2007; Eisenman et al., 2007). During infection,
cryptococcal melanin is synthesized from exogenous precursors such as
catecholamines, including epinephrine, norepinephrine, L-DOPA, dopamine, and
aldehydes, obtained from host cells, but not from endogenous chemicals like
amino acids (Williamson, 1997; McFadden and Casadevall, 2001; Steenbergen
and Casadevall 2003; Frases et al., 2007; Eisenman et al., 2007).
Melanin (or the cryptococcal melanin-like pigment) has the properties of a
stable free-radical that allow it to function as an efficient antioxidant (Jacobson and
Emery, 1991a; Jacobson and Tinnell, 1993; Steenbergen and Casadevall 2003)
and also provides protection against both cold and heat, helping C. neoformans to
survive at the host body temperature (Nosanchuk and Casadevall, 2003). Melanin
can also induce complex immunomodulatory effects that increase the virulence of
C. neoformans by eliciting changes in the host cytokine/chemokine response to
infection (Mednick et al., 2005; Huffnagle et al., 1995). Additionally, melanized
cryptococcal cells are less susceptible to the action of amphotericin B (Van Duin
et al., 2002), an anti-fungal agent.
C. neoformans melanin or melanin-like pigments are produced by enzymes
known as laccases, members of the multicopper oxidase family of proteins, using
copper as the co-factor (Walton et al., 2005). These laccase enzymes are
important, since laccase-deficient mutants of C. neoformans with a corresponding
melanin deficiency have reduced virulence (Kwon-Chung et al., 1982; Rhodes et
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al., 1982). In C. neoformans, melanin is produced using two laccase enzymes,
Lac1 and Lac2, which are spatially separated. Lac1 is abundantly associated with
the cell wall, whereas Lac2 is present in the cytoplasm (Zhu et al., 2001; Waterman
et al., 2007). Although it has been suggested that Lac1 plays the predominant role
in infection, the genes for the two enzymes share 75% identity, and both isoforms
are required for full virulence (Missall et al., 2005; Pukkila-Worley et al., 2005).
Once produced, melanin is deposited in the cell wall, creating an electron
dense layer (Solano, 2014) from where the melanin fulfils its antioxidant function,
offering protection to the cryptococcal cells from free oxygen and nitrogen radicals
and other toxic molecules generated within macrophages to attack the fungal cell
wall, membrane and other internal components (Williamson, 1997; Eisenman and
Casadevall, 2012; Wang and Casadevall, 1994a, 1994b, 1994c). It is possible that
more than one melanin-like pigment is produced, and that insoluble melanin is
deposited in granules in the cell wall, while soluble melanin-like pigments are also
localized to the cell wall but can diffuse (Nosanchuk and Casadevall, 2003).
Regardless, this cell wall deposition is probably achieved by vesicular secretion of
melanin outside the cell membrane and even of the laccase enzymes themselves
(Rodrigues et al., 2008b, Eisenman et al., 2009). Both are commonly found in
cryptococcal extracellular vesicles (Rodrigues et al., 2008b). Such vesicle
mediated melanin deposition has also been reported in other fungi like Candida
albicans (Walker et al., 2010).
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The laccases have additional roles besides melanin production. For
example, by catalyzing the production of prostaglandin E2 from extracellular,
macrophage-derived arachidonic acid (Erb-Downward et al., 2008), laccases can
modulate the immune response and interfere with the control of infection by the
host. Prostaglandins have been shown to reduce phagocytosis, lymphocyte
proliferation, chemokine production, and Th1 response. (Erb-Downward and
Huffnagle, 2007; Noverr et al 2002). Moreover, by functioning as an iron oxidase,
laccase enzymes can convert Fe(II) to Fe(III), thereby neutralizing the antimicrobial
oxidative effect of hydroxyl radicals generated inside the macrophages, and
protecting the fungal cells (Liu et al., 1999; Casadevall et al., 2000). Laccase
activity in Cryptococcus is induced by metals or metal ions like copper and calcium,
and is repressed by the presence of nutrients such as nitrogen and glucose and
nitrogen (Zhu and Williamson, 2004; Wang et al., 2001; Nyhus and Jacobson,
1999; Jacobson and Compton., 1996; Zhu et al 2003). Copper regulates laccase
activity not only as a co-factor, but also through the transcription factor encoded
by CUF1, which drives the expression of LAC1 (Jiang et al., 2009). The presence
of iron within the phagolysosome of an engulfing macrophage should be toxic to
the fungal cell; instead, it induces the abovementioned iron oxidase function of the
laccase, which acts to reduce potentially toxic Fenton reactants and hydroxyl
radicals (Liu et al., 1999). Likewise, infected brain tissue has decreased levels of
glucose, which should decrease survival by C. neoformans inside the neurons, but,
instead, the low glucose levels induce laccase expression (i.e., expression of both
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LAC1 and LAC2) through the protein encoded by TSP2-1, facilitating further
infection of brain cells by the pathogen (Zhu and Williamson, 2004; Li et al., 2012;
Pukkila-Worley et al., 2005). Fortunately for the host, other metals and
biomolecules, as well as elevated host temperatures, can repress laccase activity
(Jacobson and Emery, 1991b; Zhu and Williamson, 2004). Thus, while
inflammation of the brain is harmful, it may also be the way that the body tries to
raise the brain temperature to repress laccase activity, as well as the activity of
other enzymes, in meningoencephalitis.
Laccase gene expression is also regulated by signaling pathways. It has
been observed that the Gα-cAMP-PKA signaling pathway, initiated by the
activation of the Gα protein Gpa1 upon binding of extracellular stimuli like
hormones and nutrients to receptors, might be involved in the modulation of
laccase expression in C. neoformans (Pukkila-Worley et al., 2005; Zhu and
Williamson, 2004; Alspaugh et al., 1997, 2002). Likewise, the HOG1 pathway
negatively regulates melanin production on a serotype-specific basis; serotype A
(H99 strain) but not serotype D (strain JEC21) hog1 mutants exhibit significantly
increased melanin production (Bahn et al., 2005). Other studies have shown a role
for MAP kinase cascade targets Ste12a and Ste12alpha in regulating laccase
expression (Chang et al., 2000, 2001). Wang et al. (2001) have demonstrated a
role for two homologues of cyclophilin A, a protein involved in the inflammatory
response in humans, in laccase activity, and C. neoformans lacking both isoforms
of cyclophilin A have reduced melanin levels.
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Thermotolerance
C. neoformans is capable of growing at the mammalian host body
temperature of 37°C, which gives C. neoformans an advantage over other fungi
when it comes to infecting mammalian hosts (Steenbergen and Casadevall, 2003;
Perfect, 2005). Less than 0.01% of outdoor fungi possess this virulence factor;
most soil fungi and even most cryptococcal species lack this ability and are
therefore non-pathogenic (Steenbergen and Casadevall, 2003; Perfect, 2005).
The importance of thermotolerance as a virulence factor is evidenced by the
inability of temperature-sensitive mutants of C. neoformans to infect a mammalian
host, despite being capable of producing a capsule and melanin (Kwon-Chung et
al., 1982; Odom et al., 1997). However, at temperatures of 39°C-40°C, even C.
neoformans grows poorly, and intracellular vacuolization, aberrant budding, and
the formation of pseudohyphal structures indicate that the cells are not healthy at
this temperature (Mitchell and Perfect, 1995; Steenbergen and Casadevall, 2003).
Cryptococcal thermotolerance involves a number of cellular pathways. A
genome-wide transcriptome analysis of C. neoformans cells subjected to two
different temperatures (25°C and 37°C) revealed the upregulation of several
important genes at the higher temperature (Steen et al., 2002). In particular,
differences were observed in the levels of C. neoformans mRNAs encoding
histones, heat shock proteins, components of the translational machinery,
mitochondrial proteins, and stress-response proteins such as superoxide
dismutase (Steen et al., 2002). The upregulation of the expression of (the mRNAs
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for) heat shock proteins (and chaperones) Hsp60 and Hsp70 was especially
significance, as these proteins have been found to be prominent antigens in
cryptococcal infection of animals and humans (Steen et al., 2002). Additionally,
higher levels of transcripts encoding phenolic metabolism enzymes at 37°C
suggest a direct correlation between increased temperature and a greater need
for melanin synthesis inside the mammalian host (Steen et al., 2002).
In addition to the observed upregulation of certain genes in response to
higher temperature, which may or may not be necessary for virulence, several
genes have been demonstrated to be important for the basic survival of
Cryptococcus at the human physiological temperature (Perfect, 2005). For
example, the vacuolar ATPase VPH1, CCN1 (a protein used in DNA replication,
transcription and splicing), basic amino acid metabolism genes such as ILV2, and
signaling pathways genes such as RAS1, CNA1, CNB1, MPK1 and CTS1, are all
important in high temperature growth (Perfect, 2005). Disruption of RAS1 or CNA1
causes severe deleterious effects on fungal virulence at 37°C, as does disruption
of TPS1 or SOD2 (Perfect, 2005; Alspaugh et al., 2000). It makes sense that
SOD2, which encodes the C. neoformans mitochondrial manganese superoxide
dismutase involved in neutralizing ROS (Giles et al., 2005a), is necessary to deal
with the stress caused by higher temperature. Likewise, the Ras proteins regulate
cellular morphogenesis and RAS1 encodes a C. neoformans Ras protein
responsible for attachment, mobility, and cytoskeletal integrity at high
temperatures (Alspaugh et al., 2000). Ras1 fulfills these functions via Cdc42,
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expression of which is increased in, and necessary for survival of, cryptococcal
cells at 37°C (Ballou et al., 2010). TPS1 and TPS2 encode trehalose-6-phosphate
synthase and trehalose-6 phosphate phosphatase, respectively, and both are
necessary to provide the thermotolerance effect of the trehalose sugar metabolite
(Perfect, 2005). Trehalose has been reported to play an important role in the
survival of several bacteria and fungi under stress conditions (Chen and Haddad,
2004; Gancedo and Flores, 2004), and likely does so for C. neoformans. Other
genes, such as STE20α and CPA1 (which encodes cyclophilin) are required for
survival at very high temperature (39°C to 40°C), even if they are not strictly
necessary for growth at 37°C (Perfect, 2005).
Resistance to hypoxia
Since the brain uses a vast amount of ATP energy and is therefore a highly
oxidative organ, it consumes a disproportionately large portion of the body's
oxygen pool (Erecinska and Silver, 2001). Despite this, there is a highly variable
but generally low oxygen concentration and partial pressure in the brain (Erecinska
and Silver, 2001), posing a challenge to the survival of C. neoformans cells that
have disseminated into brain tissue. However, the pathogenic fungus adapts to
these conditions and causes infection in both immunocompromised and normal
patients (Ingavale et al., 2008). In order to adapt to the variable oxygen
concentrations in the brain and other tissues that it infects, C. neoformans must
first be able to sense to the concentration of oxygen. In Schizosaccharomyces
pombe, cells respond to environmental oxygen concentrations by sensing changes
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in sterol levels in cell membranes, using the sterol response element binding
protein (SREBP) pathway in which the proteins Sre1 and Scp1 monitor oxygen
dependent sterol synthesis (Hughes et al., 2005; Todd et al., 2006). Under low
sterol conditions, SREBP (Sre1) is cleaved by SREBP cleavage activating protein
(SCAP/Scp1), and is thus activated (Hughes et al., 2005). The activated Sre1
facilitates the transcription of genes involved in sterol biosynthesis and uptake
(Hughes et al., 2005; Todd et al., 2006). In S. pombe, the Sre1 protein is also
activated in response to low oxygen conditions, and stimulates the expression of
genes required for survival under hypoxia (Hughes et al., 2005). These genes have
orthologues in C. neoformans that have been shown to be important for
cryptococcal survival under hypoxic conditions; for example, deletion of SRE1 in
C. neoformans decreases the growth of the pathogen under low oxygen
conditions, both in vitro and in an animal model (Chang et al., 2007; Bien et al.,
2007). The in vitro experiments also established that, like in S. pombe, C.
neoformans Sre1p is activated by hypoxia via cleavage of the precursor protein
(Chang et al., 2007; Chun et al., 2007). Hypoxia can be mimicked in vitro by the
use of cobalt chloride, and both Sre1p and Scp1p have been shown to be essential
during growth under a cobalt chloride induced pseudo-hypoxic environment (Lee
et al., 2007). In addition to the Sre1 pathway, Tco1, a member of a highly
conserved family of fungal-specific histidine kinases, also plays a role in the
resistance to low oxygen conditions (Chun et al., 2007). The C. neoformans tco1
mutant is sensitive to hypoxia, and a tco1-sre1 double knock-out strain shows even
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more sensitivity to hypoxia than the individual single mutants, verifying that Tco1
functions in a pathway parallel to Sre1 (Chun et al., 2007). Tco1 positively
regulates the aforementioned HOG/MAPK pathway, and thereby negatively
regulates melanin synthesis (Chun et al., 2007). Besides these pathways, several
genes in C. neoformans related to sterol, heme, and fatty acid metabolism are
upregulated, and pathways involved in translation, vesicle trafficking, and cell wall
and capsule synthesis are downregulated, in response to low oxygen conditions
(Chun et al., 2007).
Response to oxidative and nitrosative stress
Upon entry into the host pulmonary system, C. neoformans encounters
alveolar macrophages, the first line of host defense. Once the pathogen is
phagocytosed by the macrophage, it faces the toxic effects of the ROS and RNS
molecules that break down the fungal cell's membrane lipids and proteins, as well
as other cellular molecules, including the DNA (Bergamini et al., 2004; Dedon and
Tannenbaum, 2004; Upadhya et al., 2013; Missall et al., 2004a; Hampton et al.,
1998; Vieira et al., 2002; Cox et al., 2003; Liu et al., 1999; Tohyama et al., 1996).
It has been shown that macrophages produce nitric oxide (NO), a key type of RNS,
in response to infection (Tripathi et al., 2007; Maffei et al., 2004) and that the anticryptococcal activity of macrophages is mostly dependent on RNS, and, to a lesser
degree, ROS (Cox et al., 2003; Tohyama et al., 1996; Maffei et al., 2004).
Therefore, it is important for C. neoformans to protect itself from nitrosative (and
oxidative) damage in order to survive inside the host system. The pathogen also
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alters gene expression in response to ROS (Upadhya et al., 2013), and genomic
and proteomic analyses of C. neoformans cells subjected to nitrosative stress
revealed an upregulation of proteins involved in the oxidative stress response and
downregulation of proteins involved in the osmotic and starvation stress response
pathways (Missall et al., 2006),. Additionally, RNS specifically attacks and
inactivates proteins that contain iron, iron-sulfur clusters, and copper, or thiol
groups, including aconitase and ribonucleotide reductase, as well as cytochrome
c oxidase and proteins of complexe I and II of the electron transport chain, which
requires the pathogen to mount a specific response to nitrosative stress (Missall
et al., 2004a). Therefore, it is notable that the enzymes transaldolase (Tal1),
aconitase (Aco1) and thioredoxin-dependent thiol peroxidase (Tsa1) were
repeatedly found to be altered in their expression levels as well as modified posttranslationally in response to NO (Missall et al., 2006). Likewise, TSA1 and another
thiol peroxidase gene, TSA3, are transcriptionally induced in C. neoformans
treated with hydrogen peroxide, a form of ROS (Missall et al., 2004b). C.
neoformans tsa1 mutants have reduced growth and virulence (Missall et al.,
2004b). Similarly, cryptococcal mutants of glutathione reductase (GLR1), which is
upregulated following nitrosative stress, were found to be avirulent in a mouse
infection model and are also specifically sensitive to nitrosative burst (Missall et
al., 2006). C. neoformans also relies on cytochrome C peroxidase (Ccp1),
superoxide dismutase (Sod1), and catalase enzymes to defend itself from
oxidative stress (Cox et al., 2003; Giles et al., 2005b, 2006) and the absence of
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any one of these enzymes adversely affects the virulence of the pathogen
(Narasipura et al., 2003). PKC1, another important gene involved in resistance to
environmental stress that is employed in maintaining cell wall integrity, is also
upregulated in wild type C. neoformans following oxidative and nitrosative burst
(Gerik et al., 2008), while pkc1 mutants have defects in the production of melanin
and capsular polysaccharides important for protecting the pathogen against free
radicals and are unable to withstand nitrosative and oxidative stress (Gerik et al.,
2008).
Degradative enzymes involved in Cryptococcus virulence
Phospholipases B and C
Phospholipases are members of a heterogeneous group of hydrolases that
break down the ester linkages in glycerophospholipids, which are the principal
components of cell membranes and of lung surfactants (Djordjevic, 2010). Thus,
fungal phospholipases play a significant role in the process of pulmonary invasion
(Djordjevic, 2010). Phagocytosed C. neoformans cells secrete phospholipases
that can degrade membrane phospholipids in order to lyse the host cell and escape
into the bloodstream or brain (Santangelo et al., 2004; Maruvada et al., 2012).
Furthermore, even inside phagocytic cells, phospholipid degradation facilitates
damage to phagolysosomal membranes, which allows the engulfed fungus to
access the host cytoplasmic components and intracellular nutrients, thereby
ensuring fungal survival inside the host cell (Feldmesser et al., 2000).
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C. neoformans expresses two classes of phospholipases to promote its own
virulence, phospholipase B and phospholipase C (Chen et al., 1997a; Chrisman et
al., 2011). A secreted phospholipase, encoded by PLB1, can function as
phospholipase

B,

lysophospholipase,

or

lysophospholipase

transacylase,

depending on the substrate (Chen et al., 1997a,b; Chrisman et al., 2011). C.
neoformans is sensitive to the presence of phospholipids, and addition of
phospholipids to cryptococcal culture causes significant induction of Plb1 activity
(Coelho et al., 2014). Plb1 has been shown to act primarily on dipalmitoyl
phosphatidylcholine (DPPC) and phosphatidylglycerol (PG), which are abundant
in lung surfactant (Merkel et al., 1999; Chen et al., 2000). Thus, C. neoformans
utilizes Plb1 to drive the adhesion of cryptococci to human lung epithelial cells
(Ganendren et al., 2006), the initiation of interstitial pulmonary infection, and
dissemination from the lung via lymphatic and blood vessels (Santangelo et al.,
2004). Plb1 is also essential in the production of eicosanoids, such as
prostaglandins and leukotrienes, which are bioactive anti-inflammatory molecules
that suppress the host immune system, thereby promoting survival and
dissemination of the pathogen within the host (Noverr et al., 2002, 2003;
Ganendren et al., 2006). The precursor of these eicosanoids, arachidonic acid, is
not present within the fungal cell itself; rather, it is suspected that the pathogen
appropriates the host cell arachidonic acid and derives the necessary eicosanoids
from it (Wright et al., 2007). Plb1 also plays a major role in the capsule enlargement
of C. neoformans in response to macrophage interaction (Chrisman et al., 2011)
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and in the formation of titan cells (Evans et al., 2015). Plb1 is also employed by
the fungus to activate the Rac1 GTPase of endothelial cells and thereby alter the
actin cytoskeleton of these cells to allow transcytosis and penetration of the blood
brain barrier by the pathogen; lack of Plb1 significantly reduces the transcytosis
efficiency (Maruvada et al., 2012). The importance of this enzyme to the virulence
of the pathogen is confirmed by the fact that mice infected with Plb1-deficient
mutants of C. neoformans survive better than mice infected with the wild type
strain, which suggests that Plb1-deficient cryptococci have reduced pathogenicity,
including having greater difficulty in invading brain tissue (Cox et al., 2001).
Intracellular growth and survival within macrophages is also reduced in plb1
mutants (Evans et al., 2015).
C. neoformans has two phospholipase C enzymes, Plc1 and Plc2
(Chayakulkeeree et al., 2008). PLCs act on phosphatidylinositol (PI),
phosphatidylinositol-4-monophosphate (PIP), and phosphatidyl inositol-4,5bisphosphate (PIP2), as the substrate (Heinz et al., 1998). In fact, in C.
neoformans, Plc1 acts on PIP2 to produce inositol-3,4,5-triphosphate (IP3) for use
by enzymes such as the inositol polyphosphate kinase Arg1; a deficiency in either
Plc1 or Arg1 impairs thermotolerance, as well as capsule formation and melanin
production, and compromises the integrity of the cell wall (Lev et al., 2013). The
secretion of fungal Plb1 depends on the removal of a glycosylphosphatidylinositol
(GPI) anchor (Djordjevic et al., 2005; Chayakulkeeree et al.,2008), which might be
a function of one of these phospholipase C enzymes, especially Plc1. Regardless,
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deletion of plc1 also produces avirulent cryptococcal cells that are unable to
produce melanin or induce nonlytic exocytosis (Chayakulkeeree et al., 2008). In
addition to Plc1 and Plc2, a C. neoformans inositol phosphorylsphingolipidphospholipase C (encoded by ISC1) protects the pathogen from excessively low
pH and from oxidative and nitrosative stresses, conditions found in the
phagolysosome (Shea et al., 2006).
Urease
Urease is a nickel-dependent enzyme that hydrolyzes urea into ammonia
and carbamate, and the degradation of the urea causes alkalization of the
surrounding environment, thereby facilitating acquisition of nitrogen (Coelho et al.,
2014). Urease has been found to be an important virulence factor for bacterial
pathogenesis (Eaton et al., 1991) and has been postulated to have a major role in
cryptococcal pathogenesis. One feature that distinguishes C. neoformans from
other yeast species in clinical specimens is the detection of urease activity
(Canteros et al., 1996). In C. neoformans, urease is initially an apoenzyme,
encoded by URE1 (Cox et al., 2000). Similar to other organisms that use the
urease system, a nickel transporter, encoded by NIC1, and accessory proteins
encoded by the URE4, URE6, and URE7 genes, are required for the apoenzyme
to become functional (Singh et al., 2013). Another gene, URE2, is also expressed
in C. neoformans and appears to be necessary for utilization of urea as a nitrogen
source (Varma et al., 2006). Urease deficient strains of C. neoformans have been
isolated from clinical samples only rarely, suggesting the importance of the urease
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activity in virulence, and a ure1 mutant strain was less virulent in both inhalation
and intravenous injection mouse infection models (Cox et al., 2000); however, the
effect of URE2 deficiency on virulence may depend on the route of infection, since
some ure2 mutants exhibit delayed dissemination from the lung, while others are
no different from wild type controls in virulence (Varma et al., 2006). The urease
system and its components enhance either passage across the lung epithelium
into the bloodstream or passage through the endothelial layer of the blood vessel
wall into the brain (Singh et al., 2013; Shi et al., 2010; Olszewski et al., 2004).
Furthermore, the pattern of dissemination of urease-deficient C. neoformans
strains in the brain, spleen, and other organs after intravenous inoculation is
different from that of the wild type strain, suggesting that urease enhances the
sequestration of the pathogen within microcapillary beds, thereby facilitating
invasion into the CNS, but may not actually be required for dissemination to the
brain (Olszewski et al., 2004).
Proteinases
Once C. neoformans enters the human body via the respiratory pathway,
the fungus utilizes enzymes that can degrade proteins and lipids (i.e.,
proteinases/proteases and lipases, respectively), present in the lung membrane,
to penetrate lung parenchyma within a few hours after its entry into the alveolar
space (Goldman et al., 1994). Both environmental and clinical isolates of C.
neoformans have been shown to have proteinase activity (Casadevall and Perfect,
1998), and the first report of the detection of extracellular proteinase activity from
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C. neoformans dates back to 1972 (Müller and Sethi, 1972). The action of
cryptococcal proteases on host membranes during infection was evident in
histopathological sections of Cryptococcus-infected tissues from beige mice, in
which collagen fibrils were found to be degraded (Salkowski and Balish, 1991).
Similarly, Chen et al., (1996) confirmed the presence of protease activity capable
of degrading collagen fibers, and possibly elastin and fibrinogen proteins, of the
extracellular matrix around host cells (Ma and May, 2009). Cryptococcal
supernatant containing secreted serine proteinases is also capable of degrading
human fibronectin, as well as laminin and type IV collagen (Rodrigues et al., 2003).
Besides degrading host membranes and extracellular matrix proteins, fungal
proteinase activity may also be utilized by the pathogen to compromise host
immunity by degrading immunologically important proteins, such as antibodies and
complement factors (Chen et al., 1996).
Cytoplasmic and extracellular cryptococcal proteases include at least one
membrane-bound aspartyl protease and an elastinolytic-like metalloprotease, as
well as multiple serine proteases/proteinases, some of which are embedded in the
membrane by GPI anchors (Eigenheer et al., 2007; Il Yoo et al., 2004; Pinti et al.,
2007; Rodrigues et al., 2003). Metalloprotease deficient strains of C. neoformans
are incapable of crossing the endothelium of the blood-brain barrier and the Mpr1
metalloprotease is required to invade the CNS (Vu et al., 2014), verifying the
importance of proteases in cryptococcal pathogenesis. In addition to the
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metalloproteases, Cryptococcal serine protease activity also augments the
permeability of the blood-brain barrier (Xu et al., 2014).
Metabolites important for C. neoformans infection
Besides the virulence factors discussed above, C. neoformans utilizes small
metabolites to inhibit the immune system of the mammalian host and for other
survival purposes. Heat inactivated supernatant of C. neoformans, in which
proteins are presumably denatured, can induce apoptosis of neutrophils, and
characterization of these supernatants from cryptococcal cultures revealed the
presence of thirty different metabolites, including amino acids, alditols,
nucleosides, acetate, and ethanol (Wright et al., 2002). These findings confirmed
the results from a second, earlier study, in which C. neoformans grown in culture
also secreted a number of these metabolites, including mannitol, glucitol, erythritol,
glycerol, derivatives of choline and ethanolamine, γ-aminobutyric acid (GABA, an
inhibitory neurotransmitter), nucleosides, and amino acids, and, most of all,
ethanol and acetic acid (Bubb et al., 1999).
Mannitol
Mannitol is one of the alditol metabolites released in the culture media by
C. neoformans, and the presence of mannitol correlates with cryptococcal
virulence (Wong et al., 1990). As an intracellular product of the pathogen, it is
believed to protect C. neoformans from heat and osmotic stress and likely helps
during infection by scavenging and neutralizing extracellular hydroxyl radicals
produced by phagocytes (Chaturvedi et al., 1996a). Mutants of C. neoformans that
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produce less mannitol are more susceptible to in vitro killing by normal neutrophils
and ROS, suggesting that mannitol is important for virulence (Chaturvedi et al.,
1996b). Addition of mannitol in the medium as a carbon source induces capsular
polysaccharide production in C. neoformans in vitro, and, in vivo, GXM production
was found to be regulated by mannitol supplementation in a mice model
(Guimarães et al., 2010). Moreover, the large amounts of mannitol released by C.
neoformans following brain infection may increase the osmolarity of the tissue,
thereby causing cerebral edema (Chaturvedi et al., 1996a; Wong et al., 1990),
which benefits the pathogen. Increased mannitol production is thought to have
contributed to the raised intracranial pressure that resulted in mortality of
cryptococcal meningitis patients (Hoang et al., 2004). The presence of mannitol in
the CSF of HIV infected patients with cryptococcal meningitis was previously
reported to increase intracranial pressure (Megson et al., 1996), but this finding
has also been disputed (Liappis et al.,2008).
Ethanol
Ethanol is another metabolite that has been found to be secreted in vitro by
C. neoformans cultures, at a concentration as high as 0.3% (w/v), into the culture
supernatant (Bubb et al., 1999; Wright et al., 2002). However, this concentration is
much higher than the highest amount of ethanol produced (0.064%) by one strain
of C. neoformans in a previous study (Pappagianis et al., 1966), and ethanol levels
as low as 0.0004% have been reported in spinal fluid inoculated with cryptococci
(Dawson and Taghavy, 1963). Likewise, although an ethanol concentration above
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0.79% is detrimental to leukotriene generation and to the subsequent responses
of human neutrophils, such as oxidative metabolism, aggregation, elastase
release, migration, and chemotaxis (Nilsson et al., 1995), this concentration is
higher than the maximum concentration secreted from the in vitro culture. Thus,
the effect of the ethanol produced and secreted by C. neoformans during infection
and its significance as a virulence factor is questionable.
Trehalose
Alpha-glucopyranosyl-alpha-D-glucopyranoside, more commonly called
trehalose, is a disaccharide produced by several organisms, including plants,
fungi, and invertebrates. Trehalose is rapidly produced in these organisms in
response to cellular stress to act as a stress protectant (Elbein, 1974; Gancedo
and Flores, 2004), and its production in S. cerevisiae has been shown to increase
resistance to heat (Lewis et al., 1995; De Virgilio et al., 1993; Attfield, 1987) and
to dehydration and desiccation (Gadd et al., 1987; Hottiger et al., 1987), mostly by
preventing the denaturation of certain proteins (Hottiger et al., 1987). Besides
preventing denaturation of protein, trehalose also suppresses the aggregation of
already denatured proteins (Singer and Lindquist, 1998). It has also been shown
that trehalose can protect the cell membrane from stressful conditions (Crowe et
al., 1984). Like other sugars, trehalose can also be utilized by cells as a source of
carbon and energy (Francois and Parrou, 2001; Kane and Roth, 1974; Lillie and
Pringle; 1980; Thevelein and Hohmann, 1995).
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The phosphorylated trehalose sugar (trehalose-6-phosphate, T6P) has
been shown to regulate glycolytic flux by regulating hexokinase II in some fungi
(Blázquez et al., 1993). Studies conducted in S. cerevisiae have revealed that
trehalose synthesis is dependent on two enzymes, T6P synthase (Tps1) and T6P
phosphatase (Tps2) (Bell et al., 1992; Vuorio et al., 1993), while unutilized
trehalose is hydrolyzed by a neutral trehalase encoded by NTH1 (Kopp et al.,
1993).
Expression of the homologous genes involved in the trehalose synthesis
pathway has been detected in C. neoformans by transcriptional analysis of the
CSF in an experimental model of cryptococcal meningitis utilizing infected rabbits
(Steen et al., 2003), indicating that, like S. cerevisiae, C. neoformans produces
trehalose in vivo. Similarly, nuclear magnetic resonance (NMR) studies of tissues
surrounding cryptococcomas, large-mass lesions resulting from infection, in
infected rat brain and lungs, revealed a high abundance of trehalose (Himmelreich
et al., 2001, 2003).
Trehalose has been shown to be important for C. neoformans virulence. In
a murine infection model, a trehalose synthesis-deficient C. neoformans tps1
mutant was far less lethal, allowing the mice to survive for over 60 days after
infection, than the H99 wild type strain that killed infected mice by day 16 (Petzold
et al., 2006). In contrast, mutations to trehalose degrading enzyme (Nth1) did not
have much of an effect on the virulence of the pathogen in this model (Petzold et
al., 2006). However, a recent study by Botts et al. (2014) demonstrated that NTH1
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deletion results in defective germination and sexual development of cryptococcal
spores. Interestingly, deletion of a previously unrecognized and only recently
identified gene for trehalase, NTH2, results in hypervirulent fungal strains (Botts et
al., 2014), possibly indicating that accumulation of trehalose (as a result of a
degradation defect) provides for greater survival and infectivity of C. neoformans.
Acetate
Acetate is one of the major metabolites secreted by cryptococci cultured in
vitro (Bubb et al., 1999). Using NMR, substantial amounts of acetate have been
detected from pulmonary cryptococcomas (Himmelreich et al., 2001). Acetate is
believed to provide a survival advantage to the pathogen by two mechanisms, the
first of which is through its effect on pH. An excess of acetate in the infected tissue
presumably decreases the pH in cryptococcomas (Wright et al., 2002), thereby
facilitating the activity of phospholipase B at the sites of cryptococcal infection
(Evans et al., 2015; Sharon et al., 2000). Reduced pH in the environment around
C. neoformans can also shield the pathogen from an immune attack, by either
reducing the migration of neutrophils or increasing their necrosis (Hu et al., 2008;
Wright et al., 2002). Lowering of pH also increases neutralization of free radicals
and specifically decreases the formation of superoxide (Wright et al., 2002), thus
limiting the ability of immune cells to use such chemicals to kill infecting
cryptococci.
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Four eukaryotic acetate production pathways in protists
Acetate metabolism has been studied for many years in bacteria, but has
received less attention in eukaryotic microbes even though acetate is a major
metabolic end product (Wright et al., 2002; Bubb et al., 1999). Four different
pathways for the production of acetate from acetyl-CoA have been identified in
eukaryotic microbes (Tielens et al., 2010). In the first pathway, ADP-forming acetylCoA synthetase is used in acetate production by amitochondriate protists (like
Entamoeba histolytica and Giardia sp.) and some species of Archaea (Reeves et
al., 1977; Mazet et al., 2013). Kinetoplastids and Trichomonas use the second
pathway, in which acetate:succinate-CoA transferase is employed as the primary
enzyme for acetate production (Mazet et al., 2013). The third pathway is the
phosphotransacetylase-acetate kinase (Pta-Ack) pathway, which is required for
interconversion of acetate and acetyl-CoA, and is found in green algae (such as
Chlamydomonas) and Phytophthora (Atteia et al., 2006; Ingram-Smith et al.,
2006). In Chlamydomonas, two parallel Pta-Ack pathways have been identified,
and upregulation of the mRNAs encoding the enzymes of these pathways (Ack1,
Ack2, Pat1, and Pat2, with "Pat" used instead of "Pta" in Chlamydomonas) under
dark, anaerobic conditions correlates with the production and excretion of acetate
under these conditions (Yang et al., 2014; Mus et al., 2007). Based on both
proteomics analyses (Atteia et al., 2006; Terashima et al., 2010) and localization
studies, the enzymes of one of the two Chlamydomonas pathways, Pat1 and Ack2,
are localized to the mitochondria, while those of the other pathway, Pat2 and Ack1,
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are localized to the chloroplasts (Yang et al., 2014). Null ack1 and pat2 mutants
are highly sensitive to anoxia (Yang et al., 2014), possibly indicating the
importance of the Pta-Ack pathway to the production of ATP under fermentation
conditions. In fact, the Ack-Pta pathway has been shown to be critical for
Chlamydomonas survival under anoxia, although some acetate was still produced
under anoxia in an ack1-ack2 double mutant, suggesting that other pathway(s)
may also be used to produce acetate and ATP in Chlamydomonas (Yang et al.,
2014). In the fourth pathway, acetyl-CoA hydrolase is employed in peroxisomal
acetate production, including in animals and in fungi like S. cerevisiae (Lee et al.,
1990; Tielens et al., 2010).
Acetate production pathways in fungi
In addition to the above peroxisomal acetate production pathway present in
yeast, three cytoplasmic or mitochondrial acetate production pathways have been
identified in fungi. The pathways employ 1) acetyl-CoA synthetase, 2) xylulose 5phosphate/fructose 6-phosphate phosphoketolase and acetate kinase, or 3)
pyruvate decarboxylase and acetaldehyde dehydrogenase.
Acetyl-CoA synthetase
Acetyl-CoA synthetase (Acs) has generally been considered to operate
solely in the direction of acetyl-CoA formation, so enzymatic studies have largely
ignored the enzymatic reaction in the acetate-forming direction. Acetylation of a
conserved lysine in Acs enzymes from bacteria to mammals blocks acetyl-CoA
formation during the first step of the reaction (Starai et al., 2002, Starai and
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Escalante-Semerena, 2004; Gardner et al., 2006), and this acetylation is
presumed to be a deliberate regulatory mechanism by which the enzymatic activity
is directed. In Aspergillus nidulans, acetylation of the enzyme influences the
directionality of the enzymatic reaction, such that unacetylated Acs works to
synthesize acetyl-CoA, whereas acetylation of the enzyme favors synthesis of
acetate (Takasaki et al., 2004). This acetylation of Acs occurs under anaerobic
growth conditions in which the fungus both ferments ammonia and substantially
increases acetate production (Takasaki et al., 2004). The site of acetylation has
not yet been not identified, so whether this acetylation is at the conserved lysine
residue discussed above or not is unknown.
Xylulose 5-phosphate/fructose 6-phosphate phosphoketolase-acetate
kinase pathway
However, similar to other fungal species, and some bacterial species, C.
neoformans may utilize alternate sources of acetate, apart from acetyl-CoA, and
therefore alternative pathways. In lactic acid bacteria and in species of the genus
Bifidobacterium, acetate kinase can make acetate from the acetyl phosphate
produced

by

xylulose-5-phosphate/fructose-6-phosphate

phosphoketolase

(Xfp1/Xfp2) out of either xylulose-5-phosphate or fructose-6-phosphate (Meile et
al., 2001), and homologous enzymes are present in C. neoformans (Ingram-Smith
et al., 2006). Although it is missing in Saccharomyces cerevisiae

and

Schizosaccharomyces pombe, an open reading frame (ORF) encoding Ack is
present in euascomycete and basidiomycete fungi, (Ingram-Smith et al., 2006;
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Papini et al., 2012). However, these fungi lack an ORF encoding Pta and instead
express one or two XFP genes (XPF1/2), encoding xylulose 5-phosphate
phosphoketolase

to convert xylulose 5-phosphate to acetyl phosphate and

glyceraldehyde 3-phosphate and/or fructose 6-phosphate phosphoketolase to
convert fructose 6-phosphate to acetyl phosphate and erythrose 4-phosphate
(Jeffries, 1983; Ingram-Smith et al., 2006). This pathway appears to function in a
manner similar to the modified pentose phosphate pathway (called the pentose
phosphoketolase pathway) used by heterofermentative bacteria, as well as lactic
acid bacteria and bifidobacteria, to produce ethanol, acetate, and lactate (Jeffries,
1983; Meile et al., 2001; Kleijn et al., 2005; Papini et al., 2012). Therefore, in
euascomycete and basidiomycete fungi, instead of partnering with Pta, Ack
processes the acetyl-phosphate product of Xfp1/2 to acetate (Meile et al., 2001;
Ingram-Smith et al., 2006), making ATP in the process. The existence of this
pathway is supported by the fact that all fungi with an open reading frame encoding
an acetate kinase also have at least one open reading frame encoding an Xfp
enzyme, and in some cases, such as in C. neoformans, there are two,
phylogenetically distinct Xfps, designated as Xfp1 and Xfp2 (Ingram-Smith et al.,
2006). In fact, in Aspergillus nidulans, which has a single gene encoding an Xfp,
the Xfp-Ack pathway is known to function in central carbon metabolism
(Panagiotou et al.,2008), although Xfp is designated Phk in A. nidulans. Overexpression of PHK increased growth on xylose, glycerol, and ethanol as carbon
sources (Panagiotou et al.,2008). Similarly, Aspergillus niger has genes encoding
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both Xfp1 and Xfp2, as well as encoding Ack (Poulsen et al., 2012). Likewise, the
fungus Metarhizium anisopliae, an insect pathogen, has two XFP genes, encoding
Xfp1 and Xfp2, and xfp2 mutants have reduced virulence (Duan et al., 2009).
The S. pombe Xfp has not been specifically characterized, but the
phosphoketolase has been recognized in proteomics analyses (Beltrao et al.,
2009; Gunaratne et al., 2013; Meyer et al., 2014). Analysis of the S. pombe
response to environmental stresses, such as oxidative and osmotic stresses, heat,
alkylation, and heavy metal toxicity, found that the expression of mRNA encoding
fructose-6-phosphate phosphoketolase (Xfp1) is increased as part of the core
stress response (Chen et al., 2003α), and the level of this mRNA doubles during
cell entry into the G0 quiescent state in response to limited nitrogen availability,
relative to during normal growth (Marguerat et al.,2012). This indicates that the S.
pombe XFP1 may serve an important role in the stress response; however, an S.
pombe XFP1 deletion mutant is able to grow at temperatures between 25-32°C in
YES medium enriched with glucose (Kim et al., 2010; Hayles et al., 2013), so Xfp1
may not be necessary for growth under ideal circumstances. When fused via its Cterminus to yellow fluorescent protein (YFP), S. pombe Xfp1 was found in both the
nucleus and cytosol (Matsuyama et al.,2006). Additionally, it is phosphorylated at
Ser454 (Beltrao et al., 2009), an amino acid that is conserved in other fungal Xfp1
proteins but that is altered to glycine in both bacterial and fungal Xfp2 proteins,
indicating that Xpf1 proteins may need to be phosphorylated to function, but Xfp2
proteins may not (Kerry Smith, Ph.D., personal communication).
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As mentioned above, there are two ORFs for Xfp enzymes, XFP1 and XFP2
in C. neoformans (Ingram-Smith et al., 2006). However, only Xfp2 has been
biochemically characterized, and it has been found that the enzyme prefers
xylulose-5-phosphate over fructose-6-phosphate as a substrate (Glenn et al.,
2014). C. neoformans Xfp2 utilizes divalent cation in its function, preferably Mg2+,
but potentially Ca2+, Co2+, Mn2+, and Ni2+ instead (Glenn et al., 2014). It functions
optimally in the 37-40°C temperature range (Glenn et al., 2014), indicating that it
might be used after infection of a mammalian host. It requires a pH range of 4.5 to
6.0 for optimal function, with a maximal activity at pH 5.5, and does not function
well at a pH of 7.0 or above (Glenn et al., 2014). C. neoformans Xfp2 is subject to
allosteric inhibition by ATP, phosphoenolpyruvate (PEP), and oxaloacetate (OAA),
as well as positive allosteric regulation by AMP, positive cooperativity when bound
at the active site by phosphoketose substrates, and negative cooperativity when
bound at the active site by inorganic phosphate (Glenn et al., 2014). C. neoformans
also expresses an Ack enzyme, for which the crystal structure has been
determined (Thaker et al., 2013).
Pyruvate decarboxylase – acetaldehyde dehydrogenase pathway
In S. cerevisiae, the primary biosynthetic pathway for cytosolic acetate
production during growth on glucose is the pyruvate dehydrogenase bypass, which
utilizes pyruvate decarboxylase (Saint-Prix et al., 2004; Remize et al., 2000; Pronk
et al., 1996). Through this pathway, pyruvate is decarboxylated to form
acetaldehyde, which is oxidized to acetate by acetaldehyde dehydrogenase in the
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presence of NADP+ (Saint-Prix et al., 2004; Remize et al., 2000; Pronk et al.,
1996). Acetate produced by this pathway is then used for producing acetyl-CoA
(Saint-Prix et al., 2004; Remize et al., 2000). Again, the homologues for these
enzymes are present in C. neoformans (Hu et al., 2008). However, there are a
number of C. neoformans aldehyde dehydrogenases, and which one participates
in acetate production is not known. Therefore, a better understand of the function
of each of the C. neoformans aldehyde dehydrogenases would advance the overall
understanding of C. neoformans metabolism. Analysis of the C. neoformans
pyruvate decarboxylase, including by comparison to the S. cerevisiae homologue,
and determination of whether the C. neoformans pyruvate decarboxylase and
acetaldehyde dehydrogenase function in a single pathway, would also inform
possible treatment of cryptococcosis.
Pyruvate decarboxylase (PDC)
Pyruvate decarboxylase, a tetrameric enzyme that requires Mg2+ and
thiamine pyrophosphate as cofactors, catalyzes the decarboxylation of pyruvate to
acetaldehyde and CO2 (Lohmann and Schuster, 1937; Schellenberger, 1967;
Pronk et al., 1996). In S. cerevisiae, Pdc is a key player in the acetate production
pathway (Saint-Prix et al., 2004; Remize et al., 2000) as the Xfp-Ack pathway is
absent and is likely to be important for acetate production in C. neoformans (Hu et
al., 2008). It might therefore be an important target for therapeutic reduction of
fungal virulence in the treatment of cryptococcal meningitis.
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Pyruvate decarboxylase is a branch point in the choice of energy derivation
pathway used in Saccharomyces (Agarwal et al., 2013; Møller et al., 2004), so an
overview of Pdc deficient mutants and of structural and regulatory PDC genes in
S. cerevisiae is called for and yields important information. Schmitt and
Zimmermann (1982) isolated several S. cerevisiae point mutants with reduced Pdc
activity and categorized them into two complementation groups, PDC1 and PDC2.
The pdc-1 mutants have growth defects and are semi-dominant, i.e. the diploid
organism produced by mating with the wild type strain has reduced pyruvate
decarboxylase activity, but not to the extent of the haploid mutant (Schmitt and
Zimmermann, 1982). One of these mutants, pdc1-8, completely fails to grow on
glucose-containing medium (Schmitt and Zimmermann, 1982), indicating that S.
cerevisiae requires pyruvate decarboxylase activity for normal growth. In contrast,
the pdc-2 mutants have reduced enzyme activity as a recessive phenotype; diploid
strains produced by mating with the wild type strain have normal growth (Schmitt
and Zimmermann, 1982). The pdc-1, pdc-2 double mutants do not show any
pyruvate decarboxylase activity and are unable to ferment glucose (Schmitt and
Zimmermann, 1982).
Since the work of Schmitt and Zimmermann (1982), it has been discovered
that there are actually six Pdc-encoding genes, PDC1 through PDC6, in
Saccharomyces species (Seeboth et al., 1990; Kaiser et al., 1999; Agarwal et al.,
2013). However, under normal growth conditions, the enzyme encoded by the
PDC1 gene is the main contributor of pyruvate decarboxylase activity in wild type
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strains of fermenting yeast cells (Schmitt and Zimmermann, 1982; Schmitt et al.,
1983; Kellermann et al., 1986; Hohmann and Cederberg, 1990; Hohmann 1991a;
Hohmann, 1993). Mutation of the PDC1 gene causes decreased growth because
of over accumulation of pyruvate, which can slow down the production of energy
by glucose breakdown in S. cerevisiae (Schmitt and Zimmermann, 1982). For
example, the pdc1-8 point mutant exhibits excessive secretion of pyruvate and a
redox imbalance in the cytosol (Van Maris et al., 2004) and, even though pyruvate
decarboxylase is normally connected with a fermentation pathway, this S.
cerevisiae mutant is unable to use glucose to grow under either respiratory or
fermentative conditions (Schmitt et al., 1983).
Surprisingly, unlike with the abovementioned point mutants, a complete
deletion mutant of the PDC1 gene (pdc10) generated by Seeboth et al. (1990) has
no effect on the growth of S. cerevisiae on glucose-containing medium, since 6070% of pyruvate decarboxylase activity is still present. This remaining activity is
the result of upregulation of expression of the PDC5 gene, which is 88% identical
to PDC1, in response to the complete absence of PDC1 in these S. cerevisiae
mutants (Seeboth et al., 1990; Agarwal et al., 2013; De Assis et al., 2013). It
appears that Pdc5 is expressed at low levels when functional Pdc1 is present in
wild type cells, and is expressed at a much higher level in null or deletion mutants
than in point mutants of the PDC1 gene, suggesting that expression of PDC genes
is autoregulated in S. cerevisiae based on the level of pyruvate decarboxylase
activity already present in the cell (De Assis et al., 2013; Muller et al., 1999;
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Eberhardt et al., 1999; Hohmann and Cederberg, 1990; Schaaff et al., 1989; Kaiser
et al., 1999). However, even if Pdc5 and/or the other pyruvate decarboxylases are
expressed in pdc1 null mutants, the rate of the reaction they catalyze appears to
be one-fourth that of Pdc1, therefore allowing the level of pyruvate in the pdc1 null
mutant to accumulate to over twice that of the wild type strain; yet, the rate of
reaction appears to be high enough to produce enough acetaldehyde (and ethanol)
to match the relatively low levels present in the wild type strain (Remize et al.,
2000). Because of this (or due to the production of acetate via another pathway)
the acetate concentration in the pdc1 null mutant is about the same as that of the
wild type strain (Remize et al., 2000).
Insertional mutagenesis of both PDC1 and PDC5 genes results in doublemutant S. cerevisiae strains with essentially no detectable pyruvate decarboxylase
activity, and a triple mutant that is also knocked out for PDC6 cannot grow for very
long using glucose as the energy source (Flikweert et al., 1996). The S. cerevisiae
PDC6 gene is weakly expressed and the function of the corresponding protein is
not clear (Hohmann, 1991b; Kaiser et al., 1999), but sulfur limiting conditions and
high sugar stress have been shown to induce ScPdc6 expression (Erasmus et al.,
2003; Fauchon et al.,2002). In summary, under normal growth conditions, Pdc1p
appears to be the major pyruvate decarboxylase in S. cerevisiae and, when it
cannot be expressed, the yeast prefers to use Pdc5p instead of Pdc6p unless the
cells are under certain types of stress (De Assis et al., 2013; Muller et al., 1999;
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Eberhardt et al., 1999; Hohmann and Cederberg, 1990; Schaaff et al., 1989; Kaiser
et al., 1999).
Both PDC1 and PDC5 mRNA levels and the activity levels of the
corresponding enzymes are dependent on the carbon source; low levels of PDC1
and PDC5 mRNA are observed when S. cerevisiae is provided with ethanol as the
carbon source, while the addition of glucose leads to rapid increase in the level of
PDC1 mRNA (Hohmann and Cederberg, 1990; Schmitt et al., 1983). This is
because of ethanol-repressed elements in the promoters of the PDC1 and PDC5
genes that suppress the expression of the genes in the presence of ethanol
(Liesen et al., 1996). Thus, while Pdc1 activity is regulated by glucose
concentrations (Schmitt and Zimmermann, 1982), the transcription of PDC1 is
regulated based on the presence or absence of ethanol (Liesen et al., 1996).
The regulation of transcription of PDC1 and PDC5 and the level of Pdc1p
and/or Pdc5p enzyme activity also depends on the product of the PDC2 gene,
which has an important but indirect role in pyruvate metabolism as a regulatory
protein in S. cerevisiae (Hohmann, 1993; Kaiser et al., 1999). Transcription of the
PDC5 gene, and high-level transcription of the PDC1 gene, requires the presence
of Pdc2p, a transcriptional activator that is strongly expressed in fermenting yeast,
and Pdc2p may be involved in the PDC1/PDC5 autoregulation in S. cerevisiae
(Hohmann, 1993; Kaiser et al., 1999). A PDC2 deletion mutant and, to a lesser
extent, a point mutant of the gene, both demonstrate significantly reduced pyruvate
decarboxylase activity, and exhibit slow, oxygen-dependent growth on glucose
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and accumulation of pyruvate, as expected of S. cerevisiae mutants that are
unable to use fermentation and the pyruvate decarboxylase-dependent pyruvate
dehydrogenase by-pass pathway (Hohmann, 1993). In short, although PDC2 does
not encode an enzyme, Pdc2p is still important for pyruvate decarboxylase enzyme
activity, and mutants with reduced Pdc2p levels are unable to grow on glucose
because of their inability to properly express the PDC1 and PDC5 genes
(Velmurugan et al., 1997).
PDC3 was identified by Wright et al., (1989) as the affected gene in the
pdc1-30 mutant that complemented both, and was therefore not allelic to either,
the pdc1 and pdc2 mutant groups identified by Schmitt and Zimmermann (1982).
Like PDC2, PDC3 also encodes a regulatory subunit, based on the finding that,
unlike PDC1 mRNA, the level of PDC3 mRNA does not change between glycolytic
and gluconeogenic growth, indicating that PDC3 is not a structural gene (Wright et
al., 1989). Similarly, PDC4 also appears to encode a regulatory protein (Seeboth
et al., 1990). Thus, while S. cerevisiae has six PDC genes, Pdc2p, Pdc3p, and
Pdc4p regulate the expression and/or activity of Pdc1p, Pdc5p, and Pdc6p, the
three pyruvate decarboxylase enzymes.
Unlike S. cerevisiae, there is only one known PDC gene in C. neoformans,
which was found to be expressed abundantly at both 25°C and 37°C, i.e. room and
mammalian body temperatures (Steen et al., 2002). This implies that there may be
a role for this enzyme in the thermotolerance. A transcriptomic analysis of C.
neoformans isolated from the lungs of infected mice showed an elevated
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expression of the PDC transcript, along with the transcripts of other genes
putatively involved in acetate formation (Hu et al., 2008). Pdc was identified among
the proteins present in the extracellular vesicles produced by C. neoformans
(Rodrigues et al., 2008b).
Aldehyde dehydrogenases (ALDs)
Organic compounds like aldehydes are present ubiquitously in nature; even
low level accumulation of many of these aldehydes causes toxicity and thus, it is
important to regulate their levels in the cells (Perozich et al., 1999). The aldehyde
dehydrogenase (Aldh) superfamily constitutes a class of enzymes that catalyzes
the oxidation of aldehydes to their corresponding carboxylic acids, which are less
toxic to the cells (Perozich et al., 1999). This superfamily is highly conserved
throughout Eubacteria, Archaea, and Eukarya, which suggests an important role
of this enzyme throughout evolutionary history (Perozich et al., 1999). In
eukaryotes, there are close to twenty families of aldehyde dehydrogenase (Aldh or
Ald) enzymes (Sophos and Vasiliou, 2003). In recent years, a great deal more
information regarding gene and protein sequences of a large number ALDH genes
(also referred to as ALD genes) has been made available than has been previously
analyzed. For example, in 2002 alone, 555 ALD gene sequences were reported,
including 32 sequences from Archaea, 351 from Eubacteria, and 172 from Eukarya
(Sophos and Vasiliou, 2003).
The large variety of Aldhs take part in a wide range of different physiological
processes and exhibit specificity for various substrates. Some Aldhs act on only a
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few specific substrates, while others have a broader specificity, yet most Aldhs
require the presence of NAD+ or NADP+ as a cofactor in order to function (Lindahl,
1992; Yoshida et al., 1998). Although most Aldh family members protect the cell
by keeping in check the levels of harmful aldehydes, they also demonstrate
enzymatic functionality beyond detoxification. For example, Aldhs are important for
the synthesis of important biomolecules like retinoic acid, betaine, and folate
(Marchitti et al., 2008; Vasiliou et al., 2000; Sobreira et al., 2011). Aldhs also
modulate cell proliferation, differentiation, and cell survival, mainly by participating
in retinoic acid synthesis (Marchitti et al., 2008). Some of the members of the
superfamily also exhibit roles independent of their enzymatic activity, including
acting as crystallins and absorbing ultraviolet irradiation in the cornea and binding
to hormones and other small molecules including androgens, cholesterol, thyroid
hormone, and acetaminophen (Pereira et al., 1991; Marchitti et al., 2008; Estey et
al., 2007). ALDH activity is important for cellular function, and enzyme deficiency
in humans leads to diseases and medical conditions such as cataracts (ALDH1A1,
ALDH3A1, ALDH18A1), seizures (ALDH7A1), hyperprolinaemia (ALDH4A1),
heart disease (ALDH2), alcohol sensitivity (ALDH1A1, ALDH1B1, ALDH2) and
some cancers (ALDH2) (Marchitti et al., 2008).
Aldehyde dehydrogenase in fungi
Fungi are continually exposed to different stresses during their growth; in
particular, the metabolic products ethanol and acetaldehyde can accumulate to
toxic levels (Ingram and Buttke, 1985; Jones, 1990). In order to convert these and
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other aldehyde toxic by-products to less harmful chemicals, yeast employ
dedicated enzymatic pathways that involve one or more of the aldehyde
dehydrogenases (Marchitti et al., 2008; Vasiliou and Nebert, 2005; Black et al.,
2009; Sládek, 2003). For example, via pathways utilizing acetaldehyde
dehydrogenase, acetaldehyde derived from pyruvate, ethanol, or other sources is
oxidized to form acetate (Pritchard and Kell, 2002; Saint-Prix et al., 2004). Just like
C. neoformans, S. cerevisiae also has multiple aldehyde dehydrogenases, but, in
the latter species, the role of each of the enzymes in a number of both distinct and
overlapping metabolic pathways on a number of aldehyde substrates, including
acetaldehyde, has been thoroughly investigated (Aranda and del Olmo, 2003;
Saint-Prix, et al., 2004). In S. cerevisiae, Ald6p, Ald2p, and Ald3p are cytosolic
aldehyde dehydrogenases, while Ald4p and Ald5p are mitochondrial (Aranda and
del Olmo, 2003; Meaden et al., 1997; Saint-Prix et al., 2004). The cytosolic
enzymes are activated by Mg2+, use NADP+ as a coenzyme, and are expressed
independent of the level of glucose (Aranda and del Olmo, 2003; Meaden et al.,
1997). In contrast, the mitochondrial enzymes are activated by K+ and thiols and
use NAD+ or NADP+ as coenzymes, and their expression is suppressed in the
presence of glucose (Aranda and del Olmo, 2003). Functionally, the cytosolic
enzymes form acetate (from acetaldehyde) as a final product of anaerobic glucose
metabolism, whereas the mitochondrial enzymes are employed when S.
cerevisiae needs to utilize ethanol as the carbon source (Aranda and del Olmo,
2003). Nevertheless, the mitochondrial enzymes can play an important role in
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acetate production in S. cerevisiae; studies on aldehyde dehydrogenase mutants
suggest that cytosolic and mitochondrial enzymes can compensate for each other
(Aranda and del Olmo, 2003).
Similarly, the S. cerevisiae enzyme encoded by ALD6, a homologue of at
least one Ald in C. neoformans, plays an important role in the formation of acetate,
as demonstrated by Meaden et al. (1997), and Ald6p may function as the major
cytosolic acetaldehyde dehydrogenase. This is supported by Remize et al. (2000),
who found that S. cerevisiae cells lacking Ald6p display abnormal growth and
reduced acetate production when undergoing fermentation. In agreement with
these other two groups, Saint-Prix et al. (2004) analyzed the growth and acetate
production of several single-deletion and multiple-deletion ald mutants in two S.
cerevisiae strain backgrounds, and found that both Ald6p and Ald5p play an
important role in acetate production during fermentation. Deletion of either ALD5
or ALD6 reduces acetate production significantly during anaerobic growth (SaintPrix et al., 2004). Although this result was in contrast to a study by Wang et al.,
(1998), Saint-Prix et al., (2004) concluded that Ald5p is required for full acetate
production, based on a decrease in acetate production by 22-26% in yeast deleted
for ALD5, and based on the observation that the levels of ALD5 mRNA are
upregulated in the exponential growth phase and during fermentation (Saint-Prix
et al., 2004).
Another S. cerevisiae aldehyde dehydrogenase, Ald4p, localized in the
mitochondria, is not considered to be primarily involved in acetate formation
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(Aranda and del Olmo, 2003; Meaden et al., 1997; Saint-Prix et al., 2004; Remize
et al., 2000). ALD4 expression starts only in the late exponential phase of
fermentation, and deletion of ALD4 does not affect the acetate levels in at least
two S. cerevisiae strain backgrounds (Saint-Prix et al., 2004). However, it is
possible that the activity of Ald4p is dependent on the level of glucose present and
on genetic background (Saint-Prix et al., 2004). Furthermore, it appears that Ald4p
plays a minor role in acetaldehyde metabolism and is partly able to compensate
for Ald6p, since the ald6, ald4 double mutant has a reduced growth rate, and
exhibits reduced acetate production, relative to either single mutant (Saint-Prix et
al., 2004; Remize et al., 2000). Furthermore, the ald6 mutant yeast appears to use
the partial redundancy between Ald4p and Ald6p to its advantage; Ald4p levels,
and even ALD4 mRNA levels, are increased in this mutant, and ALD4 expression
begins earlier than in wild type yeast, to allow the mutant to survive by
compensating for the loss of Ald6p with increased levels and possible
accumulation of Ald4p (Saint-Prix et al., 2004).
Similar to the limited acetaldehyde dehydrogenase function of the
mitochondrial Ald4p, and unlike the confirmed role of cytosolic Ald6p, whether the
other two cytosolic aldehyde dehydrogenases, Ald2p and Ald3p, are actually
acetaldehyde dehydrogenases is uncertain, and the evidence indicates that they
are not involved in acetate production in S. cerevisiae (Navarro-Aviño et al., 1999;
Saint-Prix et al., 2004). Double mutants of the two genes have lower growth rates
on ethanol (Navarro-Aviño et al., 1999), but Ald2p and Ald3p may function primarily
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in redox metabolism under stress, particularly under osmotic stress but also in
glucose depletion, heat shock, and oxidative stress (Navarro-Aviño et al., 1999;
Blomberg and Adler, 1989). In fact, Saint-Prix et al. (2004) suggests that Ald2p
and Ald3p are not involved in the acetate production pathway at all, since the ald2,
ald3, ald4, ald6 quadruple mutant phenotype is no different than that of the ald4,
ald6 double mutant, and a mutant that is null for ALD2, ALD3, ALD4, ALD5, and
ALD6 has a similar phenotype to that of the ald4, ald5, ald6 triple mutant.
Given the number and possible functional overlap of aldehyde
dehydrogenases in S. cerevisiae, the regulation of expression of each of the genes
is also important. Although which of the specific S. cerevisiae ALD genes is
expressed under various growth conditions, and which of the corresponding
enzymes are active, can depend on both environmental conditions and genetic
background, one environmental condition of interest is the ethanol and
acetaldehyde stress faced by S. cerevisiae specifically during the fermentation and
biological ageing of wine (Aranda and del Olmo, 2003). In order to determine the
effect of these stress conditions on aldehyde dehydrogenase activity, Aranda and
del Olmo (2003) studied the differential ALD gene expression and the
corresponding enzymatic activities in fermentative and flor yeast strains, the latter
of which are industrial strains responsible for the biological aging of sherry wines,
when these two types of yeast were grown in media with and without acetaldehyde.
Previously, Aranda et al. (2002) had demonstrated that aldehyde stress can
modulate transcription of heat shock protein genes, which may, in turn, regulate
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the stability of other proteins. Aranda and del Olmo (2003) determined that
acetaldehyde stress can also affect the expression of aldehyde dehydrogenase
genes directly, although the effect of aldehyde stress on the transcription of ALD
genes is also determined by the genetic background of the yeast strain, the carbon
source available for yeast growth, and the gene itself. In particular, when
acetaldehyde is added to glucose-rich media, yeast generally decrease expression
of ALD6. However, if yeast are grown in ethanol-rich media, acetaldehyde stress
increases ALD6 mRNA levels well above that of the normally low ALD6 expression
in ethanol without acetaldehyde (Aranda and del Olmo, 2003). Conversely, in flor
yeast grown in glucose media, supplementation with acetaldehyde increases
ALD2 and ALD3 mRNA levels from the normally low level of expression in glucose
media only, while the mRNA levels decrease in ethanol upon addition of
acetaldehyde (Aranda and del Olmo, 2003). Likewise, ALD2 and ALD3 expression
is increased with growth in ethanol versus with growth in glucose, while ALD6
expression is the opposite (Aranda and del Olmo, 2003). Thus, the expression
patterns of ALD2 and ALD3 are essentially inverted to those of ALD6, even though
all three genes encode cytosolic aldehyde dehydrogenases, possibly indicative of
the relative roles of the corresponding enzymes in the acetate production (or
acetaldehyde degradation) pathway. Similar functional compensation between
aldehyde dehydrogenases, such as between Ald6p, Ald5p, and, under certain
conditions, Ald4p, in S. cerevisiae, as well as expression regulation of the
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corresponding genes, may also apply to the C. neoformans aldehyde
dehydrogenases.
Aldehyde dehydrogenase pathways are of significance in C. neoformans
since acetate production is tightly correlated with the virulence of this pathogen
(Hu et al., 2008). ALD transcripts were found to be upregulated in the fungus during
the onset of pulmonary infection in mice and cryptococcal meningitis in rabbits (Hu
et al., 2008; Steen et al., 2003). ALD gene expression, in particular the expression
of ALD5, was also increased in C. neoformans (var grubii) following engulfment by
macrophages (Derengowski et al., 2013), even though expression of Pdc, which
produces acetaldehyde, was decreased (Derengowski et al., 2013). Thus,
elucidation of the function of the various aldehyde dehydrogenases, and of which
ones, if any, work with C. neoformans pyruvate dehydrogenase to produce
acetate, may reveal whether or not these enzymes can be targeted in order to treat
potentially lethal cryptococcal meningitis.
Summary and Study Objective
Cryptococcus neoformans, the most frequent cause of fungal meningitis, is
a huge threat to immunocompromised patients (Loftus et al., 2005; Sorrell, 2001;
Litvintseva et al., 2011; Chayakulkeeree and Perfect, 2008; Park et al., 2009;
Rajasingham et al., 2017; Limper et al., 2017; Brown et al., 2012). The pathogen
enters the respiratory system upon inhalation and the spores can pass through the
lungs to the alveoli to establish a successful pulmonary infection (Taylor-Smith,
2017; Sabiiti and May, 2012). From there it can disseminate to other organs like
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the brain, and can cause meningoencephalitis or other lethal conditions, especially
if combined with immunosuppression such as occurs in HIV-infected patients (Liu
et al., 2009; Jarvis and Harrison, 2007; Hernandez, 1989; Sabesin et al., 1963;
Goldman et al., 1994; Chrétien et al., 2002; Sabiiti and May, 2012; Park et al.,
2009; Rajasingham et al., 2017; Limper et al., 2017). The death toll is larger in
parts of the world where efficient medical treatment is not available or where the
HIV pandemic rate is higher (Mitchell and Perfect, 1995; Park et al., 2009;
Rajasingham al., 2017; Brown et al., 2012; McQuiston and Williamson, 2012;
Kaplan et al., 2000; Mirza et al., 2003; Warnock, 2006; Pyrgos et al., 2013).
Therefore, C. neoformans infection is a serious issue regarding the health of
immunocompromised individuals in a large part of the world.
Once within the host, C. neoformans can counter attack by multiple
components the cell mediated immune system; it can even survive within engulfing
macrophages after being phagocytosed and manipulate the macrophages or the
other aspects of cellular immunity to spread throughout the host (Sabiiti and May,
2012; Noverr et al., 2003; Shoham and Levitz, 2005; Voelz and May, 2010;
Okagaki et al., 2010; Zaragoza et al., 2010; Okagaki and Nielsen, 2012; May et
al., 2016; Levitz and Tabuni, 1991; Xie et al., 2012; Geunes-Boyer et al., 2012;
Schelenz et al., 1995; Van de Wetering et al., 2004; Feldmesser et al., 2001; Nicola
et al., 2011; Alvarez and Casadevall, 2006; Charlier et al., 2005, 2009). Such
robust survival is mostly attributed to various virulence factors, including the ability
to grow at human physiological temperature, the production of capsule and
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melanin, resistance to hypoxia and to oxidative and nitrosative stress, and the use
of many degradative enzymes (Coelho et al., 2014; Casadevall et al., 2000;
Kronstad et al., 2011; Ma and May, 2009; Cox et al., 2001, 2003; Chrisman et al.,
2011; Ganendren et al., 2006; Sabiiti and May, 2012; Noverr et al., 2002, 2003;
Ingavale et al., 2008; Missall et al., 2004a, 2004b, 2006; Giles et al., 2005b, 2006;
Santangelo et al., 2004; Maruvada et al., 2012; Feldmesser et al., 2000; Chen et
al., 1997a,b; Chayakulkeeree et al., 2008; Goldman et al., 1994). The pathogen
also produces a variety of metabolites that confer survival advantages, as well as
create a suitable microenvironment for the fungi, such as mannitol, trehalose,
ethanol, and acetate (Bubb et al., 1999; Wright et al., 2002; Chen and Haddad,
2004; Gancedo and Flores, 2004; Perfect, 2005; Wong et al., 1990; Chaturvedi et
al., 1996a; Guimarães et al., 2010; Steen et al., 2003; Himmelreich et al., 2001,
2003; Hu et al., 2008).
As a metabolite, acetate could play a crucial role in the survival of C.
neoformans under anaerobic conditions, including the potential use as a source of
carbon and/or energy in a glucose deficient environment (Price et al., 2011; Hu et
al., 2008; Kronstad et al., 2012). Acetate can also be used by Cryptococcus to
change the local environmental pH to increase the efficiency of fungal enzymes
that act as virulence factors while decreasing the effectiveness of the immune
response to infection, as well as to neutralize reactive oxygen and nitrogen species
used by the immune system to destroy the pathogen (Hu et al., 2008; Wright et al.,
2002). This might explain the findings that acetate is one of the major metabolites

65

secreted by C. neoformans, both when this pathogen is grown as an in vitro culture
(Bubb et al., 1999) and when the cryptococci are localized in pulmonary
cryptococcomas following infection (Himmelreich et al., 2001). Two possible
pathways have been identified for the production of acetate in Cryptococcus: the
Xfp1/2 – Ack pathway that produces acetate from D-xylulose 5-phosphate or Dfructose 6-phosphate and the Pdc-Ald pathway to produce acetate from pyruvate.
Surprisingly, relatively little attention has been given to uncovering the precise
metabolic pathway for the production of acetate and to revealing its role in the
virulence of this pathogen. Given that it might be possible to treat cryptococcal
meningitis or general cryptococcal infection by inhibiting the corresponding
enzymes in order to save lives, it would be especially unfortunate this avenue
remains unexplored. Therefore, even gaining a better understanding of the
enzymes in one or more of the putative acetate production pathways could be
highly useful.
In S. cerevisiae which lacks the Xfp-Ack pathway (Ingram-Smith et al.,
2006), the pathway for acetate synthesis is the pyruvate dehydrogenase bypass
(Saint-Prix et al., 2004; Remize et al., 2000), which appears to depend on either
cytosolic or mitochondrial acetaldehyde dehydrogenases. The enzyme encoded
by ALD6 is the primary cytosolic aldehyde dehydrogenase in S. cerevisiae, and
mutants of this gene produce reduced levels of acetate and exhibit growth defects
(Remize et al., 2000; Saint-Prix et al., 2004). The mitochondrial aldehyde
dehydrogenase encoded by ALD5 is upregulated in S. cerevisiae during
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fermentation, and ald5 mutants produce reduced acetate levels (Saint-Prix et al.,
2004). Similarly, C. neoformans PDC and ALD genes, especially ALD5, are
upregulated in the fungal cells recovered from the lungs of infected mice (Hu et al.,
2008). Together, these findings support a pathway involving the use of Ald and
Pdc enzymes in the production of acetate by C. neoformans that is highly
advantageous, if not absolutely necessary, for the growth of the pathogenic fungus
inside a human host. The possible contribution of Ald and Pdc enzymes in the
survival, growth, and virulence of C. neoformans under physiological conditions
was investigated, and the functional family of C. neoformans aldehyde
dehydrogenases was studied, as described herein.
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Figure 1.1: Global burden of HIV-related cryptococcal meningitis in 2017. The
estimated yearly cases of meningitis caused by cryptococcal infection in HIV
patients in various geographical regions across the world are shown. Sub-Saharan
Africa has the highest number of occurrences per year. Data adapted from
Rajasingham et al., Lancet Infectious Diseases 2017.
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Figure 1.2: Cryptococcal infection is the fourth leading cause of death,
excluding HIV, in Sub-Saharan Africa. Deaths due to cryptococcal infection are
more prevalent than those due to tuberculosis, but less prevalent than those due
to malaria. Image adapted from Park et al., AIDS 2009.
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Figure 1.3: Cryptococcus neoformans pathogenesis cycle. After spores or
dry cryptococcal cells are inhaled, they reach the alveoli in the lungs via
mucocilliary

movement.

Activated

alveolar

macrophages

attempt

to

phagocytose and kill the fungal cells, but C. neoformans can survive due to
antiphagocytic functions and other protective properties of the fungal capsule
(Sabiiti and May, 2012; ). a) Upon immuno-suppression of the host, latent
cryptococci in granulomas or inside parasitized macrophages are reactivated
and can enter the systemic circulation by lytically or non-lytically exiting the
macrophages, resulting in fungemia, or reside, replicate, and ride inside the
macrophages (Sabiiti and May, 2012). Alternatively, C. neoformans can form
large "titan cells" that resist phagocytosis and thereby enter the systemic
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circulation directly (Sabiiti and May, 2012). b) Once it moves through the
circulation to the capillaries of the blood brain barrier (BBB), the fungal cell gets
through the BBB via any one of three mechanisms: i) Paracytosis: entry
between endothelial cells, enhanced by damage to tight junctions (facilitated by
activation of host plasminogen by fungal mannoproteins); ii) Transcytosis:
adherence to brain microvascular endothelial cells, followed by endocytosis and
then exocytosis on the other side of the cell; or iii) Trojan horse: riding in
parasitized immune cells such as macrophages (Sabiiti and May, 2012) that can
force their way through tight junctions. Image adapted from May et al., 2016,
with permission.
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CHAPTER TWO
THE ROLE OF C. NEOFORMANS ALDEHYDE DEHYDROGENASE FAMILY
MEMBERS IN STRESS AND VIRULENCE
Mufida Ammar, Erin Mihealsick, Nitya Muppala, and Kerry Smith
Department of Genetics and Biochemistry, Clemson University, Clemson, South
Carolina, USA
Abstract
Cryptococcus neoformans is a fungal pathogen that quickly senses changes in the
host environment and adapts to it by producing a range of metabolites important
for optimizing the pH of the host environment, evading the host immune system,
use as carbon sources, or other purposes. One of the major metabolites found in
biopsies of infected mouse brain and lung tissues, and secreted in vitro, is acetate.
Herein, aldehyde dehydrogenases, previously identified in S. cerevisiae as
important in acetate production, are characterized in terms of their role in the
pathogenesis and stress survival response of C. neoformans. Comparison of the
nine different aldehyde dehydrogenases (Alds) of C. neoformans with putative
homologues suggested that they may have diverse functions. Subsequent
analysis of knockouts of eight of the nine ALD, revealed interesting deficiencyassociated phenotypes. All of the mutants displayed a statistically significant but
incomplete reduction in acetate production, but only three mutants, CNAG_06628
(ald5Δ), CNAG_05113 (designated ald13Δ), and CNAG_03269 (designated
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ald69Δ), displayed growth defects when cultured on media containing different
carbon sources. The ald5Δ mutant failed to grow on ethanol-containing media
suggesting that it might encode an acetaldehyde dehydrogenase. The ald13Δ
mutant produced small colonies on acetate and ethanol but grew normally on
glucose. Conversely, the ald69Δ mutant failed to grow on glucose but grew
normally on acetate or ethanol, likely reflecting distinct roles for the corresponding
enzymes in the use of different carbon sources. With regard to virulence factors,
none of the mutants produced a capsule of normal thickness. Only the ald69Δ
mutant showed a reduced level of melanin, whereas the ald5Δ mutant exhibited
increased melanization. The deficiency of certain aldehyde dehydrogenases
negatively impacted various stress responses, with the exception of a normal
response to osmotic stress. The ald29Δ mutant had reduced growth under
hypoxia-mimicking conditions, but, notably, was rescued with acetate. The ald69Δ
mutant could not maintain cell wall integrity nor survive under oxidative stress, and
demonstrated partial inhibition of the adenine biosynthesis pathway under
nitrosative stress. The observed abnormal phenotypes apparently affected in vitro
virulence, since the ald5Δ, ald29Δ, and ald69Δ mutants had a statistically
significant reduction, as did the ald78Δ and ald13Δ mutants, but to a lesser extent,
in survival after engulfment by murine macrophages. Similarly, Galleria mellonela
larvae, an in vivo infection model, injected with ald5Δ or ald78Δ mutant C.
neoformans (but not those injected with the ald13Δ strain) survived longer than
those injected with the wild type strain, indicating that the ald5Δ and ald78Δ
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mutants were significantly less virulent. Overall, these genetic and biochemical
assays establish the roles of different Ald enzymes in modulating the stress
response and virulence of C. neoformans.
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Introduction
Cryptococcus neoformans is an invasive opportunistic pathogen of the
central nervous system (CNS) and the most frequent cause of fungal meningitis in
humans (Lin and Heitman, 2006), leading to significant annual global mortality,
especially in sub-Saharan Africa (Park et al., 2009, Pappas, 2001; Lui et al., 2006;
Franzot et al., 1999; Dromer et al., 1996; Tortorano et al., 1997; Powderly, 1993;
Jarvis and Harrison, 2007; Kisenge et al., 2007). This fungus mainly affects
immunosuppressed individuals (Hull and Heitman, 2002), especially HIV/AIDS
patients and solid-organ transplant recipients, with a reported mortality of up to
82% (Abhilash et al., 2015; Park et al., 2009). The source of C. neoformans
infections are desiccated yeast cells or spores, which are found in the environment
after deposition or aerosolization of bird guano as well as in decomposing organic
material and in the soil (Steenbergen and Casadevall, 2003; Velagapudi et al.,
2009). These desiccated cells or fungal spores are inhaled by mammalian hosts
and pass into the lungs, leading to an initial pulmonary infection which often
disseminates to the brain, causing a potentially lethal meningoencephalitis (Sabiiti
and May, 2012; Velagapudi et al., 2009). There are a number of virulence factors
that allow the pathogen to survive and spread in the host body, including
production of a polysaccharide capsule and melanin (or a melanin-like pigment)
and the ability to grow at the 37°C host body temperature (Coelho et al., 2014;
Casadevall et al., 2000; Kronstad et al., 2011; Ma and May, 2009). One of the
other mechanisms C. neoformans utilizes to propagate and disseminate inside the
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host body, in which the availability of glucose can vary, is to adapt to utilization of
different carbon sources to obtain energy (Price et al., 2011). C. neoformans can
utilize glucose or ethanol inside the host to produce energy, and it can also use
acetate for a similar purpose (Hu et al., 2008; Price et al., 2011). C. neoformans
also adapts metabolically to the environment inside the mammalian host to infect,
survive, spread, and cause disease. In particular, the pathogen produces a range
of metabolites including acetate (Figure 2.1) that confer survival advantages by
creating an optimal microenvironment for itself (Bubb et al., 1999; Wright et al.,
2002; Hu et al., 2008; Price et al., 2011; Himmelreich et al., 2001; Kronstad et al.,
2012).
Acetate is one of the major metabolites secreted by cryptococci cultured in
vitro (Bubb et al., 1999). Acetate has also been found to be a major metabolite
associated with infection, based on analyses of brain and lung tissue biopsies from
infected rats (Wright et al., 2002; Himmelreich et al., 2003). Furthermore,
substantial

amounts

of

acetate

have

been

detected

from

pulmonary

cryptococcomas, using nuclear magnetic resonance (NMR) (Himmelreich et al.,
2001). Although the role of acetate in virulence has not yet been fully elucidated,
there is much evidence that it augments fungal survival, perhaps via
immunomodulatory mechanisms (Rakesh et al., 2008; Vecchiarelli et al., 2011; Hu
et al., 2008; Ellerbroek et al., 2004a, b, c; Li et al., 2018; Siegemund and Alber,
2008; Villena et al., 2008; Yauch et al., 2006).

113

Two putative pathways for the production of acetate in C. neoformans have
been identified: the xylulose 5-phosphate/fructose 6-phosphate phosphoketolase
(Xfp) – acetate kinase (Ack) pathway and the pyruvate decarboxylase (Pdc) –
acetaldehyde dehydrogenase (Ald) pathway. In fungi that lack the Xfp – Ack
pathway such as Saccharomyces cerevisiae, the primary pathway makes use of
pyruvate decarboxylase (Pdc) and an acetaldehyde dehydrogenase function of
one or more of the aldehyde dehydrogenase (Ald) enzymes (Saint-Prix et al., 2004;
Remize et al., 2000; Pronk et al., 1996).
We have identified nine C. neoformans aldehyde dehydrogenases, but
which, if any, participate in acetate production is not known. The expression of the
transcript encoding one of these aldehyde dehydrogenases (ALD5) is increased in
C. neoformans obtained from the lungs of infected mice, as is the expression of
mRNAs encoding other enzymes (i.e. pyruvate decarboxlyase and acetyl-CoA
synthetase) believed to function in acetate metabolism in this pathogen (Hu et al.,
2008). An mRNA encoding a C. neoformans aldehyde dehydrogenase was also
found to be upregulated in a rabbit infection model (Steen et al., 2003). Similarly,
various other studies using nuclear magnetic resonance (NMR) analysis have
reported high levels of acetate in the media from C. neoformans culture and from
infected-tissues (Bubb et al., 1999; Himmelreich et al., 2003). Thus, it is likely that
at least one C. neoformans Ald is an acetaldehyde dehydrogenase that may plays
a role in cryptococcal virulence. A thorough characterization of these nine putative
aldehyde dehydrogenases has not yet been reported, and the exact role of each
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aldehyde dehydrogenase in cryptococcal virulence needs to be fully elucidated. A
better understanding of the function of each of the C. neoformans aldehyde
dehydrogenases would advance the overall understanding of C. neoformans
metabolism.
For eight out of the nine Ald genes, knockout mutants were available from
the Madhani laboratory (UCSF) through the Fungal Genetics Stock Center (Chun
and Madhani, 2010). In order to determine which, if any, of these genes are
important in C. neoformans pathogenesis, the mutants were assayed for
phenotypes associated with virulence, including growth on different carbon/energy
sources, survival and growth under various stress conditions (i.e. osmotic stress,
oxidative and nitrosative stresses, and hypoxia), and maintenance of cell wall
integrity. The effect of the loss of each Ald on the avoidance of, or survival after,
phagocytosis by immune cells was also assayed, as was in vivo virulence using
an invertebrate infection model. The effect of deficiency of each of the aldehyde
dehydrogenases on these phenotypes was correlated with the effect on acetate
production by the corresponding mutant, which was also assayed. Overall, this
study demonstrated that deficiency of at least some of the aldehyde
dehydrogenases negatively impacts the production of acetate and the survival and
growth of C. neoformans in vitro and in vivo.
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Materials and methods
Fungal Strains:
A wild type strain in the KN99a background was used as the control in all
experiments unless specified otherwise. All eight ald mutant strains of
Cryptococcus neoformans var grubii (in a KN99a strain background) were
obtained from the Madhani lab University of California San Francisco (UCSF) gene
deletion collection (via the Fungal Genetics Stock Center). These single knockout
mutants were maintained under selection for nourseothricin (NTC) resistance,
since a nourseothricin acetyltransferase cassette (NAT, which encodes an enzyme
that neutralizes NTC) was used to replace each gene by insertional mutagenesis
mediated by homologous recombination (Chun and Madhani, 2010). Table 2.1
shows the gene identification numbers of all of the strains (and corresponding gene
and protein identification numbers) used in this study, the predicted mitochondrial
or cytoplasmic cellular location of each protein (determined using the MitoFates
website; Fukasawa et al., 2015), as well as the chromosomal location of each
corresponding

gene

(obtained

from

the

Fungi

Database,

https://fungidb.org/fungidb/).
Phylogenetic tree:
The amino acid sequences of 43 proteins including of the C. neoformans
aldehyde dehydrogenases and putative homologs in other species were
downloaded from the FungiDB website (http://fungidb.org/fungidb/srt.jsp).
Alignment and phylogeny reconstruction were performed using Molecular

116

Evolutionary Genetics Analysis (MEGA X) software (Kumar et al., 2001). First,
alignment was carried out with Clustal W software (Thompson et al., 1994). Then,
aligned sequences were used to construct a Maximum Likelihood (ML) tree, under
an assumption of a uniform rate of substitution among all amino acid sites, using
the Jones-Taylor-Thornton model (Jones et al., 1992), with 1000 bootstrap
replicates (Felsenstein, 1985) to verify the reliability of the tree. The initial tree was
constructed using both Neighbor Joining (NJ) and BioNJ algorithms and optimized
via the Nearest Neighbor Interchange (NNI) version of the ML heuristic method
with a "moderate" branch swap filter setting.
Confirmation of deletion of the corresponding gene in each aldehyde
dehydrogenase mutant by PCR analysis:
Deletion of the aldehyde dehydrogenase genes was confirmed by PCR
analysis using primers specific to each gene (Table 2.2) and assessing the
absence of PCR product. Since all of the ald mutant strains at UCSF were
generated in the Madhani lab by replacing the corresponding gene with the NAT
gene conferring resistance to the nourseothricin (NTC) antibiotic (Chun and
Madhani, 2010), the presence of NAT was also verified using primers synthesized
based on sequences obtained from the Madhani lab, as follows:
NAT Forward primer (107): CCTAGCAGCGGATCCAAC
NAT Reverse primer (108): CGCATCCCTGCATCCAAC
DNA was isolated from all the strains using the cetyl/hexadecyltrimethylammonium bromide (CTAB) DNA isolation protocol (Pitkin et at, 1996).
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Gene amplification was performed using the KOD Hot Start DNA Polymerase kit
(Novagen/Millipore-Sigma, St. Louis, MO) with a thermocycler program as follows
for the ALD genes: initial denaturation at 95°C for 2 min, followed by 35 cycles of
denaturation at 94°C for 30 sec., annealing at 60°C for 30 sec., and extension at
72°C for 2 min., followed by final extension at 72°C for 5 minutes. The thermocycler
program utilized to amplify NAT differed only in that 30 cycles were used and the
annealing temperature was set to 55°C.
Quantitative and qualitative growth analysis in various carbon sources:
C. neoformans strains mentioned above were cultured overnight in Yeast
Extract Peptone Dextrose (YPD) media (1% Difco Yeast extract, 2% Bacto
Peptone, and 2% glucose) at 30°C, in a rotating shaker at 200 rpm (Barnstead
MaxQ 4000 Orbital Incubator Shaker). The next morning, ~25 μl from each
overnight culture was used to inoculate a corresponding 2 ml volume of YPD, to
produce a refreshed culture with an optical density at 600 nm wavelength (OD600)
of ~0.075, which was then incubated to OD600 of ~0.2 as measured using an
Evolution 60 spectrophotometer (ThermoScientific, Waltham, MA). The refreshed
cells were pelleted at 8,000×g, washed twice in Corning Dulbecco’s Phosphate
Buffered Saline (D-PBS; LifeSciences, Oneonta, NY), and counted using a
hemocytometer.
For qualitative analysis, spot assays were performed. Refreshed cells were
initially diluted to 5×103 cells/μl, and then 10-fold serially diluted three times. From
each dilution, 2μl were spotted onto Yeast Nitrogen Base (YNB; HiMedia) plus
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agar (YNB-agar) supplemented with 2% of either glucose, acetate, or ethanol.
Thus, 1×104 cells, 1×103 cells, 100 cells, and 10 cells of the wild type strain and
each of the mutant strains were plated and were allowed to grow at 30°C for
approximately 3 days. Images of colonies were captured using the Canon EOS
Rebel T1i camera.
For quantitative growth analysis 1×104 cells/μl were used to inoculate YNB
media supplemented with 2% of either glucose, acetate, or ethanol as the carbon
source. Cultures were set up in each medium in triplicate in microtiter plates. Cells
were allowed to grow in a shaking incubator at 30°C for 48 hours, and their growth
was monitored over time using the Epoch Multi-Volume Microplate Reader (BioTek
Instruments, Inc., Winooski, VT) to measure the OD600.
Measurement of acetate production:
To analyze acetate production by C. neoformans, the hydroxamate assay
was performed as described previously (Fowler et al., 2012; Aceti and Ferry, 1988;
Rose et al., 1954). As detailed above, C. neoformans strains were grown overnight
in YPD media at 30°C. To refresh cells, 25 μl from each of these overnight cultures
was used to inoculate a corresponding 5 ml volume of YNB supplemented with 2%
glucose, which was incubated to an OD600 of ~0.2. Cells were counted using a
hemocytometer and each of the 5 ml cultures were adjusted to a concentration of
1×104 cells/μl. The 5 ml cultures were vortexed briefly to fully resuspend the cells
and 1 ml of each culture was transferred to a corresponding eppendorf tube, which
was centrifuged at 10,000×g. The recovered supernatants were transferred to
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fresh tubes and frozen down at –80°C. The remaining culture volumes were
incubated at 30°C, and, every 12 hours, up to and including 48 hrs, the process
was repeated. Once all supernatants were collected, the hydroxamate assay was
performed on triplicate 225 μl samples from each 1 ml of supernatant media from
each strain as described by Aceti and Ferry (1988). Briefly, 75 μl of hydroxamate
reaction mix (2.4 M hydroxylamine-HCl at pH 7.0, 0.4 M Tris at pH 7.5, 80 mM
MgCl2, and 90 μM ATP disodium salt hydrate) was added to each 225 μl of
supernatant and the mixture was incubated at 37°C for 5 minutes. Then, 5 μl of
Methanosarcina thermophila acetate kinase (purified by Dr. Cheryl Ingram-Smith)
was added to a final concentration of 0.023 ng/μl, and the reaction was mixed to
homogeneity by pipetting and incubated at 37°C for 15 minutes. Finally, the
reaction was quenched using an equal volume of a stop solution (10%
trichloroacetic acid and 2.5% FeCl3 in 2 N HCl) and the absorbance was read at
540 nm using the Epoch Multi-Volume Microplate Reader spectrophotometer. A
standard curve was prepared by performing exactly the same protocol using
known concentrations of acetate solution ranging from 0.1 mM - 2 mM instead of
supernatant media.
Capsule formation assay:
Capsule production by C. neoformans was induced using previously
published conditions (Zaragoza and Casadevall, 2004). Briefly, wild type and
mutant strains were grown overnight in 2 ml of Sabouraud medium (4% glucose
and 1% bacto peptone, pH 5.6) at 30°C. The following day, cells were collected by
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centrifugation (8,000-10,000×g) for 2 minutes at room temperature, washed twice
with PBS (137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4, and 8.5 mM Na2HPO4),
and resuspended in 0.1x Sabouraud medium (pH of 7.3). Cells were counted,
diluted to 5×106 cells/ml in 2 ml of the above 0.1x Sabouraud medium, and
incubated for 24 hours at 37°C to induce capsule formation.
Capsules of the wild type and mutant strains were observed under the
Axiovert Inverted Microscope (Carl Zeiss, Inc., Thornwood, NY) after 10 μl of each
cell suspension were mixed with 10 μl of India Ink (Becton Dickinson, NJ) to
provide contrast. Images were taken at 40x magnification and processed with
Zeiss software and Image J. At least five different fields were randomly chosen
and photographed, and 25 to 30 cells were observed.
Melanin production assay:
C. neoformans wild type and ald mutant strains were grown as described
above and then harvested by centrifugation for 2 min at room temperature, washed
twice in D-PBS, and counted using the hemocytometer. Each strain was diluted to
1×10 cells/ml and a 5μl volume of each strain was plated on agar-containing
5

melanin-induction medium (8 mg/ml KH2PO4, 2 mg/ml glucose, 2 mg/ml L-glycine,
1 μg/ml D-biotin, 1 μg/ml thiamine, 0.92 mg/ml MgSO4×7H2O, and 0.4 mg/ml L-3,4dihydroxyphenylalanine [L-DOPA]) in order to induce melanin production (Li et al.,
2018). Plates were incubated at 30°C for 2-3 days, and then imaged using the
Canon EOS Rebel T1i camera. The experiment was performed thrice.
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Growth under hypoxia and under oxidative and nitrosative stresses:
C. neoformans wild type and ald mutant strains were grown overnight and
refreshed the next morning as described above, then harvested by centrifugation
for 2 min at room temperature, washed twice in D-PBS, counted using the
hemocytometer, and diluted to 5×103 cells/μl. Next, three 10-fold serial dilutions of
cells were prepared, and 2μl of each of these four dilutions were spotted at 1×104,
1×103, 100 and 10 cells per spot onto media that mimicked different stress
conditions that the fungus encounters during infection. To mimic hypoxia, cells
were spotted onto YES-agar (0.5% yeast extract, 2% glucose, 1.5% agar and 225
μg/mL of each of uracil, adenine, leucine, histidine, and lysine) supplemented with
0.7 mM CoCl2 (Lee et al., 2007). To test the effects of oxidative and nitrosative
stresses, cells were spotted onto sodium succinate-adjusted YNB-agar medium
(1.34 g/liter yeast nitrogen base without amino acids, 4 g/L glucose, and 5 mM
sodium succinate to adjust the pH to 4.0, filter sterilized and mixed 1:1 with 4%
agar to a final concentration of 2% agar) supplemented with either 1 mM hydrogen
peroxide (H2O2) or 1.5 mM sodium nitrite (NaNO2), respectively, or not
supplemented as control (Gerik et al., 2008). Plates were incubated at 30°C for 23 days and then imaged using the Canon EOS Rebel T1i camera. Each experiment
was repeated thrice.
Growth under osmotic stress:
Wild type and ald mutant fungal cells were cultured overnight, refreshed and
counted the next day, diluted, and spotted as described above, except that osmotic
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stress generating medium (1% yeast extract, 2% Bacto Peptone, 2% glucose, and
2% agar, supplemented with either 1.5 M NaCl or 1.2 M KCl) was used. Plates
were incubated at 30°C for 3 days and then imaged using the Canon EOS Rebel
T1i camera. Each experiment (with NaCl or KCl) was repeated thrice.
SDS and Congo red assays for cell wall integrity:
Wild type and ald mutant fungal cells were cultured overnight, refreshed and
counted the next day, diluted, and spotted onto plates as above, except that the
various strains were spotted onto media with 1% yeast extract, 2% Bacto Peptone,
2% agar, and 1% glucose (all from Difco) supplemented with either 0.5% Congo
red (Sigma-Aldrich/Millipore Sigma, St. Louis, MO) or 0.03% sodium dodecyl
sulfate (SDS; Calbiochem/Millipore Sigma, St. Louis, MO). Plates were incubated
at 30°C for ~72 hours and then images were captured using the Canon EOS Rebel
T1i camera. Each experiment was repeated three times.
Macrophage culture:
A murine macrophage-like cell line J774A.1 (gift From Dr. Jeffrey Anker,
Clemson University), originally derived from a BALB/c mouse reticulum cell
sarcoma (Fan et al., 2005), was maintained in macrophage medium (Dulbecco’s
Modified Eagle Medium [DMEM] supplemented with 10% heat-inactivated fetal
bovine serum, 1% non-essential amino acids, 1% penicillin-streptomycin, and 10%
NCTC-109 medium, all from Gibco Life Technologies). Cells were passaged at a
1:10 split approximately every 5-7 days when they reached 80% confluence.
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Macrophage survival assay:
At ~80% confluence, cultured macrophages were washed twice with DPBS, harvested by scraping after addition of fresh macrophage medium, and then
diluted to 1×103 cells/μl. Into two 96-well flat-bottom tissue culture treated plates
(Corning Inc., Corning NY), one for one-hour co-incubation and the other for 24hour co-incubation with fungal cells, 100 μl of the cell suspension (1×105 cells) in
macrophage media were transferred into three wells per C. neoformans strain.
Both plates were incubated overnight at 37˚C in the 5% CO2 incubator.
Concurrently, wild type (KN99a) and mutant C. neoformans strains were
grown overnight in liquid YPD media at 30°C. The next day, the strains were
pelleted by centrifugation at 8,000×g for 1 min, washed twice with D-PBS, and
resuspended in macrophage medium. The fungal cells were then diluted to 125
cells/μl in 1 ml of macrophage media (i.e. 1.25×104 C. neoformans cells per 100
μl). To enhance macrophage phagocytosis by opsonization, each strain of C.
neoformans was incubated for one hour at 37˚C with 1μg/ml (final concentration)
of the MAb18B7 monoclonal antibody (gift from Dr. Arturo Casadevall, Johns
Hopkins University School of Medicine) that binds to the glucuronoxylomannan
(GXM) capsule component (Casadevall et al., 1998). As soon as the C.
neoformans strains with antibody were placed in the incubator, two plates
containing macrophages were processed as follows. The media was gently
removed from each well and replaced with 100 µl macrophage media containing
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10 nM phorbol myristate acetate (PMA), and then both plates were incubated at
37˚C in 5% CO2 for one hour to activate the macrophages (Forman and Torres,
2001).
After separate one hour incubations of the macrophages and fungal cells,
the medium in each well from both 96-well macrophage plates was replaced,
without disrupting the macrophage monolayer, with a 100 µl volume of cell
suspension (i.e. 1.25×104 cells) of one of the wild type or ald mutant C. neoformans
strains, in triplicate, at an 8:1 macrophage to fungal cell ratio. In a third, 96-well
tissue culture treated plate, the cell suspensions of C. neoformans wild type or
mutant strains were added, in triplicate, at 100 µl (i.e. 1.25×104 cells) per well, in
the absence of macrophages as a control. All three plates were left at 37˚C in 5%
CO2 for one hour, after which, each well in the one-hour and 24-hour plates with
macrophages, but not in the control plate without macrophages, were gently
washed thrice with 200 μl D-PBS to remove non-phagocytosed C. neoformans. To
the 24-hour plate, 100 μl of fresh macrophage media were added to each well, and
the plate was placed back into the 37˚C, 5% CO2 incubator for 24 hours.
To the one-hour plate, 200 µl of sterile distilled, deionized water (ddH2O)
were added to each well, and the plate was incubated at room temperature for 5
minutes to lyse the macrophages. A pipette tip was then scraped against the
bottom of the wells to lift up the adherent macrophages, and the cells suspended
in the water were pipetted up and down to disrupt and further lyse the
macrophages. The 200 µl lysate was then transferred to a microfuge tube. Again,
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200 µl of sterile ddH2O were added to each well, the wells were scraped, and the
suspensions were pipetted up and down. The additional lysates generated were
combined with the corresponding original lysates. These steps were repeated
twice more, but with 300 µl of sterile ddH2O, so that, by the end of the procedure,
each microfuge tube held 1 ml final volume of lysate. For the plate of C.
neoformans strains without macrophages, since the wells were not washed prior
to addition of sterile ddH2O, the volume of original media plus sterile ddH2O
transferred to each microfuge tube was 300 µl; then 200 µl, 200 µl, and 300 µl
volumes were used and transferred to the corresponding microfuge tube. The
same procedure that was used on the one-hour plates with macrophages was
used, without modification, to obtain macrophage lysates from the 24-hour plate
the next day. For each 96-well plate, macrophage lysis (or recovery of fungal cells
from wells without macrophages) was conducted in sets of one well per strain, in
triplicate sets, to obtain the fungal cells from the three wells per strain.
Immediately after C. neoformans cells were obtained from the macrophage
lysates or from the fungal cell suspensions (i.e. from the no-macrophage control
plate), the cells were diluted 1:10, then again 1:2.5 for a final dilution of 1:25, or a
(theoretical) maximum concentration of 500 cells/ml in a total volume of 0.5 ml. For
each C. neoformans strain, from this final dilution, 100 μl were plated on YPD-agar
plates, one plate per corresponding well from each 96-well plate. This resulted in
triplicate YPD-agar plates for each wild type and mutant strain, with a maximum of
50 cells per plate from each corresponding well of the 96-well plates (at least from
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the 1-hour plate, although due to replication of the fungal cells, more than this
number was possible from the 24-hour plate). YPD-agar plates were incubated at
30°C for ~48 hours and then colony forming units (CFU) were counted for each
plate and the percentage survival was calculated for each strain using the following
formula, in which MΦ refers to macrophages and the CFU are the average of the
individual CFU from the triplicate YPD-agar plates:
% Phagocytosis = (CFUC. neoformans with MΦ @ 1hr ÷ CFUC. neoformans without MΦ) × 100
% Survival = (CFUC. neoformans with MΦ @ 24 hrs ÷ CFUC. neoformans with MΦ @ 1 hr) × 100
In vivo C. neoformans virulence assay using an invertebrate model:
To examine the virulence of mutant C. neoformans strains, either the wild
type C. neoformans strain or one of ald5, ald13, or ald78 mutant strains, all in the
H99 strain background, were injected into the larvae of the greater wax moth,
Galleria mellonella, and larval survival was assayed. C. neoformans strains to be
injected were grown in YPD media at 30°C overnight and refreshed the next
morning by inoculation of new 2 ml cultures and incubation to an OD600 of ~0.2.
The cells were then pelleted and washed once with sterile water and twice with DPBS. Each strain was then resuspended in D-PBS to a final concentration of 1×105
cells/µl. Subsequently, milky-white G. mellonella larvae without any dark spots and
weighing between 0.27 g and 0.30 g were chosen. Ten larvae per C. neoformans
strain were selected and disinfected using alcohol wipes just prior to inoculation.
Using Hamilton syringes, each of the ten larvae were injected in the bottom-left
proleg with 10 µl of one of the C. neoformans strain resuspensions. To determine
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the level of death due solely to injection, 10 µl of D-PBS were injected into ten
more larvae (as a control) and survival was monitored over time. Similarly, as a
negative control, the C. neoformans wild type strain (in the H99 background) was
heat-killed via incubation at 65°C for one hour and 1×106 of these dead cells were
injected into each of ten larvae. After all strains and controls were injected into G.
mellonella, the larvae were incubated at 37°C and monitored daily. Death was
scored based on blackened appearance (indicative of either necrosis or complete
melanization) and a lack of normal rolling-over behavior. The numbers of dead
larvae in each injection group were tallied and graphed in a Kaplan-Meier survival
curve.
Statistical analysis of results:
All of the graphs were prepared using GraphPad Prism; the significance of
the results were determined using the analysis of variance (ANOVA) software
within Prism, with Dunnet, Sidak, or other post-test multiple comparison, as
recommended by the software. One-way ANOVA was used when triplicate values
generated at the end of the experiment were compared, but when multiple time
points were compared as well as the various strains, two-way ANOVA was utilized.
For the macrophage survival assay, data was first analyzed using Microsoft Excel
to calculate the relative percent survival (or recovery, versus the wild type strain)
after phagocytosis of each strain prior to graphing the data and conducting
statistical analyses via Prism. For Kaplan-Meier survival curves, the Gehan-
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Breslow-Wilcoxon test and/or Log-Rank test was used to compare the virulence of
mutant strains to that of the wild type strain.
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Results
Phylogeny of the C. neoformans Ald family:
In C. neoformans, nine genes have been predicted to encode proteins that
could have aldehyde dehydrogenase (Ald) activity. In order to further understand
the function of these genes, sequence similarity analysis was performed on the
corresponding protein sequences using Molecular Evolutionary Genetics Analysis
(MEGA X) (Kumar et al., 2001) phylogenetic software (Figure 2.2).
A mutant strain deficient for one aldehyde dehydrogenase in C.
neoformans, CNAG_02377, also known as CKF44_002132 (in the H99 and H99derived KN99 strains, respectively), was not available for experimental analysis.
However, by the phylogenetic analysis, the protein sequence for this Ald was found
to diverge from a common ancestor with, and was evolutionarily most related to,
CNBG_4084, an Ald from Cryptococcus deuterogattii. CNAG_02377 is next most
closely related to AGR57_15224, the NAD-Ald of Phanerochaete chrysosporium,
a basidiomycota, and then to FOC4_Q10007570, the lactaldehyde dehydrogenase
of Fusarium oxysporam. These four Ald sequences form GROUP 1 in the
phylogenetic tree (Figure 2.2).
CNAG_05029 (Ald29) in the H99 strain of C. neoformans (var grubii), known
as CKF44-004510 in the KN99 strain, is closest to CC1G_03873, the Ald of
Coprinopsis cinerea, a basidiomycota fungi. According to the fungi database, both
proteins are referred to as meiotic Sister-Chromatid recombination aldehyde
dehydrogenases (https://fungidb.org/fungidb/app/record/gene/CNAG_05029, and
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https://fungidb.org/fungidb/app/record/gene/CC1G_03873). The next most closely
related protein to these is PH9BL_176604, a betaine aldehyde dehydrogenase
from Phycomyces blakesleeanus, a filamentous fungi in the phylum Zygomycota.
These sequences form GROUP 2 of the phylogenetic tree.
CNAG_06018 (Ald18) and CNAG_06010 (Ald10) in the H99 strain have
corresponding putative enzymes in the KN99 strain, CKF44_005401 and
CKF44_005393,

respectively.

CNAG_06010

is

most

closely

related

to

CGBM_0210C, an Ald in Cryptococcus gattii, but CNAG_06018 is the next most
closely related aldehyde dehydrogenase from among all of those considered.
These sequences, along with the next most closely related sequence,
AGR57_7717,

the

NAD-aldehyde

dehydrogenase

from

Phanerochaete

chrysosporium, a basidiomycota fungi, form GROUP 3 of the phylogenetic tree.
CNAG_03269 (Ald69) in the H99 strain, known as CKF44_002909 in the
KN99 strain, is closest to CGB_G2310C, an Ald in C. gattii. Together with the next
closest protein, ACLA_062670, an Ald in Aspergillus clavatus, these sequences
form GROUP 4 of the phylogenetic tree.
Phylogenetic GROUP 5 consists of CNAG_00735 (Ald35) in the H99 strain
or CKF44_000642 in the KN99 strain, along with AGR57_4875, an NAD-Ald in P.
chrysosporium,

and

BDEG_01128,

the

Ald

family

7

member

A1

of

Batrachochytrium dendrobatidis, a fungus known to cause chytridiomycosis in
amphibians (Rebollar et al., 2014; Zumbado-Ulate et al., 2019).
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CNAG_01078 (Ald78) and CNAG_05113 (Ald13) in the H99 strain have
corresponding proteins CKF44_000949 and CKF44_004585, respectively, in the
KN99 strain. CNAG_05113 is most closely related to the CNBG_4577 NAD-Ald
from C. deuterogatti, but is next most closely related to CNAG_01078.
CNAG_06628 (Ald5) in the H99 strain, or CKF44_005930 in the KN99 strain, is
the next most closely related Ald to both CNAG_01078 and CNAG_05113 and
completes the phylogenetic GROUP 6. These three C. neoformans Alds are the
most closely related, among all C. neoformans Alds, to S. cerevisiae Ald4p, Ald5p,
and Ald6p, which can act as acetaldehyde dehydrogenases to produce acetate
(Remize et al., 2000; Saint-Prix et al., 2004). However, as C. neoformans Ald5,
Ald13, and Ald78 are more closely related to each other than any is to S. cerevisiae
Ald4p, Ald5p, and Ald6p, and, conversely, since these S. cerevisiae enzymes are
more closely related to each other than to any C. neoformans Alds, it is difficult to
predict, based on the function of the S. cerevisiae enzymes, which one of Ald5,
Ald13, or Ald78 may function in acetate production.
Verification of ALD deletions:
The ald mutants obtained from the Madhani deletion collection (Chun and
Madhani, 2010) were checked for the deletion of the appropriate ALD and for the
presence of the nourseothricin acetyltransferase (NAT) cassette, that was used to
replace the ALD gene. Primers specific for each ALD were designed and used in
PCRs to amplify a portion of the corresponding gene from wild type and mutant
strain genomic DNAs. Similarly, primers specific for the NAT cassette were used
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to amplify this gene from genomic DNA from the mutant strains. The results from
each PCR confirmed the deletion of the respective ALD genes in the mutants used
in this study (Figure 2.3a). Amplification of NAT (~1600 bp) from all of the ald
mutants, but not from the wild type KN99a strain, was also observed (Figure 2.3b).
Impact of ALD deletions on the growth of C. neoformans on different carbon
sources:
Under normal conditions, C. neoformans favors glucose over other carbon
sources for growth (Hu et al., 2008; Sabiiti and May, 2012). However, during early
stages of infection, it is challenged by low glucose and low amino acid conditions
and must utilize alternative carbon sources like acetate and lactate to survive (Hu
et al., 2008; Price et al., 2011). To investigate whether each of the ald mutants
could grow in media supplemented with alternative carbon sources like acetate
and ethanol as well as they could in glucose-rich media, spot assays and growth
curve analyses were performed by spotting the yeast on YNB-agar, or by culturing
them in YNB liquid medium, respectively, supplemented with 2% glucose, 2%
acetate, or 2% ethanol.
All of the ALD mutants exhibited normal growth when cultured on YNB-agar
supplemented with 2% glucose except the ald69Δ (CNAG_03269) mutant, which
demonstrated a major growth defect on this media (Figure 2.4a). Under this growth
condition, the ald69Δ mutant produced fewer colonies of very small size, a
phenotype which was clearly visible at the lower dilutions of cells (Figure 2.4a). In
contrast, the ald69Δ mutant strain did not have a significant defect in growth on
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YNB-agar supplemented with either 2% acetate or 2% ethanol (Figure 2.4b and
2.4c).
Conversely, in the ald13Δ (CNAG_05113) mutant, the absence of the Ald13
protein, which is predicted to reside in the mitochondria (MitoFates website,
http://mitf.cbrc.jp/MitoFates/cgi-bin/top.cgi; Fukasawa et al., 2015), resulted in
smaller sized colonies on YNB-agar plates containing 2% acetate or 2% ethanol
relative to colonies on YNB-agar plates containing 2% glucose, and versus the
average colony size of the wild type strain on 2% acetate or 2% ethanol
supplemented YNB-agar (Figure 2.4). However, no difference in the number of
colonies, as compared with the wild type strain (or other mutant strains), was
observed.
In addition to the phenotypes of the ald69Δ and ald13Δ strains, the ald5Δ
mutant strain exhibited a severe growth defect (i.e. no growth) specifically when
plated on YNB-agar with 2% ethanol, but not on YNB media supplemented with
2% glucose or 2% acetate (Figure 2.4c).
In order to quantify the previous decline in growth of ald69Δ and ald5Δ
mutants, but not of other mutants, all aldehyde dehydrogenase mutants were
cultured in liquid medium containing 2% glucose, 2% acetate, or 2% ethanol as
the carbon source. A quantitative growth analysis was performed over a 48-hour
time course. The ald69Δ mutant displayed a growth defect reminiscent of the
smaller number of colonies observed in the spot assay. Specifically, this mutant
exhibited a slower growth rate at later time points in medium with 2% glucose
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(Figure 2.5a; P-value = 0.0210, 0.0429, 0.0315, and 0.0320 at 24, 31, 38, and 48
hours, respectively, all less than the 0.05 cutoff value for significance), but not in
media with 2% acetate or 2% ethanol. Similarly, the ald5Δ mutant grew poorly in
medium supplemented with 2% ethanol (Figure 2.5c; P-value = 0.0052 for the
overall growth curve versus the wild-type growth curve), just as it did on the
equivalent plates in the spot assay, but grew normally in media with 2% glucose
(Figure 2.5a) or 2% acetate (Figure 2.5b), just as it did on the 2% glucose and 2%
acetate supplemented YNB-agar. The quantitative growth curve analysis
conducted over 48 hours correlated with the qualitative spot assay results, with
clear growth defects in ald5Δ and ald69Δ. All strains, including the wild type strain,
exhibited slower growth in media supplemented with 2% acetate, so no significant
differences were observed between the wild type and any of the mutant strains
(Figure 2.5b).
Acetate production is reduced in ald mutants:
Acetaldehyde dehydrogenase has been shown to be involved in the
production of acetate in S. cerevisiae (Pronk et al., 1996). In order to determine
whether each Ald enzyme in C. neoformans functions in the production of acetate,
the levels of acetate produced by the various ald mutants cultured in YNB media
supplemented with 2% glucose were measured. The concentration of acetate
produced by the wild type strain and each of the various strains deficient in different
aldehyde dehydrogenases was determined every 12 hours. All of the mutants
could utilize glucose in the media and produce acetate. However, although the
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acetate production by the ald mutants was not eliminated, it was significantly
reduced relative to the wild type KN99a strain at all time points after 12 hours
(Figure 2.6; P-value < 0.0001 overall). In particular, after 12 hours, ald5Δ, ald10Δ,
ald18Δ, ald35Δ, and ald78Δ exhibited very significantly (P-value < 0.01) reduced
acetate production versus the wild type strain, (with P-values of 0.0095, 0.005,
0.0033, 0.0092, and 0.0053, respectively), while ald13Δ and ald29Δ exhibited
highly significantly (P-value < 0.001) reduced acetate production versus the wild
type strain (with P-values of 0.0008 and 0.0002, respectively), and ald69Δ
exhibited extremely significantly (P-value < 0.0001) reduced acetate production
versus the wild type strain.
Capsule formation:
C. neoformans forms a polysaccharide capsule that protects the fungal cell
from the immune response and increases fungal virulence (Reese and Doering,
2003; Bose et al., 2003). To characterize capsule formation in wild type and ald
mutants, strains were incubated in capsule-inducing medium and then stained with
India Ink to visualize capsule thickness under the microscope. It was found that
the capsules of all ald mutants were smaller than that of the wild type KN99α strain,
although the ald10 mutant had a larger capsule than the other mutants (Figure
2.7). This suggests that production and completion of the capsule is highly
compromised in the absence of any one of the Alds.
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Melanin production:
Melanin neutralizes reactive oxygen species and prevents oxidative
killing by phagocytes, thus acting as another important virulence factor during
infection (Ma and May, 2009). Spot assays were performed in L-DOPA
supplemented plates to determine whether a deficiency of any of the aldehyde
dehydrogenases has an effect on melanin production. Most of the mutants,
namely ald13Δ, ald78Δ, ald10Δ, ald18Δ, ald29Δ, and ald35Δ, had no melanin
production defect and produced melanin at levels comparable to the wild type
strain (Figure 2.8). However, there was a significant reduction in the production
of melanin by the ald69Δ mutant, suggesting a role for the corresponding
enzyme in the production of melanin (Figure 2.8). Surprisingly, the ald5Δ mutant
displayed increased melanin production, relative to the wild type strain (Figure
2.8), suggesting that the normal function of the Ald5 enzyme has, either directly
or indirectly, a negative effect on the production of melanin. This data suggests
that Ald69 is required for optimal production of melanin, while functional Ald5
apparently reduces the need for melanin.
Response to hypoxia, and oxidative and nitrosative stresses:
In the host brain, C. neoformans faces low oxygen conditions, which are
detrimental to its survival (Ingavale et al., 2008; Erecińska and Silver, 2001). In
order to understand whether any of the Alds are important for the survival of the
pathogen under hypoxic conditions, each mutant was tested for the ability to grow
in YES medium supplemented with CoCl2, which induces the Sre1p ergosterol
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production pathway used by the cells as an oxygen sensing pathway, and thereby
drives the cells into a metabolic state similar to that induced by hypoxia (Lee et al.,
2007). All of the mutants survived normally when subjected to hypoxia conditions
except ald29Δ (Figure 2.9b). The ald29Δ mutant, which grew normally in YES
media without CoCl2, i.e. under normoxia (Figure 2.9a), exhibited defective growth
when subjected to the low oxygen simulating conditions (Figure 2.9b). Surprisingly,
when this mutant was provided with acetate in the CoCl2 containing plates, it
recovered normal growth (Figure 2.9c).
While surviving hypoxia matters after dissemination to the brain, at the
initiation of infection, upon inhalation of cryptococcal cells or spores, the fungal
cells encounter alveolar macrophages in the lungs that attempt to engulf them and
to destroy them using ROS and RNS (Hampton et al., 1998; Vieira et al., 2002;
Cox et al., 2003; Tohyama et al., 1996). To determine if any of the Alds play a role
in the survival of the pathogen under oxidative conditions, wild type and ald mutant
strains were grown on YNB-agar (buffered to pH 4.0 using sodium succinate),
either alone as control or supplemented with 1 mM H2O2. When subjected to this
oxidative stress condition, all of the mutants except ald69Δ had growth comparable
to the wild type KN99α strain (Figure 2.10). The ald69Δ mutant displayed reduced
growth under oxidative stress (Figure 2.10). This result suggests a specific
requirement for the Ald69 enzyme in C. neoformans survival under the oxidative
stress conditions encountered within macrophages, indicating that this Ald may
play a role in C. neoformans virulence.
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Similarly, when the wild type and mutant strains were grown under
nitrosative stress by 1.5 mM sodium nitrite, only the ald69Δ mutant displayed a
phenotype different from that of the wild type strain (Figure 2.11b). However,
instead of showing a defect in growth, the ald69Δ mutant formed pink/red colonies
(Figure 2.11b, bottom row). It has long been established that S. cerevisiae mutants
with deficiencies in either adenine or biotin production grow as pink/red colonies
(Smirnov et al., 1967). Therefore, to test whether the ald69Δ mutant turned pink
under nitrosative stress due to adenine deficiency, 225 μg/ml adenine was added
to the media along with 1.5 mM sodium nitrite and the growth of all wild type and
mutant strains was reanalyzed. The red pigmentation was not observed, even in
the ald69Δ mutant, when the cells were grown in adenine-supplemented
nitrosative stress media (Figure 2.11c). This suggests that the ALD genes are not
required for growth under nitrosative stress conditions; however, the function of
the Ald69 enzyme plays a role in the production of adenine in the pathogen under
nitrosative stress.
All ald mutants exhibited a normal osmotic stress response:
C. neoformans has evolved specialized pathways, including the production
and use of mannitol (Chaturvedi et al., 1996) and the HOG1 pathway (Bahn et al.,
2005), to survive high osmolarity environments inside the host body and the
corresponding osmotic stress. To investigate whether the C. neoformans aldehyde
dehydrogenases function in the osmotic stress response, the wild type strain and
each of the ald mutants were grown on YPD-agar supplemented with either 1.5 M
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NaCl or 1.2 M KCl to osmotic stress. It was found that all of the ald mutants grew
normally under these high salt conditions, that is, to a degree similar to that of the
growth of the wild type strain (Figure 2.12). These results suggest that the ALD
genes are not required for growth under osmotic stress.
The ald mutants, especially ald69Δ, have partially compromised cell wall
integrity:
The C. neoformans cell wall protects the fungal cell from environmental
challenges. in order to survive attack by ros and rns produced by macrophages
when they phagocytose a pathogen, the cryptococcal cells upregulate pathways
used to build the cell wall (Gerik et al., 2005). The capsule is attached to the cell
membrane via the cell wall, and melanin is deposited in the cell wall; therefore,
these virulence factors that protect against reactive oxygen species require an
intact cell wall for their functioning (Baker et al., 2007; Van Dyke and Wormley,
2018). The integrity of the cell wall of the wild type and aldehyde dehydrogenase
mutant strains was tested by spotting serial ten-fold dilutions of cells on YPD-agar
treated with sodium dodecyl sulfate (SDS) or Congo red. Congo red binds to
components of chitin and of the cell wall and interferes with cell wall construction,
while SDS dissolves and thereby disrupts the plasma membrane, lysing the cells
(García et al., 2015; Banks et al., 2005; Ram and Klis., 2006; Baker et al., 2007;
Gerik et al., 2005; Wood et al., 1983). Strains with cell wall integrity defects will not
survive in the presence of either Congo red or SDS, depending which layer of
capsule, cell wall, or chitin is deficient. The growth of cryptococcal cells on media
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with SDS was not affected in the ald mutant strains (Figure 2.13b), indicating that
the SDS could not pass through the chitin layer to dissolve the cell membrane in
these mutants. While media with Congo red inhibited the growth of both wild type
and mutant strains (Figure 2.13c) in comparison to normal media (Figure 2.13a),
the Congo red affected the growth of ald mutants more. Even when spotted at
higher cell concentrations, mutant cells did not grow as robustly as the wild type
cells on the Congo red supplemented media, and the mutant strains displayed
smaller colonies overall (Figure 2.13c), possibly reflecting the effect of their smaller
capsules. The most affected mutant was ald69Δ, which did not grow at all when
lower concentrations of cells were spotted, and grew poorly when the highest
concentration of cells was used (Figure 2.13c, bottom row). This indicates that the
corresponding enzyme may have a special role in the maintenance of cell wall
integrity.
The majority of ald mutants exhibited reduced survival and/or recovery after
phagocytosis:
To investigate the contribution of the various aldehyde dehydrogenases to
the survival of C. neoformans against attack by host immune cells, the percentage
of wild type or ald mutant fungal cells surviving engulfment by murine
macrophages was determined. First, fungal cells were co-incubated, in triplicate,
with macrophages for 1 hour, after which the non-phagocytosed fungal cells were
removed, the macrophages were lyzed, and the fungal cells from within those
macrophages were plated onto YPD. The average percent phagocytosis of each
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triplicate set was determined by comparing the number of colonies to the colonies
from identically cultured fungal cells without macrophages, and then normalized to
the wild type result. The relative percentages of input cells phagocytosed (ald5Δ:
111.32%; ald10Δ: 98.44; ald13Δ: 133.74; ald18Δ: 98.8; ald29Δ: 144.32; ald35Δ:
107.08; ald69Δ: 165.17; ald78Δ: 136.76) were not significantly different from that
of the wild type strain (100%). In a parallel plate, after removal of non-internalized
fungal cells, the macrophages were given 24 hours to destroy the phagocytosed
C. neoformans cells and were then lysed to release surviving, presumably growing,
C. neoformans cells, which were plated on YPD. The number of colonies of each
strain were divided by the average percent phagocytosis from the previous step to
determine the percent survival (and recovery) after phagocytosis. The percent
survival was reduced, relative to the wild type strain, for most, but not all, mutant
strains (Figure 2.14). The mutant strains designated ald10, ald18, and ald35 did
not exhibit a significant difference in survival/recovery after phagocytosis
compared with the wild type strain. In contrast, the C. neoformans cells from the
ald5, ald13, ald29, ald69, and ald78 mutants, showed significantly reduced relative
survival (and recovery) inside the macrophages (40.45%, 65.47%, 28.08%,
22.95% and 30.09% survival, respectively, with P-value = 0.0006, P-value =
0.0417, P-value < 0.0001, P-value = 0.0004, P-value = 0.0028, respectively). In
short, the lack of the corresponding enzymes in the ald5Δ, ald29Δ, and ald69Δ
mutant strains, significantly diminished survival after engulfment by macrophages.
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The ald5 and ald78 mutants had significantly reduced virulence in the
invertebrate Galleria mellonella infection model:
Virulence of mutant strains of C. neoformans in vivo is often assayed using
an invertebrate model, the larvae of the greater wax moth Galleria mellonella. To
determine whether each of the corresponding Ald enzymes has a role in
pathogenesis, in three independent experiments,1×106 of the wild type or ald5Δ,
ald13Δ, or ald78Δ mutant C. neoformans H99 strains were injected into ten
healthy larvae in parallel.
The results of a representative experiment demonstrated increased
survival of the G. mellonella larvae that were infected with any of the three ald
mutant C. neoformans strains, when compared with those infected with the wild
type H99 strain (Figure 2.15). Specifically, larvae infected with wild type H99 cells
started dying on day 6 post-injection and all such larvae were dead by day 9, while
at least some larvae infected with the ald5Δ, ald13Δ, or ald78Δ strain survived
until day 12, 13, or 17 respectively, with the ald78Δ strain-infected larvae starting
to die only on day 9. For comparison, the two negative controls, larvae injected
with PBS or with heat-killed wild type H99 cells, only started to die on day 8, and
at least some larvae survived until day 18 at minimum. Larvae injected with the
ald78Δ strain did not display any significant difference from the negative control
larvae. The median survival time of wild type H99-injected larvae was 8 days,
whereas the median survival time of ald5Δ strain-injected larvae was 8.5 days,
and that of ald13Δ strain-injected larvae was 8.5 days. The ald78Δ strain-injected
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larvae had a median survival time of 12 days. The survival curve of the ald5Δ
strain-injected larvae was statistically different from that of the wild type H99injected larvae (P-value = 0.0243, as determined using a Gehan-BreslowWilcoxon test, or, according to the Log-Rank test, P-value = 0.0188), but the
survival curve of the ald13Δ strain-injected larvae was not statistically different
from that of the wild type injected larvae (P-value = 0.1386 using the GehanBreslow-Wilcoxon test, or, using the Log-Rank test, P-value = 0.0734). The
ald78Δ strain-injected larval survival curve was extremely statistically significantly
different from the survival curve of larvae injected with wild type C. neoformans
(P-value < 0.0001 from both statistical tests). These results indicate that the
absence of Ald5 has a greater effect on the virulence of C. neoformans than that of
the aldehyde dehydrogenase deficient in the ald13Δ mutant, but still allows for
pathogenicity, unlike a deficiency of the aldehyde dehydrogenase deficient in the
ald78Δ mutant, which appears to abolish virulence.
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Discussion
C. neoformans has evolved several mechanisms to survive inside the host
system by producing virulence factors like the capsule and melanin, enzymes like
phospholipase B, urease, and proteases, and metabolites like trehalose, ethanol
and acetate (Ma and May., 2009; Coelho et al., 2014; Bubb et al., 1999; Wright et
al., 2002). This pathogen also shows the ability to switch to different carbon
sources and use them as sources of energy whenever necessary, and therefore
can survive in host tissues with low glucose (Hu et al., 2008; Price et al., 2011).
One of the carbon sources that C. neoformans can depend on is acetate, which
the pathogen can convert into acetyl-CoA to use in the tricarboxylic acid cycle,
gluconeogenesis, or the glyoxalate cycle (Hu et al., 2008).
It has also been seen that high amounts of acetate are produced by C.
neoformans, both in vitro and after infection of lung tissue in a mouse model (Bubb
et al., 1999; Wright et al., 2002; Hu et al., 2008). Acetate is believed to provide a
survival advantage to the pathogen, among other ways, through its effect on pH.
Unlike other fungi, such as Aspergillus fumigatus or Candida albicans, C.
neoformans grows only in a specific pH range; however, this range includes a pH
of 7.4, which is the pH of human blood and cerebrospinal fluid, as well as in the
more acidic environment inside the macrophage phagolysosome, with a pH of 4.05.0 (O'Meara et al., 2010; Nyberg et al., 1992), which it actually prefers. When
growing in a location in the host body that has a pH outside this preferred acidic
range, such as in cerebral cryptococcomas, the pathogen secretes excess acetate
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into the infected tissue in order to decrease the pH of the local environment (Wright
et al., 2002), thereby optimizing the activity of phospholipase B, and potentially
other enzymes, at the site of cryptococcal infection (Evans et al., 2015; Sharon et
al., 2000). Reduced pH in the environment around C. neoformans can shield the
pathogen from an immune attack by either reducing the migration of neutrophils or
increasing their necrosis, as well as by permitting the neutralization of free radicals
and decreasing the formation of superoxide, thereby limiting the ability of immune
cells to use such chemicals to kill infecting cryptococci (Hu et al., 2008; Wright et
al., 2002).
The exact pathway(s) by which C. neoformans produces acetate is
unknown. In S. cerevisiae, the primary biosynthetic pathway for cytosolic acetate
production during growth on glucose is the pyruvate dehydrogenase by-pass,
which utilizes pyruvate decarboxylase; in this pathway, pyruvate, originally
produced via glycolysis, is decarboxylated to form acetaldehyde, which is oxidized
to acetate by one or more of the aldehyde dehydrogenase (Ald) enzymes
functioning as an acetaldehyde dehydrogenase (Saint-Prix et al., 2004; Remize et
al., 2000; Pronk et al., 1996). Not only does C. neoformans express similar
enzymes, but mRNAs encoding both pyruvate decarboxylase and an aldehyde
dehydrogenase are increased in C. neoformans cells recovered from the lung
tissue of infected mice (Hu et al., 2008) or from the cerebrospinal fluid of a rabbit
cryptococcal meningitis model (Steen et al., 2003). An aldehyde dehydrogenase
has also been shown to be upregulated following engulfment by macrophages
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(Derengowski et al., 2013). This suggests that the Pdc-Ald pathway may be used
by C. neoformans to generate acetate, which may augment the virulence of the
pathogen. However, C. neoformans may also use Pdc and Ald to enhance
virulence in other ways. To better understand the functions of C. neoformans
aldehyde dehydrogenases in growth and pathogenicity, mutants for the genes
encoding aldehyde dehydrogenase enzymes were analyzed via various assays.
This approach was complicated by the fact that nine different genes coding for
different aldehyde dehydrogenases exist in the C. neoformans genome. These
aldehyde dehydrogenases may have a wide array of functions, including reducing
the toxicity of chemicals that the fungus may encounter, or producing various
metabolites.
Like C. neoformans, S. cerevisiae has multiple aldehyde dehydrogenases,
so a review of the functions of the different S. cerevisiae enzymes and of their roles
in survival under stress can inform the analysis of the results obtained in C.
neoformans in the assays described above. To cope with the continuous stress
they are subjected to during growth, most yeast species have devised stress
detection and response mechanisms, including the high osmolarity glycerol (HOG)
response pathway and pathways that respond to oxidative stress and DNA
damage, heat shock, and nutritional starvation (Brewster et al., 1993; Hohmann,
1997; Siderius et al., 1997; Estruch, 2000). Most relevant here, the accumulation
of ethanol and acetaldehyde in growing cells can eventually lead to toxic cell death
(Ingram and Buttke, 1985; Jones, 1990), so yeast utilize alcohol dehydrogenase
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and one or more of the aldehyde dehydrogenases, respectively, to metabolize
them into less toxic molecules (Aranda and del Olmo, 2003). For example, more
than one S. cerevisiae aldehyde dehydrogenase can function as an acetaldehyde
dehydrogenase to oxidize acetaldehyde into acetate (Pritchard and Kell, 2002;
Saint-Prix et al., 2004).
In S. cerevisiae, although the cytosolic aldehyde dehydrogenases Ald2p
and Ald3p may not function as acetaldehyde dehydrogenases (Navarro-Aviño et
al., 1999; Saint-Prix et al., 2004), the cytosolic Ald6p and the mitochondrial Ald5p,
as well as the mitochondrial Ald4p specifically in ALD6 deletion strains, all appear
to convert acetaldehyde to acetate, such that these three can partly, but not
completely, compensate for each other (Aranda and del Olmo, 2003; Meaden et
al., 1997; Saint-Prix et al., 2004; Remize et al. 2000). For example, both Ald6p and
Ald5p play an important role in acetate production, and deletion of either
corresponding gene reduces acetate production and growth under anaerobic
conditions; additionally, levels of ALD5 mRNA are upregulated during both
exponential growth and fermentation (Remize et al. 2000; Saint-Prix et al., 2004).
Similarly, in the ald6Δ mutant, ALD4 mRNA is expressed earlier, and the levels of
this mRNA and of Ald4p protein are increased to compensate for the loss of Ald6p
with increased levels and possible accumulation of Ald4p (Saint-Prix et al., 2004).
Thus, in an organism in which more than one aldehyde dehydrogenase exists, the
enzymes might compensate for each other (Remize et al., 2000). This would
explain the results from the various C. neoformans ald mutants, which had
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reduced, but not abolished, acetate production, indicating a similar partial
redundancy of the various Ald enzymes.
Functions and evolutionary relatedness of aldehyde dehydrogenases in
various species
Aldehyde dehydrogenases are not only present in fungi, but also in a vast
array of species, since their substrates, organic compounds known as aldehydes,
are present ubiquitously in nature (Perozich et al., 1999). Accumulation of these
aldehydes causes toxicity, so it is important to regulate their levels in the cells
(Lindahl, 1992; Perozich et al., 1999; Kozak et al., 2014). The aldehyde
dehydrogenase (ALDH) superfamily consists of a class of enzymes that catalyzes
the oxidation of aldehydes to their corresponding carboxylic acids, which are less
toxic to the cells (Perozich et al., 1999). The various activities of these enzymes,
including but not limited to this detoxification, have likely been critical throughout
evolutionary history, since this superfamily is highly conserved in Eubacteria,
Archaea, and Eukarya (Perozich et al., 1999). As seen in S. cerevisiae, some
ALDHs are localized to the mitochondria, while others are localized to the cytosol,
depending on the specific enzyme (Marchitti et al., 2008; Vasiliou and Nebert,
2005; Black et al., 2009; Sládek et al., 2003).
There are a large variety of ALDHs in nature, and they take part in different
physiological processes and exhibit specificity for various substrates. Some
ALDHs will act on only a few specific substrates, while others have a broader
specificity, yet most ALDHs require the presence of NAD+ or NADP+ as a cofactor
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in order to function (Lindahl, 1992; Yoshida et al., 1998). Although most ALDH
family members protect the cell by keeping in check the levels of harmful
aldehydes, they also demonstrate functionality beyond detoxification; for example,
aldehyde dehydrogenases are important for the synthesis of vital biomolecules like
retinoic acid, folate, and betaine (Marchitti et al., 2008; Vasiliou et al., 2000;
Sobreira et al., 2011). ALDHs also modulate processes like cell proliferation,
differentiation, and cell survival, mainly through participation in retinoic acid
synthesis (Marchitti et al., 2008). Some of the members of the ALDH superfamily
also exhibit functions independent of their enzymatic activity. These alternate
activities include acting as crystallins in the cornea, absorbing ultraviolet radiation
there, and binding to hormones or other small molecules, including androgens,
cholesterol, thyroid hormone, and acetaminophen (Pereira et al., 1991; Marchitti
et al., 2008; Estey et al., 2007), as well as roles in abiotic stress tolerance, male
fertility/sterility, embryo development, and seed viability and maturation in plants
(Kotchoni et al., 2010). ALDH activity is also required for catalysis of the
phytohormone indole-3 acetic acid (IAA) from indole-3-acetaldehyde (Cooney and
Nonhebel, 1989; Basse et al., 1996; Tam and Normanly, 1998; Fedorova et al.,
2005; Spaepen et al., 2007; Reineke et al., 2008). Moreover, ALDH proteins can
participate in osmoregulation and can operate as antioxidants (Marchitti et al.,
2008; Vasiliou and Nebert, 2005).
The protein sequences of human and horse mitochondrial and cytosolic
ALDHs, as well as the sequence of rat dioxin-inducible ALDH, have been known

150

since as early as 1988 (Von Bahr-Lindström et al., 1984; Hempel et al., 1985, 1989;
Johansson et al., 1988). In 1999, Perozich and coworkers investigated the
evolutionary relationships between 145 ALDH family members, spanning multiple
phyla. This led to the identification of several conserved residues and motifs in the
ALDH superfamily (Perozich et al., 1999). There are ten highly conserved motifs,
all clustered around the active site, suggesting the importance of these motifs to
the function of all ALDH enzymes, regardless of specific substrate (Perozich et al.,
1999). Perozich et al., (1999) reported that there were 13 ALDH families, but this
number has been increased to 20 (Sophos and Vasiliou, 2003), following the
availability of improved and more efficient sequencing and alignment technologies
and access to sequences of more aldehyde dehydrogenases. In fact, a great deal
of information is now available for gene and protein sequences of far more ALDHencoding genes (usually referred to as ALD genes) than previously analyzed. As
of 2002, 555 ALD gene sequences were reported, including 351 from Eubacteria,
32 from Archaea, and 172 from Eukarya (Sophos and Vasiliou, 2003).
The evolutionary relatedness of the nine C. neoformans aldehyde
dehydrogenases to each other and to enzymes from other fungal species was
analyzed (Figure 2.2), to attempt to discern specific roles for each C. neoformans
aldehyde dehydrogenase. Three important observations were made from the
phylogenetic tree. First, the nine proteins could be divided principally into two major
groups based on their predicted common ancestor. CNAG_01078 (Ald78),
CNAG_05113 (Ald13), and CNAG_06628 (referred to as Ald5 because that is the
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official designation of the protein) formed the first monophyletic group, whereas
CNAG_06010

(Ald10),

CNAG_06018

(Ald18),

CNAG_05029

(Ald29),

CNAG_03269 (Ald69), CNAG_00735 (Ald35), and CNAG_02377 formed a second
monophyletic group. Within this second group, Ald10 and Ald18 are most closely
related, and then most closely related to Ald29, then to CNAG_02377, next to
Ald69, and finally to Ald35. All of the enzymes in this second group are
evolutionarily very distant from the aldehyde dehydrogenases of S. cerevisiae and
A. nidulans, which was the second major observation.
The above two major groups could be further divided into six groups, in
which one or more of the proteins showed evolutionary relatedness to specific
aldehyde dehydrogenases from other species. For example, CNAG_05029
(Ald29),

the

predicted

meiotic

sister-chromatid

recombination

aldehyde

dehydrogenase in C. neoformans var grubii, is closely related to the meiotic sisterchromatid recombination aldehyde dehydrogenase of Coprinopsis cinerea,
supporting the prediction of a role for Ald29 in sister-chromatid exchange, and also
to the betaine aldehyde dehydrogenase of Phycomyces blakesleanus. These
three enzymes are predicted to have oxidoreductase activity, utilizing NAD+ as an
electron acceptor.
Ald18 (CNAG_06018) and Ald10 (CNAG_06010) were found to be closely
related, not only to each other, but also to aldehyde dehydrogenases in
Cryptococcus gattii and Phanerochaete chrysosporium, suggesting that they could
function in a similar role in C. neoformans as these enzymes. Unfortunately, the
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specific functions of those enzymes in C. gattii and P. chrysosporium are not
known. Nevertheless, the phylogenetic relatedness of CNAG_06018 and
CNAG_06010 is based on their similarity in amino acid sequence, indicating these
proteins are sufficiently alike that they may have redundant or overlapping
functions.
ALD10 and ALD18 (CNAG_06010 and CNAG_06018, respectively) are not
only evolutionarily closely related to each other, but also physically close to each
other in the same chromosome, which might lead one to speculate that they may
be similar to the S. cerevisiae genes ALD2 and ALD3, which are also located in
tandem (Navarro-Aviño et al., 1999). However, S. cerevisiae ald2p and ald3p are
outgroups in the MEGA phylogeny tree and therefore are not closely related to any
of the C. neoformans ALD genes assayed herein. According to the phylogenetic
tree, they are not even closely related to each other, with Ald3p acting as the outlier
group to all other aldehyde dehydrogenases.
Ald69 (CNAG_03269) was found to be most closely related to a C. gattii
aldehyde dehydrogenase (CGB_G2310C), which, according to the Fungi
Database (https://fungidb.org/fungidb/app/record/gene/CGB_G2310C), is in turn
homologous to vanillin dehydrogenases from other fungal species, indicating that
Ald69 may function as a vanillin dehydrogenase or other oxidoreductase. Ald35
(CNAG_00735) was found to be most closely related to an NAD-aldehyde
dehydrogenase in P. chrysosporium (AGR57_4875), which the Fungi Database
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indicated is homologous to succinate-semialdehyde dehydrogenase enzymes
from other species, suggesting that Ald35 may have this function in C. neoformans.
Ald78 (CNAG_01078) and Ald13 (CNAG_05113) were found to be most
closely related to an aldehyde dehydrogenase from Cryptococcus deuterogattii;
unfortunately, a search in the Fungi Database for this protein did not reveal a more
specific function. However, these aldehyde dehydrogenases, along with Ald5
(CNAG_06628) and the equivalent aldehyde dehydrogenase in the KN99 strain,
were determined to be similar to each other and evolutionarily related to S.
cerevisiae aldehyde dehydrogenases Ald4p (YOR374W), Ald5p (YER073W), and
Ald6p (YPL061W) that all act on acetaldehyde as a substrate and/or produce
acetate under different conditions (Aranda and del Olmo., 2003; Saint-Prix et al.,
2004). This was the third major observation based on the phylogenetic analysis,
and it was an important one, since it strongly suggests that one or more of
CNAG_01078, CNAG_05113, and CNAG_06628 (Ald5) are most likely to be the
acetaldehyde dehydrogenase(s) in C. neoformans that function in acetate
production.
All ald mutants have reduced acetate production
In order to determine whether any of the eight out of nine C. neoformans
Alds for which mutants were obtained from the Madhani library, especially Ald5,
Ald13, or Ald78, can function as an acetaldehyde dehydrogenase (leaving
CNAG_02377 as the last option if not), all of the mutants were confirmed to be
deleted for the corresponding gene and assayed for production of acetate. It was
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observed that acetate production was decreased in each of the mutant strains
relative to the wild type strain (Figure 2.6), but, interestingly, was not completely
eliminated. In other words, a complete loss of acetate production did not occur in
cells deficient for any given Ald, suggesting that when a single ALD gene is
deleted, either one or more of the aldehyde dehydrogenases encoded by the other
genes may partially compensate and produce acetate. As mentioned above, this
has been previously shown for the ald6 mutant in S. cerevisiae, in which the yeast
compensates for the deletion of ALD6 by upregulating ALD4 (Saint-Prix et al.,
2004). Alternatively, other pathways not utilizing aldehyde dehydrogenases, such
as one employing Xfp1/2 and Ack, may be used for the production of acetate when
one of the ALD genes is lost, or may contribute to acetate production in general
(Figure 2.1). The retention of some degree of acetate production disproves the
hypothesis that only one of Ald78, Ald13, or Ald5 is the sole C. neoformans
acetaldehyde dehydrogenase, but it strengthens the hypothesis that one of these
may be the major acetaldehyde dehydrogenase, with the other Alds acting as
"backup." Therefore, it is informative to review the results of the other assays to
determine the relative contribution of the various aldehyde dehydrogenases to the
degradation of acetaldehyde (to prevent toxicity) and to the production of acetate,
as well as to identify clues as to the alternative, specific functions of the eight
aldehyde dehydrogenases for which mutants were available.
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Growth assays reveal abnormalities in three C. neoformans ald mutants
The first of these other assays measured growth using glucose or
alternative primary carbon sources. In order to propagate and disseminate inside
the host body despite possible location-to-location differences in the availability of
glucose, C. neoformans utilizes different carbon sources to obtain energy,
including glucose, ethanol, and acetate (Hu et al., 2008; Price et al., 2011).
Therefore, the growth of the mutants on glucose, ethanol, or acetate supplemented
minimal media was compared, both qualitatively and quantitatively, with the growth
of the wild type strain, to determine whether each of the aldehyde dehydrogenases
was necessary for the growth on alternative carbon sources, and therefore in
virulence.
The ald5Δ mutant had a growth defect when it was provided with ethanol
instead of glucose as the primary carbon source (Figures 2.4c and 2.5c). Under
anaerobic conditions, pyruvate, produced from glucose, or ethanol, via alcohol
dehydrogenase, can be converted to acetaldehyde and then to acetate in order to
store energy (within NADPH) in S. cerevisiae (Pronk et al., 1996; Cheung et al.,
2017). At the same time, acetaldehyde is toxic to S. cerevisiae at or above certain
levels (Aranda and del Olmo, 2003; Aranda and del Olmo, 2004), so an inability to
convert it to acetate could kill the cells. In C. neoformans, when ethanol is the sole
or primary carbon source, as it was when the ald5Δ mutant was unable to grow
normally, the ethanol is likely converted to acetaldehyde by the fungus, even under
the aerobic conditions of the experiment. It is therefore possible that the growth
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defect of the ald5Δ mutant may be due to accumulation of acetaldehyde to toxic
levels if deletion of ALD5 results in deficiency of the acetaldehyde dehydrogenase
that converts the acetaldehyde to acetate. In other words, the growth defect on
ethanol suggests that ALD5 encodes the principal acetaldehyde dehydrogenase
and that, to the extent that any mutant cells are able to grow on ethanol, the
aldehyde dehydrogenases encoded by the other ALD genes may partially
compensate by processing the acetaldehyde at lower rates of conversion.
In contrast, the growth assays did not support a role for the enzyme deficient
in the ald13Δ strain as an acetaldehyde dehydrogenase. The ald13Δ mutant
displayed small colonies in the spot assay when grown using acetate or ethanol
(Figure 2.4b or c, respectively), but otherwise grew normally, including producing
normal size colonies when grown using glucose as the carbon source (Figure
2.4a). It also grew normally in the quantitative growth curve assay in liquid media
(Figure 2.5), in which colonies do not form, indicating that deficiency of the Ald13
enzyme has a relatively minor, non-cell autonomous effect on the growth of C.
neoformans, since it did not affect the cells individually, only en masse. Thus, other
than concluding that Ald13 facilitates the use of alternative carbon sources besides
glucose, and that accumulation of its aldehyde substrate by multiple cells
eventually hinders colony growth, it is difficult to discern the specific role for this
enzyme based on the growth assays alone.
The ald69Δ mutant exhibited diminished growth (relative to the wild type
strain) in media supplemented with glucose (Figure 2.4a, 2.5a), whereas it grew
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normally on media containing acetate or ethanol as the primary carbon source
(Figure 2.4 b and c; Figure 2.5 b and c), suggesting that the Ald69 enzyme has a
role in a glucose metabolism pathway. One possible role for this aldehyde
dehydrogenase is as a glyceraldehyde-3-phosphate dehydrogenase in glycolysis.
However, two other C. neoformans var. grubii glyceraldehyde-3-phosphate
dehydrogenases,

CKF44_06699

and

CKF44_004057

(FungiDB;

http://fungidb.org/fungidb/), have been identified, and their protein sequences are
not similar enough (i.e. sharing only 17.67% and 16.67% identity, respectively)
with that of Ald69 to support this hypothesis. Nevertheless, the fact that the ald69Δ
mutant can grow using acetate or ethanol, but not glucose, supports a role for the
enzyme in an upstream part of a glucose metabolism pathway, and not a role as
an acetaldehyde dehydrogenase.
Capsule defects and loss of cell wall integrity was observed in the ald
mutants
In addition to the use of organic molecules as carbon sources to obtain
energy from the environment, C. neoformans also uses them to form, among more
complex molecules, carbohydrates employed as virulence factors. For example,
acetate, via acetyl-CoA, is important in acetylation of the GXM capsule
polysaccharide that constitutes 90-95% of the capsule carbohydrates, and this
acetylation is necessary for the GXM that is shed from the capsule to be able to
reduce neutrophil migration (Rakesh et al., 2008; Vecchiarelli et al., 2011; Hu et
al., 2008; Ellerbroek et al., 2004a, b, c). Additionally, GXM or other capsule
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polysaccharides, when shed into the extracellular space, can inhibit the ability of
host immune cells to generate and secrete pro-inflammatory cytokines (Li et al.,
2018; Siegemund and Alber, 2008; Villena et al., 2008), deplete complement
proteins, and reduce the migration of immune cells, including leukocytes, to sites
of infection (Li et al., 2018; Ellerbroek et al., 2004a,b,c). These capsule
polysaccharides, when shed near or within macrophages, can also directly
interfere with phagocytosis and with the ability of macrophages to present peptides
from phagocytosed fungal cells via their surface MHC molecules (Li et al., 2018;
Siegemund and Alber, 2008; Villena et al., 2008), and even cause macrophage
death, as well as induce macrophages to express Fas ligand and thereby trigger
apoptosis of nearby Fas receptor-expressing T cells (Monari et al., 2005; BenAbdallah et al., 2012; Lupo et al., 2008; Vecchiarelli et al., 1994b). The shed
polysaccharides can also drive down the T-cell response in other ways and
interfere with the activation and proliferation of T cells (Vecchiarelli et al., 2011;
Yauch et al., 2006). Hence, capsule polysaccharides are used for a number of
virulence-enhancing immunomodulatory functions and the fungus may use acetate
to enhance these functions.
The intact capsule is also important for C. neoformans virulence. Upon
entering the lungs, C. neoformans attempts to evade phagocytosis by
macrophages by enlarging its polysaccharide capsule (Okagaki et al., 2010;
Zaragoza et al., 2010; Okagaki and Nielsen, 2012; Levitz and Tabuni, 1991; Xie et
al., 2012; Sabiiti and May, 2012; May et al., 2016). A larger capsule prevents
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macrophages from phagocytosing the fungal cells and allows any phagocytosed
C. neoformans to neutralize the destructive reactive oxygen species produced by
the macrophage (Giles et al., 2009, Velagapudi et al., 2009). Capsule attachment
to the cell wall depends on the chitin monomer, β-1,4 N-acetyl glucosamine, the
production of which requires acetyl groups that can be generated from acetate
(Ramos et al., 2012; Vecchiarelli et al., 2011; Fonseca et al., 2009; Rodrigues et
al., 2008a; Huang et al., 2002; Levitz, 2001; Van Dyke and. Wormley, 2018; Erwig
and Gow, 2016; Hu et al., 2008). Although mutants that are defective in capsule
acetylation are actually hypervirulent (Janbon et al., 2001), acetate production is
likely very important in capsule formation, stability, and function.
It is possible that, through a negative effect on acetate production, or via
other mechanisms, the lack of one or more of the aldehyde dehydrogenases could
negatively affect capsule formation. Therefore, capsule formation/size in the ald
mutants was compared to that of the wild type strain. All of the mutants had much
thinner capsules than the wild type strain, except for the ald10Δ mutant, which also
displayed a smaller capsule, but which was affected to a lesser degree (Figure
2.7). As a further step, the capsule and cell wall integrity of the mutant and wild
type strains were assayed on media containing Congo red or SDS. By binding to
(1,4) β-glucans (or to the chitin monomer, β-1,4 N-acetyl glucosamine), Congo red
interferes with cell wall construction and with the attachment of the chitin and
capsule to the cell wall, while SDS that traverses gaps in the capsule, chitin, or cell
wall lyses the cells by dissolving the plasma membrane (García et al., 2015; Banks
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et al., 2005; Ram and Klis, 2006; Baker et al., 2007; Gerik et al., 2005; Wood et
al., 1983). Thus, in the assays, cells with incompletely formed capsules or cell walls
will have growth defects on these media. While the SDS had no visible effect on
colony growth of either the wild type or mutant strains, all of the mutants were more
seriously affected than the wild type strain by the Congo red, and developed fewer,
smaller colonies (Figure 2.13c), indicating a partial loss of capsule and/or cell wall
integrity. In other words, the lack of ability to grow in media containing Congo red
may reflect a greater permeability for the dye due to the thinner capsules of the ald
mutants. The ald5Δ mutant (Figure 2.13c, second row from the top) while unable
to grow as well as the wild type strain, was least affected by the Congo red, which
may given the potential importance of acetate in capsule formation, weaken the
argument for Ald5 being the principle acetaldehyde dehydrogenase. In contrast,
the ald69Δ mutant exhibited the most severe growth defect. It did not grow at all if
plated at low cell concentrations and grew poorly at higher concentrations of plated
cells (Figure 2.13c, bottom row). This indicated that the enzyme lacking in the
ald69Δ mutant is necessary for capsule and cell wall integrity, likely via a role in
cell wall construction or attachment of the cell wall to the capsule; this may involve
a function for the enzyme in the production or utilization of acetate. Alternatively or
additionally, the failure to process a particular aldehyde due to a lack of the
aldehyde dehydrogenase in each mutant may lead to accumulation of the
respective aldehyde to levels that impede capsule formation. The aldehyde
processed by the Ald69 enzyme might be the most toxic, potentially most strongly
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inhibiting an enzyme, or inhibiting the most enzymes, involved in cell wall
production or in maintaining cell wall and capsule integrity, while the aldehyde
processed by Ald5 appears to be least inhibitory to the maintenance of capsule/cell
wall integrity. This interpretation of the results also matches with the acetate
production results, in which all of the mutants exhibited a similarly reduced ability
to make acetate. If acetate production was the limiting factor in capsule and cell
wall integrity, all of the mutants should have been equally affected by Congo red.
The ald69Δ mutant was sensitive to oxidative and nitrosative stress.
One of the reasons why capsule and cell wall integrity matter to C.
neoformans virulence is that, upon engulfment by an alveolar (or other)
macrophage, C. neoformans is chemically attacked by high concentrations of
reactive oxygen and nitrogen species inside the phagolysosome, leading to its
destruction if it cannot neutralize these free radicals (Missall et al., 2004a).
Therefore, to be pathogenic, C. neoformans that is unable to avoid phagocytosis
must be able to survive oxidative and nitrosative stress, and, to do this, it must be
able to maintain cell wall and capsule integrity (Gerik et al., 2005). As mentioned
above, the capsule protects against reactive oxygen and nitrogen species
produced by phagocytes by neutralizing them and generally keeping them away
from the cell wall (which acts as a second protective layer) and from the cell
membrane (Zaragoza et al., 2008; Zaragoza, 2011). Furthermore, if one or more
of the aldehyde dehydrogenases that are variously deficient in the mutants
produces acetate, since acetate itself or the change in pH it can induce in the
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environment protects the pathogen from the ROS and RNS produced by
macrophages (Giles et al., 2009, Velagapudi et al., 2009), the mutant lacking the
appropriate Ald enzyme should be more sensitive to oxidative or nitrosative stress.
Thus, it was important to determine whether the various ald mutants were more
sensitive to ROS or RNS than the wild type strain. All strains were grown on plates
with hydrogen peroxide as an ROS source or sodium nitrite as an RNS source
(Figures 2.10 and 2.11, respectively). Surprisingly, in both cases only the ald69Δ
mutant was affected. Under oxidative stress, the ald69Δ mutant grew poorly
(Figure 2.10b, bottom row), while under nitrosative stress it turned pink (Figure
2.11b, bottom row), a phenotype reversed when adenine was added to the media
with the sodium nitrite (Figure 2.11c, bottom row). This indicated that the ald69Δ
mutant was inhibited in the production of adenine, such that the accumulation of
either of two red intermediates in the adenine biosynthesis pathway caused the
color change, whereas providing adenine to the cells eliminated the need to use
the pathway and produce the intermediate. The same phenotype has been
observed in S. cerevisiae mutants with deficiencies in adenine production (Smirnov
et al., 1967). Whether the lack of the enzyme deficient in the ald69Δ mutant caused
inhibition of the adenine production pathway via the lack of the enzyme product or
by accumulation of the aldehyde substrate of the enzyme, is unknown. Likewise,
whether an already existing suppression of the adenine biosynthesis pathway due
to lack of Ald69 was enhanced by nitrosative stress or the nitrosative stress
activated the adenine synthesis pathway, which was then inhibited downstream by
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the lack of Ald69, is also unknown. Together with the growth defect on glucose
observed for the same mutant, it does seem that the ald69Δ mutant may have a
more general growth defect than that expected from a role as an acetaldehyde
dehydrogenase or from a lack of acetate production alone. Regardless, it is
interesting that only the ald69Δ mutant, and not the ald5Δ, ald13Δ, or ald78Δ
mutant, or, for that matter, any other aldehyde dehydrogenase deficient mutant,
exhibited sensitivity to both ROS and RNS.
Melanin production is altered in the ald69Δ as well as in the ald5Δ mutant
The correlation between resistance to ROS/RNS and virulence is well
established, indicating that more than one mechanism must be used by virulent
cryptococci to neutralize free radicals. Indeed, secondary to the capsule, melanin
production and deposition in the cell wall promotes resistance to ROS and RNS
(Wang et al., 1995; Xie et al., 1997; Wang and Casadevall, 1994) because melanin
is itself a stable free radical that can react with and directly neutralize ROS/RNS
(Jacobson and Emery, 1991a; Jacobson and Tinnell, 1993; Steenbergen and
Casadevall, 2003). Melanin is therefore used by fungal cells to provide protection
from oxygen and nitrogen derived radicals produced by macrophages, thus
protecting C. neoformans from immune attack, by scavenging these free radicals
(Samarasinghe et al., 2018; Jacobson and Tinnell, 1993; Polacheck and KwonChung, 1988). In fact, melanin deficient mutants of C. neoformans that produce
100-fold less melanin are less virulent than melanin producing strains (Wang et
al., 1995).
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C. neoformans synthesizes melanin (or at least a black, melanin-like
pigment) from chemicals obtained from host cells or from the environment, namely,
catecholamines like L-DOPA, and potentially, aldehydes (Williamson, 1997;
Casadevall et al., 2000; McFadden and Casadevall, 2001; Steenbergen and
Casadevall, 2003; Frases et al., 2007; Eisenman et al., 2007). Conversely, lack of
melanin production may make a mutant more vulnerable to aldehyde accumulation
resulting from ROS/RNS-mediated membrane damage. A failure to counteract
oxidative stress leads to oxidative degradation of cell membrane lipids (i.e. lipid
peroxidation), which gives rise to hundreds of different reactive and toxic
aldehydes (Singh et al., 2013). Thus, C. neoformans aldehyde dehydrogenases
may be necessary to protect against the effects of ROS and RNS by reducing the
levels of those aldehyde by-products (Singh et al., 2013). The ald69Δ mutant
produced abnormally low levels of melanin, which may be directly related to the
growth defect under oxidative and nitrosative stress also exhibited by this mutant.
In contrast, the ald5Δ mutant appeared more melanized than the wild type strain,
which should have made it more resistant to ROS/RNS than the wild type strain,
but it was not. Thus, the mechanisms for the melanin phenotypes of the two
mutants appear to be divergent.
Melanin, and the laccase enzyme that produces it, are located in the
cryptococcal cell wall (Perez-Dulzaides et al., 2018; Walton et al., 2005; Zhu et al.,
2001; McFadden and Casadevall, 2001), which allows the melanin to neutralize
any free oxygen and nitrogen radicals before they can reach the cell membrane
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(Wang et al., 1995; Wang et al., 1996). However, this localization also means that
disruption of cell wall integrity leads to leaking out and loss of the melanin (PerezDulzaides et al., 2018). Along with low melanin levels, the ald69Δ mutant also
exhibited significant defects in capsule formation and thickness, as well as in cell
wall integrity in the Congo red assay. So, it is reasonable to hypothesize that the
loss of cell wall integrity in the ald69Δ mutant is directly responsible for the lack of
melanin, and that, in combination with a deficiency in the ability to eliminate a
potentially toxic aldehyde from the cell, this results in increased cell death under
oxidative stress in the ald69Δ mutant. The reduced capsule thickness observed in
the ald69Δ mutant supports this melanin leakage hypothesis. However, since
melanization of the cell wall increases cell wall thickness (McFadden and
Casadevall, 2001; Feldmesser et al., 2001), it is also possible that the lack of
melanin contributes to the lack of cell wall integrity, either causatively or in a
negative feedback cycle. The block in the adenine synthesis pathway observed in
the ald69Δ mutant under nitrosative stress may be an indicator of a constitutive
defect (that is simply enhanced in the presence of RNS) resulting in generally low
cyclic AMP (cAMP) levels. Since laccase function is regulated by a signal
transduction pathway that is dependent on cAMP (Pukkila-Worley et al., 2005), low
levels of cAMP in the ald69Δ mutant could result in low laccase activity, low
melanin production, and low cell wall integrity, in that order.
As mentioned above, in contrast with the ald69Δ mutant, the ald5Δ mutant
produced more melanin. The capsule of the ald5Δ mutant is no larger than the
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capsule of the ald69Δ mutant, precluding the possibility that more melanin is simply
being retained. Therefore, the simplest explanation for the increased pigmentation
of the ald5Δ mutant is that deficiency of the Ald5 enzyme lead either to a lack of a
metabolic product that normally inhibits laccase activity or to an excess of the
aldehyde substrate of Ald5, which then accumulated and was used as a substrate
by one or both laccases to produce more melanin (Williamson, 1997). Another
possibility is that the ALD5 gene might enhance or play a role in the high osmolarity
glycerol/HOG1 pathway that inhibits melanin production specifically in serotype A
strains of C. neoformans, so a deficiency of ALD5 lead to increased melanin in the
KN99a-derived, and thus serotype A (Nielsen et al., 2003), ald5Δ mutant strain
assayed herein, similar to that observed in the hog1 mutant of this serotype (Bahn
et al., 2005). However, if the ALD5 deficiency does interfere with the high
osmolarity glycerol pathway, then the ald5Δ mutant should have had an abnormal
response to hyperosmolarity in the NaCl/KCl osmotic stress assay, which neither
it nor any other ald mutant exhibited. Yet, it is still possible that Ald5 directly or
indirectly inhibits melanin production downstream of the HOG1 pathway, or that
the aldehyde accumulated in the ald5Δ mutant inhibits the HOG1 pathway
downstream of the response to hyperosmolarity. The substrate or product of Ald5
may also regulate melanin production by influencing some other signaling
pathway.
Since melanin pigmentation was found to be unaltered in the other ald
mutants, either the corresponding genes play no role in the regulation of melanin
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production or the corresponding enzymes are somewhat redundant in function, so
loss of one aldehyde dehydrogenase is compensated for by the other enzymes
and thus has no effect on melanin production. In either case, it is clear that at least
Ald5 plays either a metabolic or regulatory role in melanin production, regardless
of whether or not it functions in acetate production, while the enzyme deficient in
the ald69Δ strain plays a role either in melanin production or in cell wall or capsule
integrity, or both.
Only the ald29Δ mutant has a defective hypoxia response, which is rescued
by the presence of acetate
After dissemination, C. neoformans encounters and must cope with a
hypoxic state in infected tissues (Erecińska and Silver, 2001; Kronstad et al., 2012;
Chang et al., 2007). For example, oxygen concentrations in the human brain are
significantly lower, at 1-5%, than atmospheric levels and levels present in the lungs
(i.e. ~14-21% oxygen), requiring C. neoformans to adapt to this hypoxia to infect
the brain (Erecińska and Silver, 2001; Kronstad et al., 2012; Chang et al., 2007).
Growth under hypoxia forces the use of fermentation, in which acetaldehyde
dehydrogenase activity may be utilized by wild type C. neoformans to produce
acetate and NADPH. So, a growth defect of an ald mutant under hypoxia might
signify a deficiency of the acetaldehyde dehydrogenase function of the
corresponding enzyme. Therefore, the survival/growth of the wild type and mutant
strains under conditions mimicking hypoxia was assayed.
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Many mammalian studies have used cobalt chloride (CoCl2) to induce
hypoxia-mimicking conditions (Goldberg et al., 1987; Wang and Semenza,
1993a,b; Wang et al., 2000; Huang et al., 2003; Grasselli et al., 2005). Likewise, it
has been shown that growth of fungi on media containing CoCl2 can be used to
mimic hypoxia in fungal assays, although the mechanism of action is different from
that in animals (Goldberg et al., 1987; Wang and Semenza, 1993a, b; Lee et al.,
2007; Chun et al., 2007; Chang et al., 2007). In fungi, including in C. neoformans,
CoCl2 induces the Tco1/HOG pathway, as well as expression and activation of
Sre1p and Scp1p, which drive the oxygen dependent, and therefore oxygen
sensing, sterol synthesis pathway; CoCl2 does this in the same way as hypoxia
itself, making the fungal cells behave as if they are in low oxygen (Lee et al., 2007;
Chun et al., 2007; Chang et al., 2007; Bahn et al., 2005). Hence, the growth of the
ald mutant and wild type strains on cobalt chloride containing media was assayed.
Of note, cobalt chloride treatment also increases the production of ROS (Guzy et
al., 2007), since the cobalt ion in the cobalt chloride can drive the production of
ROS via the Fenton reaction just like iron (Ingavale et al., 2008), so results from
the hypoxia and oxidative stress assays were analyzed together to determine if
any mutant phenotype was due to hypoxia or ROS.
Only the ald29Δ mutant (and not the ald5Δ nor the ald69Δ strain) was
sensitive to the use of cobalt chloride to mimic hypoxia. Moreover, this sensitivity
was due to the lack of ability of the mutant to respond properly to hypoxia, and not
due to a sensitivity to ROS or RNS, since this mutant grew normally on media with
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hydrogen peroxide or sodium nitrite. This, together with the finding that
supplementing CoCl2 treated plates with acetate restored normal growth of the
ald29Δ mutant, strongly suggests that the corresponding aldehyde dehydrogenase
functions in fermentation and acetate production. Therefore, it is possible that
Ald29 functions as a major acetaldehyde dehydrogenase and produces acetate,
despite the lack of homology to the major acetaldehyde dehydrogenases in S.
cerevisiae. The specific requirement for the Ald29 enzyme for cryptococcal survival
under low oxygen conditions indicates that this Ald is a virulence factor in C.
neoformans and that either it plays a role in the production of acetate by an
anaerobic, fermentation-based pathway such that supplementing with acetate
eliminates the need for the enzyme, or it functions in a hypoxia response pathway
that can be replaced by a secondary, acetate-dependent pathway.
In vitro and in vivo virulence assays reveal a role for several Alds in
pathogenicity
Once the effects of a deficiency of the various aldehyde dehydrogenases
on survival under the assortment of stresses associated with infection of a host
were determined, the next logical step was to test the effects on virulence itself,
using in vitro and in vivo assays. Part of the virulence for C. neoformans involves
evading or surviving phagocytosis. C. neoformans var neoformans isolated from
the lungs of previously infected mice express high levels of an ALD transcript (Hu
et al., 2008) encoding a protein with 96.25% sequence identity to Ald5 from C.
neoformans var. grubii. Moreover, after ingestion by macrophages, C. neoformans
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var grubii upregulates expression of ALD5 (Derengowski et al., 2013). This
indicates that expression of this aldehyde dehydrogenase is important to protect
the fungal cell from phagocytosis or from destruction by the macrophage after
engulfment. Expression of other ALD genes may also be required to survive
phagocytosis. Furthermore, the smaller capsules observed for the aldehyde
dehydrogenase mutants in the capsule formation assay should make these
mutants more prone to phagocytosis and destruction by macrophages. Therefore,
the effect of deficiency of each Ald, in the corresponding knockout mutant, on
phagocytosis and survival after engulfment was quantified in an in vitro
macrophage assay (Figure 2.14). The C. neoformans ald5Δ, ald13Δ, ald29Δ,
ald69Δ, and ald78Δ mutants exhibited statistically significantly reduced survival
inside the macrophages and recovery afterwards, versus the wild type strain
(40.45%, 65.47%, 28.08%, 22.95% and 30.09% survival after phagocytosis,
respectively, with P-value = 0.0006, P-value = 0.0417, P-value < 0.0001, P-value
= 0.0004, and P-value = 0.0028, respectively). This confirms a role for each of the
corresponding Ald enzymes in virulence. However, it does not reveal their specific
roles in pathogenesis. Whether the inability of the ald5Δ mutant to grow on ethanol
plays any role in its low survival inside macrophages is uncertain, and the ald5Δ
and ald69Δ mutants have opposite defects in melanization, eliminating a common
melanin-production defect as the cause for low survival. While the growth defect
of the ald29Δ mutant under hypoxia-mimicking conditions, and the dependence of
this defect on the absence or presence of acetate, as well as the lack of cell wall
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integrity and sensitivity to ROS/RNS of the ald69Δ mutant, are most likely relevant
to the decreased survival of these mutants inside the macrophages, these
phenotypes are not shared between ald5Δ, ald29Δ, and ald69Δ mutants, so no
one phenotype is associated with reduced recovery from phagocytosis. Likewise,
all of the mutants, including those that had normal survival after phagocytosis,
exhibited smaller capsules and produced lower than normal levels of acetate, so
these phenotypes, while potentially relevant, are not the cause of the reduced postengulfment survival of the ald5Δ, ald13Δ, ald29Δ, ald69Δ, and ald78Δ strains.
Thus, it appears that each of these mutants was more vulnerable to phagocytosis
than the wild type strain due to the loss of individual pathways resulting from the
deletion of the corresponding gene. Nevertheless, Ald5 and the enzymes deficient
in the ald29Δ and ald69Δ mutants are clearly required for virulence of C.
neoformans, at least in vitro.
For the in vivo virulence assay, the larvae of Galleria mellonella, commonly
known as the greater wax moth, were used. G. mellonella is an ideal model to study
the processes of C. neoformans infection and virulence. The larvae are quite easy
to obtain, are inexpensive to grow and maintain in the lab since they can be kept
in Petri dishes with wood chips, and can be infected or treated with various reagents
via any one of multiple delivery systems, including topical application, oral delivery,
or injection, without significantly traumatizing the insect (Fuchs et al., 2010;
Kavanagh and Sheehan, 2018). The latter property permits relatively quick
infection of multiple larvae with specific fungal pathogens. G. mellonella
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encounters various microbes in its natural environment and has therefore evolved
the capacity to produce specific immune responses that are similar to those of
potential mammalian hosts of C. neoformans (Fuchs et al., 2010; Kavanagh and
Sheehan, 2018). Specifically, the early phagocyte response can be studied using
this model organism, as it possess 6 different types of phagocytic cells:
prohemocytes, coagulocytes, spherulocytes, oenocytoids, plasmatocytes, and
granulocytes; additionally, a change in the concentration of hemocytes subsequent
to infection reflects the overall immune response (Arvanitis et al., 2013; Tsai et al.,
2016). Moreover, the structural, cellular, humoral, and molecular level responses of
these phagocytic cells are similar to those of the mammalian innate immune
response (London, et al., 2006). Furthermore, the ability of G. mellonella to grow
at 37°C, which is human body temperature, as opposed to 25°C, the preferred
temperature for many other non-mammalian model organisms, makes it an ideal
system to study factors required for mammalian infection by fungi like C.
neoformans, without the expense associated with a mammalian model organism
(Fuchs, et al., 2010; Kavanagh and Sheehan, 2018). To study the virulence of C.
neoformans, the mortality rate of the larvae can be assessed over a short span of
time after infection, due to a relatively short time course from infection to lethality,
and thus, the importance of numerous C. neoformans genes in virulence can be
investigated with high efficiency (Arvanitis et al., 2013). Here, the wild type and
certain ald mutant strains were injected into the larvae and their virulence was
assayed in vivo. At the time that the G. mellonella larvae were available in the lab,
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only a version of the ald5Δ, ald13Δ, and ald78Δ mutant strains in the H99
background, had been obtained. When these mutants were tested for their ability
to kill the G. mellonella larvae, the ald5Δ strain exhibited statistically significantly
reduced virulence relative to the wild type H99 strain, in that the larvae infected
with ald5Δ mutant cells survived longer than the larvae infected with the same
number of wild type cells (Figure 2.15). Larvae injected with the ald13Δ strain also
survived longer than those injected with the wild type strain, but the overall
difference in the larval survival curves was not significant, likely because the first
larvae of each group died on the same day post-injection. The ald78 mutant
exhibited severely reduced virulence, and larvae injected with this mutant had
close to the same survival as larvae injected with PBS alone or with heat killed wild
type cells, the two negative controls. These results confirm that Ald5 is required
for full C. neoformans virulence in vivo just as it is in vitro, and strongly supports
the in vitro assay result that the enzyme deficient in the ald78Δ strain is critical for
the virulence of C. neoformans. It is possible that, if the virulence of the other
mutant strains were assayed in the G. mellonella model, the ald29Δ and ald69Δ
strains would also take longer to kill the larvae, and this should be tested in the
future.
In summarizing the evidence for a role in overall pathogenicity across
multiple assays, several Ald enzymes rise to prominence. Ald5 seems to be an
important virulence factor, based on the results of the melanin production assay,
the macrophage survival assay, and the Galleria infection/survival assay (Figures
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2.8, 2.14, and 2.15, respectively). The enzyme deficient in the ald78Δ mutant is
also important for pathogenicity, since the mutant has reduced survival after
macrophage engulfment and severely attenuated virulence in Galleria larvae
(Figures 2.14 and 2.15, respectively). The fact that the ald29Δ mutant is unable to
grow under hypoxia-mimicking conditions unless acetate is provided (Figure 2.9b
and 2.9c, respectively) and exhibits reduced survival/recovery after engulfment by
macrophages relative to the wild type strain (Figure 2.14), strongly suggests that
the corresponding enzyme is also required for C. neoformans virulence. The
ald69Δ mutant not only lacked the ability to utilize glucose (Figure 2.4a and Figure
2.5a), but also exhibited a growth defect under oxidative stress (Figure 2.10), a
mutant phenotype, albeit an unexpected one, under nitrosative stress (Figure
2.11), a severe growth defect when its cell wall integrity was challenged (Figure
2.13c), reduced levels of melanin compared with the wild type strain (Figure 2.8),
and, finally, a statistically significant reduced survival after engulfment by
macrophages (Figure 2.14), all indicative of a role for the corresponding enzyme
in virulence.
Ald5 and Ald29 are the leading candidates for the C. neoformans
acetaldehyde dehydrogenase
Following infection, C. neoformans may depend for survival inside the host
on alternate carbon sources like acetate or ethanol (Ries et al., 2018), the latter of
which is first converted to acetaldehyde and then, via acetaldehyde
dehydrogenase, to acetate for use. The evolutionary relatedness of C. neoformans
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Ald5 (CNAG_06628), Ald78 (CNAG_01078), and Ald13 (CNAG_05113) to the S.
cerevisiae acetaldehyde dehydrogenases Ald4p, Ald5p, and Ald6p (Saint-Prix et
al., 2004), suggests that may be used by C. neoformans to produce acetate. The
finding that the ald5Δ mutant was unable to grow on ethanol, both in the spot assay
(Figure 2.4c) and in the liquid media quantitative assay (Figure 2.5c), is in line with
a role for Ald5 as an acetaldehyde dehydrogenase. In contrast, although the
ald13Δ mutant also exhibited a growth defect on acetate or ethanol supplemented
minimal media, the lack of a cell autonomous mutant phenotype in the equivalent
growth curve assays indicates that Ald13 is not likely to function as an
acetaldehyde dehydrogenase. The ald78Δ mutant grew normally on ethanol,
implying that Ald78 also is not an acetaldehyde dehydrogenase.
Ald29 is not as closely related to the S. cerevisiae acetaldehyde
dehydrogenases, yet it is a candidate for the C. neoformans acetaldehyde
dehydrogenase. The ald29Δ mutant is unable to grow under hypoxia mimicking
conditions (Figure 2.9b), but recovers when provided acetate (Figure 2.9c), which
suggests

that

the

corresponding

enzyme

may

be

an

acetaldehyde

dehydrogenase, but, given the lack of a mutant phenotype under other stresses,
may be used only under hypoxia. Under this hypothesis, deficiency of this enzyme
prevents anaerobic production of sufficient levels of acetate for survival. One can
speculate that the pathogen primarily uses Ald5 to produce acetate to alter the pH
in an environment in which oxygen is present, for an immunomodulatory or other
protective purpose, while using Ald29 to generate acetate and NADPH under
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anaerobic/hypoxic conditions for use in fermentation and growth in ethanol. If so,
Ald29

might

have

evolved

an

acetaldehyde

dehydrogenase

function

independently, and not from any evolutionary relationship with Ald5, Ald78, or S.
cerevisiae aldehyde dehydrogenases.
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Potential future experiments
While the assay results described herein provide clues as to which C.
neoformans

aldehyde

dehydrogenases

may

function

as

acetaldehyde

dehydrogenases, greater certainty of this role might be possible with more
evidence.
As mentioned above, the reduced (but not eliminated) acetate production in
each C. neoformans ald mutant is similar to that observed in S. cerevisiae mutants
deficient in Ald6p or deficient in Ald5p. In S. cerevisiae this was considered
evidence for partial compensation for deletion of one ALD gene by the remaining
enzymes via upregulation of the remaining aldehyde dehydrogenase genes
(Aranda and del Olmo, 2003; Meaden et al., 1997; Saint-Prix et al., 2004; Remize
et al. 2000). The hypothesis that the C. neoformans enzymes also partly
compensate for each other via the same upregulation mechanism can be tested
by quantifying the expression of the remaining ALD genes in each C. neoformans
ald deletion mutant.
Additionally, quantifying the level of the mRNAs encoding each aldehyde
dehydrogenase in wild type (or pyruvate decarboxylase deficient) C. neoformans
grown on media supplemented with glucose, ethanol, acetate, or acetaldehyde
might also reveal which Ald functions in acetaldehyde/acetate metabolism. When
Aranda and del Olmo (2003) quantified the mRNA levels of the three S. cerevisiae
cytoplasmic aldehyde dehydrogenases in fermentative and flor (industrial wine
aging) yeast strains grown in glucose or ethanol containing media, they found that
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ALD2 and ALD3 expression is increased with growth in ethanol versus with growth
in glucose, while ALD6 expression is the opposite. Furthermore, yeast grown in
glucose generally decrease expression of ALD6, while yeast grown in ethanol
increase expression of ALD6, after acetaldehyde is added (Aranda and del Olmo,
2003). Conversely, flor yeast grown in glucose increase, while those grown in
ethanol decrease, ALD2 and ALD3 mRNA levels when acetaldehyde is added
(Aranda and del Olmo, 2003). These inverse expression patterns of the S.
cerevisiae cytosolic aldehyde dehydrogenase mRNAs may be imitated by the C.
neoformans aldehyde dehydrogenases. The major C. neoformans acetaldehyde
dehydrogenase(s) should have an ALD6-like expression pattern in glucose or
ethanol with and without acetaldehyde when measured by quantitative reverse
transcription PCR (qPCR).
Additionally, based on the findings of Aranda and del Olmo (2003), as well
as the SAGE analyses of Hu et al. (2008) and Derengowski et al. (2013) after
cryptococcal infection of model organisms, qPCR or RNA-Seq experiments can be
used to determine which genes involved in various metabolic and virulence
pathways are upregulated or downregulated in the mutants grown on various
carbon sources (i.e. glucose, ethanol, or acetate) with or without acetaldehyde or
under various stresses. Changes in the gene expression profile of the mutants
versus the wild type strain under these various assay conditions combined with a
gene ontology analysis of the transcriptome could provide clues about the function
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of the enzyme deficient in each mutant, including whether or not the enzyme is
necessary to process acetaldehyde.
The results of these assays could also be correlated with measurement of
acetate production by the strains grown with and without non-toxic levels of
acetaldehyde, since one would expect that the mutant lacking acetaldehyde
dehydrogenase function would not have increased acetate production through the
conversion of the acetaldehyde, but all other mutants would increase the
expression of the corresponding gene missing in this mutant.
It would be informative to conduct the assays involving growth under
oxidative and nitrosative stress, growth on Congo red containing medium, and
induction of capsule and melanin formation, all using media supplemented with
acetate to see if the mutants that exhibit phenotypes in those assays are rescued
by supplementation with acetate that they are perhaps unable to make on their
own, just as acetate supplementation rescued the ald29Δ mutant in the hypoxia
assay. If so, the deficient enzyme is likely to have a significant role in the production
of acetate, likely as one of the acetaldehyde dehydrogenases.
It might also be informative to produce ald double and triple mutants in C.
neoformans. Such mutants are informative in S. cerevisiae. For example, the
reduced growth of the ald4, ald6 double mutant compared with either single mutant
indicated a previously overlooked role for Ald4p. The role of Ald5p in acetaldehyde
and acetate metabolism is emphasized by the fact that an ald4, ald5, ald6 triple
knockout has a more severe phenotype, both in terms of a growth defect and in
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terms of acetate production, than the ald4, ald6 double mutant (Saint-Prix et al.,
2004). In contrast, Ald2p and Ald3p were revealed to be irrelevant to acetate
production based on the finding that the ald2, ald3, ald4, ald6 quadruple mutant
phenotype is no different than that of the ald4, ald6 double mutant, and a mutant
that is null for ALD2, ALD3, ALD4, ALD5, and ALD6 has a similar phenotype to
that of the ald4, ald5, ald6 triple mutant (Saint-Prix et al., 2004). Thus, generation
of double, triple, or quadruple ald mutant strains of C. neoformans, followed by
measurement of their acetate production, might reveal the relative contributions of
each C. neoformans Ald in the production of acetate, and assaying the growth and
other phenotypes of these multiple mutants might uncover the relative importance
of each Ald in virulence.
While the assays already conducted strongly suggest which aldehyde
dehydrogenase enzymes are most important for virulence of C. neoformans, it
might be informative to repeat the Galleria larval survival assay using the KN99α
strain mutants (as opposed to the H99α-based mutants), in particular the ald5Δ,
ald13Δ, ald29Δ, ald69Δ, and ald78Δ strains that exhibited significant differences
from the wild type strain in one or more of the other assays described herein. On
the other hand, while G. mellonella is an optimal invertebrate model to study the
processes of C. neoformans infection and virulence, the study of dissemination of
C. neoformans to various organs cannot be assessed using this model organism,
due to vastly different visceral organs between insects and vertebrates and the
lack of lungs and a true brain in G. mellonella. The macrophage survival assay can
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address some of these concerns, since it uses mouse macrophages, making at
least some analysis of post-infection host cell genome expression changes
possible. However, in order to truly understand the progress of infection, vertebrate
organisms, generally mice or zebrafish, must be used as infection models,
especially to study the effect of deficiency of a particular C. neoformans aldehyde
dehydrogenase on dissemination to the brain as a critical step in virulence.
Moreover, the results already described from the Galleria survival assay may
reflect a disparity between insect immune systems and mammalian immune
systems (Tojo, S. et al., 2000), and the use of a mammalian model organism is
required in order to verify these results. Therefore, it would be advisable to test the
ald5Δ, ald13Δ, ald29Δ, ald69Δ, and ald78Δ strains, as well as the wild type strain,
all in a KN99α background, for their virulence (along with PBS and heat killed wild
type strain as negative controls) in a mouse model of pulmonary infection or
cryptococcal meningitis.
Based on the results already obtained in this work, a complete analysis of
these mutants, including the experiments proposed above, will likely reveal one or
more of the corresponding aldehyde dehydrogenases to be a suitable target for
pharmaceutical intervention to treat cryptococcal meningitis in humans and reduce
its lethality.
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Table 2.1: List of genes/enzymes deficient in the mutants used in this study.
Name
used in
this
study

Official Enzyme name†

Identification
Number†

Chromosome†

Location‡

ald5

Aldehyde dehydrogenase
(NAD)

CNAG_06628

7

Cytoplasmic

ald10

Aldehyde dehydrogenase
(NAD), variant

CNAG_06010

12

Cytoplasmic

ald13

Aldehyde dehydrogenase
(NAD)

CNAG_05113

4

Mitochondria

ald18

Aldehyde dehydrogenase
(NAD), variant

CNAG_06018

12

Cytoplasmic

ald29

Meiotic Sister-Chromatid
recombination aldehyde
dehydrogenase

CNAG_05029

4

Cytoplasmic

ald35

Aldehyde dehydrogenase
family 7 member A1

CNAG_00735

1

Mitochondria

ald69

Aldehyde dehydrogenase

CNAG_03269

8

Mitochondria

ald78

Aldehyde dehydrogenase
(NAD)

CNAG_01078

5

Cytoplasmic

†The official enzyme name and identification number, as well as the chromosomal
location of each corresponding gene, were obtained from the Fungi Database,
https://fungidb.org/fungidb/app/record/gene/CNAG_06628.
‡The predicted mitochondrial or cytoplasmic cellular location of each protein was
determined

using

the

MitoFates

website

bin/top.cgi; (Fukasawa et al., 2015).
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http://mitf.cbrc.jp/MitoFates/cgi-

Table 2.2: List of primers used to verify deletion of ALD genes in mutant
strains.
Mutant
strain
ald5
ald10
ald13
ald18
ald29
ald35
ald69
ald78

ID #

Forward primer

Reverse primer

bp product

CNAG_06628
CNAG_06010
CNAG_05113
CNAG_06018
CNAG_05029
CNAG_00735
CNAG_03269
CNAG_01078

cgcttgttgaggatgcattg
caatctcctcgttcgccaag
gcaactggtgaatgagtccc
tgaacccctcatgtcccttc
agtcgtcgagttctgcatcc
tcgattgcttgtttccctcg
ccgaaaagctcagtcactcg
acgtcacggaatttcttgcc

tatcaaggtcccgctccatc
ggtactgaagaagcacctcg
caagcttatcactgtcccgc
tgcttgatactcatacagcgc
gcacccaaccacgaacattac
gatttggcgaacgacctctc
ctcacgtttccagttcaccg
tctttgctggcggtttgaac

1496
1381
1473
1317
1641
1630
1559
1718
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Figure 2.1: Various C. neoformans metabolic pathways that utilize pyruvate.
Ethanol, glucose and acetate can be used as sources of carbon by C. neoformans.
Under anaerobic conditions glucose is converted to acetate by the action of
pyruvate decarboxylase (Pdc) and acetaldehyde dehydrogenase enzymes.
Ethanol in the cells is converted to acetaldehyde via alcohol dehydrogenase, which
is then converted to acetate via acetaldehyde dehydrogenase.
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Figure 2.2: Phylogenetic tree analysis showing evolutionary relatedness
between specific aldehyde dehydrogenases (Alds) of C. neoformans and
Ald6p, Ald4p and Ald5p of S. cerevisiae. The sequences of putative
cryptococcal aldehyde dehydrogenases and potential homologues from other
fungal species were analyzed using Molecular Evolutionary Genetics Analysis
(MEGA X) software to build a phylogenetic tree. Depending on the sequence
similarity, each of the Alds could be subdivided into 6 groups (shown in different
colors). From the analysis, it was deduced that CNAG_01078 (Ald78),
CNAG_05113 (Ald13), and CNAG_06628 (Ald5) of C. neoformans were closer to
aldehyde dehydrogenases Ald4p, Ald5p, and Ald6p of S. cerevisiae than
CNAG_06010

(Ald10),

CNAG_06018
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(Ald18),

CNAG_05029

(Ald29),

CNAG_00735 (Ald35), CNAG_03269 (Ald69), or CNAG_02377. C. neoformans
Ald78, Ald13 and Ald5 were also closely related to each other, while Ald10 and
Ald18 were closely related to each other, and to lesser extent, to Ald29.
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Figure 2.3: Verification of the deletion of each ALD gene in the
corresponding mutant. Primers specific for each aldehyde dehydrogenase gene
(either 1 and 2, or 3 and 4, as shown above) and for the NAT gene conferring
resistance to the nourseothricin antibiotic (107 and 108 above) were used in PCR
to confirm the insertional mutagenesis and deletion of the aldehyde
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dehydrogenase gene in each of the corresponding ald mutants obtained from the
Madhani lab at UCSF. Specifically, these mutants were checked for the
replacement of the ALD genes with the nourseothricin resistance cassette (NAT).
(a) The presence of a band representing each gene in the lanes corresponding to
the reactions with wild type (WT) strain DNA, but not in the lanes corresponding to
the respective mutants (D), corroborated the deletion of the respective ALD genes
in the mutants used in this study. (b) The presence of the NAT gene (~1600 bp) in
all of the ald mutants, but not in the wild type strain (KN99a) was confirmed,
verifying that resistance to nourseothricin in the mutants is due to the presence of
the NAT cassette and not due to metabolic changes in the cells.
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Figure 2.4: Qualitative growth analysis revealed growth defects in ald5Δ,
ald13Δ, and ald69Δ mutants. Four 10-fold serial dilutions (2 µl of 5000, 500, 50,
and 5 cells/µl) of each mutant strain, and of the wild type (WT) KN99a strain, of C.
neoformans were spotted from left to right on YNB-agar media supplemented with
(a) 2% glucose, (b) 2% acetate, or (c) 2% ethanol. The ald69Δ mutant strain
exhibited reduced growth (relative to wild type) on a) 2% glucose, while the ald13Δ
mutant strain had a smaller colony size (relative to wild type) on b) 2% acetate,
and c) 2% ethanol. The ald5Δ mutant grew extremely poorly on c) 2% ethanol, but
grew normally on a) 2% glucose and on b) 2% acetate.
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Figure 2.5: Quantification of the impact of deletion of ALD genes on growth
in liquid media with various primary carbon sources. Growth curves for the
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wild type (KN99a) strain and for each ald mutant strain of C. neoformans were
generated over a 48-hour time course in YNB media supplemented with a) 2%
glucose, b) 2% acetate, or c) 2% ethanol as the primary carbon source. The
ald69Δ mutant displayed a reduced growth rate in a) glucose (* = significant, P<
0.05; P-value = 0.0210, 0.0429, 0.0315, and 0.0320 at 24, 31, 38, and 48 hours,
respectively), but not in b) acetate or c) ethanol, while the ald5Δ mutant displayed
a reduced growth rate in c) ethanol (** = very significant, P<0.01; P-value = 0.0052
overall), but not in a) glucose or b) acetate.
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Figure 2.6: All ald mutants produced significantly less acetate than the wild
type strain after 12 hours. A 48-hour time course analysis revealed significantly
reduced acetate production by all of the ald mutant strains after 12 hours (P-value
< 0.0001 overall), compared with the KN99a wild type (WT) strain. The degree of
significance of the difference between the acetate production by each mutant and
the wild type strain is indicated as follows: ** P-value < 0.01 (very significant), ***
P-value < 0.001 (highly significant), **** P-value < 0.0001 (extremely significant).

211

Figure 2.7: ALD genes played an important role in capsule formation. Cells
from each of the various mutant strains and from the wild type KN99a strain were
cultured in capsule-inducing medium and stained with India Ink. A white line shows
the width of the capsule in the wild type (WT) KN99a strain (left-most image). The
width of the capsule in all of the mutant strains was reduced relative to that of wild
type, as observed visually at 40x magnification, although the capsule of the ald10Δ
mutant was slightly larger than that of the other mutants.
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Figure 2.8: The ald69Δ mutant produced less melanin and the ald5Δ mutant
produced more melanin than the wild type strain. A spot assay was conducted
to visually compare the level of melanin production in ald mutants relative to the
wild type (WT) KN99a strain. Cells from each strain were allowed to grow on plates
supplemented with L-DOPA, which is converted to the brown, melanin-like pigment
by laccase enzymes (Williamson, 1997; Li et al., 2018). The ald69Δ mutant
displayed a lighter coloration, whereas the ald5Δ mutant exhibited a darker
coloration, compared with the wild type strain.
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Figure 2.9: The ald29Δ mutant grew poorly under hypoxia-mimicking
conditions. Spot assays were conducted in which the wild type (WT) KN99a strain
and ald mutants (in the same strain background) were grown on a) nutrient rich
YES media without CoCl2 as normoxic control (Normoxic Control), or b) YES
media supplemented with 0.7 mM CoCl2, which induces cells to behave
physiologically as if they were growing in hypoxia (0.7 mM CoCl2). The ald29Δ
mutant grew normally on the control plate but exhibited a growth defect when
conditions mimicked hypoxia. c) This growth defect was reversed when plates with
CoCl2 were supplemented with acetate (0.7 mM CoCl2 + 2% Acetate).
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Figure 2.10: Ald69 was important for the survival of C. neoformans under
oxidative stress. Wild type (WT) and ald mutant strains (in the KN99a strain) were
grown on YNB-agar media with sodium succinate pH 4.0 buffer, either a) alone as
control or b) supplemented with 1 mM H2O2 to generate reactive oxygen species.
All mutants grew normally relative to the wild type strain, except the ald69Δ mutant
(bottom row), which exhibited a growth defect when subjected to oxidative stress.
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Figure 2.11: The ald69 mutant exhibited an adenine production defect under
nitrosative stress. Wild type and ald mutant strains (in a KN99a background)
were grown on YNB-agar media with sodium succinate pH 4.0 buffer, either a)
alone as control or b) supplemented with 1.5 mM NaNO2. All mutants grew
normally relative to the wild type strain, except that the ald69Δ mutant grew as pink
colonies under nitrosative stress (b, bottom row), possibly indicative of
accumulation of a red substrate, P-ribosylamino imidazole (AIR) or P-ribosylamino
imidazolecarboxylate (CAIR), (Sharma et al., 2003; Smirnov et al., 1967) in the
adenine synthesis pathway due to a blockage in the pathway. c) Nitrosative stress
from the NaNO2 was confirmed to cause this adenine production defect, and this
defect was confirmed to be the reason for the pink colonies, when all strains were
grown on media supplemented with both 1.5 mM NaNO2 and 225 µg/ml adenine;
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the addition of adenine negated the need for the manufacture of adenine by the
cells and thereby eliminated the pink color of the ald69Δ mutant colonies. The
global contrast of this image was increased by 20% to better reveal the pink color.
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Figure 2.12: ald mutants grew normally under high salt conditions. Wild type
and ald mutant strains (in the KN99a background) were grown on YPD-agar plates
a) without further salt added (as control) or supplemented with b) 1.5 M NaCl or c)
1.2 M KCl in order to induce osmotic stress. All mutants grew normally relative to
the wild type strain.
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Figure 2.13: The ald69Δ mutant had defects in cell wall and/or capsule
integrity. Wild type (WT) and ald mutant strains (in a KN99a background) were
grown on YPD-agar plates, either a) alone or supplemented b) with 0.03% SDS
for cell membrane disruption or c) with 0.5% Congo red, which disrupts cell wall
production by passing through the capsule and binding to components of the cell
wall and chitin layers. No growth defect was observed on SDS containing media
(b), whereas, in Congo red containing media (c), all mutants exhibited a slight
growth defect and smaller colonies, either reflecting the greater permeability of
their thinner capsules or indicating a loss of cell wall integrity and resulting
reduction in fitness. The ald69Δ mutant displayed the most obvious growth defect
in the presence of Congo red (c, bottom row, left spot).
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Figure 2.14: Percent survival of wild type and ald mutant C. neoformans
strains after engulfment by macrophages. The ald5Δ, ald13Δ, ald29Δ, ald69Δ,
and ald78Δ mutants demonstrated statistically decreased survival and recovery,
relative to the wild type KN99α strain, after phagocytosis and attempted killing by
macrophages (* = significant, P-value < 0.05; ** = very significant, P-value < 0.01;
*** = highly significant, P-value < 0.001; **** = extremely significant, P-value <
0.0001), but not ald10Δ, ald18Δ, or ald35Δ.
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Figure 2.15: Galleria mellonella survival assay. The survival of Galleria
mellonella larvae was analyzed after infection with 1×106 fungal cells of
various strains of C. neoformans, ten larvae per strain. The percent survival
of these larvae over time, after injection with the wild type H99 (black), ald5Δ
(orange), ald13Δ (blue), or ald78Δ (red) strains of C. neoformans, or with the
negative controls of phosphate buffered saline (PBS; dotted black) or heatkilled wild type strain (Dead H99; dashed black), are graphed as Kaplan-Meier
survival curves. Statistical analysis of the overall survival curves, using either
a Gehan-Breslow-Wilcoxon test or Log-Rank test, indicated that the ald5Δ
strain was less pathogenic (* P-value < 0.05) than the wild type strain, while
the ald13Δ strain was either only slightly (non-significantly) less pathogenic, or no
less pathogenic, than the wild type strain. Deletion of the corresponding gene
in the ald78Δ strain effectively eliminated pathogenicity of this mutant strain
(**** P-value < 0.0001).
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CHAPTER THREE

THE ROLE OF PYRUVATE DECARBOXYLASE IN THE STRESS RESPONSE
AND PATHOGENESIS OF C. NEOFORMANS
Mufida Ammar, Nitya Muppala, Erin Mihealsick, and Kerry Smith
Department of Genetics and Biochemistry, Clemson University, Clemson, South
Carolina, USA

Abstract
Acetate is one of the major metabolites secreted by cryptococci cultured in vitro
and found in biopsies of infected rat brain and lung tissues. In this study, the role
of Cryptococcus neoformans pyruvate decarboxylase, the first enzyme in a
putative acetate-production pathway, in the stress response and pathogenesis of
C. neoformans was investigated. A C. neoformans pdcΔ mutant was ineffective in
producing acetate and exhibited substantially reduced growth in an environment
where glucose was the only carbon source. Additionally, melanization and capsule
formation, which are important for pathogen virulence, negatively affected in the
mutant. Surprisingly, despite the significant capsule formation defect, the ability of
the pathogen to neutralize reactive oxygen and nitrogen species and to grow under
high osmolarity conditions was not affected in the pdcΔ strain. However, the pdcΔ
mutant was unable to cope in an assay mimicking the low oxygen conditions found
in the host brain and the survival of the pathogen inside murine macrophages was
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compromised. Nevertheless, no changes were observed in the ability of the pdcΔ
mutant versus wild type C. neoformans to kill injected larvae of the greater wax
moth Galleria mellonela in an in vivo infection model. Overall, by using genetic and
biochemical techniques, this work provides evidence for the role of Pdc in acetate
production by C. neoformans, and in the hypoxia stress response and virulence of
this pathogen.

223

Introduction
Cryptococcus neoformans is an invasive fungal pathogen that infects lung
and brain tissue and is the most frequent cause of fungal meningitis in humans,
leading to significant annual global mortality (Lin and Heitman, 2006; Park et al.,
2009, Pappas PG., 2001; Lui et al., 2006; Franzot et al., 1999; Dromer et al., 1996;
Tortorano et al., 1997; Powderly, 1993). When desiccated yeast cells or spores,
found in bird droppings, decomposing organic material, or soil (Steenbergen and
Casadevall., 2003; Velagapudi et al., 2009) are inhaled by mammalian hosts, they
enter the lungs and then may disseminate to the brain, causing a potentially lethal
meningoencephalitis (Sabiiti and May, 2012; Velagapudi et al., 2009). In order to
survive and disseminate, the pathogen requires a number of virulence factors,
including a polysaccharide capsule, melanin, and the ability to grow at the host
body temperature of 37°C (Coelho et al., 2014; Casadevall et al., 2000; Kronstad
et al., 2011; Ma and May, 2009). C. neoformans also undergoes metabolic
adaptation to conditions inside the mammalian host. For example, the pathogen
produces many metabolites, including acetate, that it then may use to create an
optimal microenvironment (Bubb et al., 1999; Wright et al., 2002; Hu et al., 2008;
Price et al., 2011; Himmelreich et al., 2001; Kronstad et al., 2012).
Acetate is one of the major metabolites secreted by cryptococci cultured in
vitro and found in biopsies of infected rat brain and lung tissues (Bubb et al., 1999;
Wright et al., 2002; Himmelreich et al., 2001, 2003). It is believed to provide a
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survival advantage to the pathogen by two mechanisms: altering pH and providing
a source of carbon or energy.
The fairly narrow pH range in which C. neoformans can grow (relative to
that of some other fungal species) includes the pH 4.0-5.5 environment inside the
macrophage phagolysosome, as well as the pH 7.4 of human blood and
cerebrospinal fluid (O'Meara et al., 2010; Nyberg et al., 1992), although the
pathogen actually prefers the former, more acidic environment as an optmal pH
range. If the pathogen infects or disseminates to a location in the body that is more
basic than this optimal range, it can secrete excess acetate into the local
environment to reduce the pH (Wright et al., 2002). This lower pH enhances the
activity of the fungal phospholipase B and potentially other enzymes at the site of
cryptococcal infection (Evans et al., 2015; Sharon et al., 2000) and can shield the
pathogen from an immune attack by neutralizing free radicals and decreasing the
formation of superoxides produced by phagocytes, or by reducing the migration or
increasing the necrosis of neutrophils (Hu et al., 2008; Wright et al., 2002).
Two putative pathways for the production of acetate in C. neoformans have
been identified: the xylulose 5-phosphate/fructose 6-phosphate phosphoketolase
(Xfp) – acetate kinase (Ack) pathway and the pyruvate decarboxylase (Pdc) –
acetaldehyde dehydrogenase (Ald) pathway. In fungi that lack the Xfp-Ack
pathway, such as Saccharomyces cerevisiae, the primary acetate production
pathway utilizes pyruvate decarboxylase (Pdc) and aldehyde dehydrogenase (Ald)
(Saint-Prix et al., 2004; Remize et al., 2000; Pronk et al., 1996).

225

In S. cerevisiae, pyruvate is an important metabolic intermediate that is
acted upon by different enzymes at the branch point of oxidative respiration and
non-oxidative fermentation, depending on growth conditions (Agarwal et al., 2013;
Møller et al., 2004). During aerobic respiration, pyruvate can be converted via
pyruvate dehydrogenase to acetyl-CoA, which can then be fed into the TCA/Krebs
cycle to produce energy. This pathway works inside mitochondria (Møller et al.,
2004; Remize et al., 2000), and the mitochondrial acetyl-CoA cannot diffuse into
the cytoplasm (Remize et al., 2000). During non-aerobic fermentation, acetyl-CoA
for use in the cytosol can be produced from pyruvate via the pyruvate
dehydrogenase

by-pass

pathway.

In

this

cytosolic

pathway

pyruvate

decarboxylase converts pyruvate to acetaldehyde, which is oxidized via
acetaldehyde dehydrogenase to acetate and subsequently to acetyl-CoA via
acetyl-CoA synthetase (Pronk et al., 1994; Remize et al., 2000). In this process,
the oxidation of acetaldehyde is used to reduce NAD+/NADP+ to NADH/NADPH to
store energy and to maintain a redox balance in the cell (Saint-Prix et al., 2004;
Remize et al., 2000). Alternatively, the acetaldehyde can serve as an electron
acceptor and be reduced to ethanol, thereby allowing the oxidation of NADH to
NAD+ for use in glycolysis (Pronk et al., 1994). At the branch point between the
respiratory and fermentative pyruvate catabolic pathways, the efficiency of
pyruvate decarboxylase determines whether pyruvate will be diverted either
towards the TCA cycle or towards fermentation (Agarwal et al., 2013). A similar
set of pathways is believed to exist in C. neoformans (Figure 3.1).
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S. cerevisiae requires pyruvate decarboxylase activity for anaerobic growth,
as is evident from early studies of pdc null mutants which were either unable to
grow or grew more slowly on media supplemented with glucose when forced to
utilize fermentation (Lam and Marmur, 1977; Schmitt and Zimmermann, 1982).
There are actually multiple Pdc-encoding genes in Saccharomyces species;
however, under normal growth conditions, Pdc1p is the main contributor of
pyruvate decarboxylase activity in wild type strains undergoing fermentation
(Schmitt and Zimmermann, 1982; Schmitt et al., 1983; Kellermann et al., 1986;
Hohmann, 1991a). Pdc1 deficiency affects the enzymatic activity more severely
than deficiency of either of the other two major Pdc enzymes, Pdc5 and Pdc6
(Flikweert et al., 1996). Nevertheless, a mutant of the PDC1 gene (pdc10)
generated by Seeboth et al. (1990) could grow on glucose even when cellular
respiration was blocked, and 60-70% of pyruvate decarboxylase activity was
retained in the mutant, probably due to the upregulation of expression of the PDC5
gene in these mutants (Seeboth et al., 1990; Hohmann and Cederberg, 1990).
Similarly, deletion of the PDC1 gene in S. cerevisiae results in no significant
change in the acetate yield or in the amount of secondary metabolites, possibly
because Pdc5 can be used instead of Pdc1 (Remize et al., 2000). The PDC6 gene
is weakly expressed and the function of the corresponding protein is not clear
(Hohmann, 1991b). The PDC2 gene, on the other hand, has an important but
indirect role in pyruvate metabolism, in that it is involved in regulating the
expression of PDC1 and PDC5 or the corresponding enzyme activities (Hohmann,

227

1993). Pdc activity in S. cerevisiae is low under ethanol-only growth conditions,
whereas it increases by 10 to 20 fold over time under high glucose conditions
(Schmitt and Zimmermann, 1982). The expression of the PDC1 gene also
increases in glucose supplemented media versus in media with ethanol as the only
major carbon source due to an ethanol-dependent repression (Schmitt and
Zimmermann, 1982; Schmitt et al., 1983). Thus, Pdc activity may play a role in the
utilization of alternative carbon sources in S. cerevisiae.
In C. neoformans, unlike in other fungal species, there is only one putative
PDC gene, which may play a role in virulence. The levels of mRNAs encoding
acetyl-CoA

synthetase

(Acs1),

aldehyde

dehydrogenase,

and

pyruvate

decarboxylase, enzymes that may function in the production of acetyl-CoA from
pyruvate via acetaldehyde and acetate, are increased in C. neoformans cells
recovered from pulmonary tissue in a mouse infection model (Hu et al., 2008). This
suggests that pyruvate decarboxylase plays an important role during pulmonary
infection.
Additionally, Rodrigues et al. (2008) identified Pdc as one of the
components of extracellular vesicles (EVs) utilized by the fungus, further evidence
for a role of C. neoformans Pdc in the virulence of the pathogen. EVs are produced
in all domains of life (Raposo and Stoorvogel, 2013) and in fungi were first
identified in C. neoformans (Rodrigues et al., 2007). Vesicular secretion is a
common mechanism used by C. neoformans for transporting many virulencerelated components, including capsular GXM polysaccharide (Rodrigues et al.,
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2007), phospholipase B (Cox et al., 2001), urease (Cox et al., 2000; Perfect and
Casadevall., 2002), melanin (Eisenman et al., 2009), superoxide dismutase (Cox
et al., 2003), and laccase (Rodrigues et al., 2008; Salas et al., 1996) through the
cell wall for use outside the cell. The presence of Pdc in these EVs is highly
unusual, since, unlike the other components and enzymes listed, Pdc is a
metabolic enzyme involved in energy production. The fact that C. neoformans
exports it out of the cell may indicate a role for the enzyme in virulence, such as in
production of acetate that is used in the acetylation of cell wall and chitin
carbohydrates as part of cell wall and capsule formation and attachment of the
capsule to the cell wall (Rakesh et al., 2008; Vecchiarelli et al., 2011; Hu et al.,
2008; Ellerbroek et al., 2004).
Thus, the role of the C. neoformans Pdc in growth on glucose, ethanol, and
acetate, during hypoxia, oxidative and nitrosative stresses, and osmotic stress, in
the production of the capsule and melanin, which are important virulence factors,
in cell wall and membrane integrity, and in actual virulence in vitro and in vivo. was
assayed herein using a knockout mutant of the C. neoformans PDC gene, and was
compared with the effect of deficiency of the pyruvate decarboxylase enzyme on
acetate production.
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Materials and methods
Fungal Strains:
Wild type and pyruvate decarboxylase (pdcΔ) mutant strains of
Cryptococcus neoformans var grubii, in the KN99a background, were obtained
from the Madhani lab, University of California San Francisco (UCSF) gene deletion
collection (via the Fungal Genetics Stock Center). These were used for all of the
experiments, except for the in vivo Galleria mellonella virulence assay, in which
similar strains in an H99a background (Fungal Genetics Stock Center) were used.
The pdcΔ knockout mutants in each background were maintained under selection
for nourseothricin (NTC) resistance, since a nourseothricin acetyltransferase
(NAT) cassette was used to disrupt the PDC gene by insertional mutagenesis
(Chun and Madhani, 2010). Information on the C. neoformans pyruvate
decarboxylase gene/enzyme, including the gene and protein identification
numbers and the predicted mitochondrial or cytoplasmic cellular location of the
protein (determined using the MitoFates website, http://mitf.cbrc.jp/MitoFates/cgibin/top.cgi; Fukasawa et al., 2015), as well as the chromosomal location of the
gene (obtained from the Fungi Database, https://fungidb.org/fungidb/) is provided
in Table 3.1.
Phylogenetic tree:
Fungal pyruvate decarboxylase protein sequences were downloaded from
the

FungiDB

(http://fungidb.org/fungidb/srt.jsp).

Alignment

and

phylogeny

reconstruction were performed using Molecular Evolutionary Genetics Analysis
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(MEGA X) software (Kumar et al., 2001) as follows. Alignment was carried out with
Clustal W (Thompson et al., 1994), and the aligned sequences were used to
construct a Maximum Likelihood (ML) tree, under an assumption of a uniform rate
of substitution among all amino acid sites, using the Jones-Taylor-Thornton model
(Jones et al., 1992), with 500 bootstrap replicates (Felsenstein J., 1985) to verify
the reliability of the tree. The initial tree was constructed using both Neighbor
joining (NJ) and BioNJ algorithms and optimized via the Nearest Neighbor
Interchange (NNI) version of the ML heuristic method with a "moderate" branch
swap filter setting.
Confirmation of deletion of PDC in the mutant by PCR analysis:
The deletion of PDC in the pyruvate decarboxylase (pdcΔ) mutant from the
Madhani lab was confirmed by PCR using the following gene-specific primers and
assaying for a lack of PCR product.
PDC forward primer: TGACGGTTCTTTGCAGTTGG
PDC reverse primer: TTGAAGGCGAAGGTTGTGTG
Additionally, the presence of the NAT gene (in replacement of PDC) was
verified using primers synthesized based on sequences obtained from the
Madhani lab:
NAT forward primer (107): CCTAGCAGCGGATCCAAC
NAT reverse primer (108): CGCATCCCTGCATCCAAC
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DNA was isolated from wild type and mutant strains using the
cetyl/hexadecyl-trimethylammonium bromide (CTAB) DNA isolation protocol
(Pitkin et at, 1996). Gene amplification was performed using the KOD Hot Start
DNA Polymerase kit (ThermoScientific) with a thermocycler program as follows for
the NAT gene: initial denaturation at 95°C for 2 min, followed by 30 cycles of
denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec, and extension at
72°C for 2 min, followed by final extension at 72°C for 5 min. The thermocycler
program utilized to amplify PDC differed only in that 35 cycles were used and the
annealing temperature was set to 60°C.
Quantitative and qualitative growth analysis in various carbon sources:
C. neoformans wild type and pdcΔ strains were cultured overnight in Yeast
Extract Peptone Dextrose (YPD) media (1% Difco Yeast extract, 2% Bacto
Peptone, and 2% glucose) at 30°C, in a rotating shaker at 200 rpm (Barnstead
MaxQ 4000 Orbital Incubator Shaker). The next morning, the cultures were
refreshed: 25 μl from each of the overnight cultures were used to inoculate a
corresponding 2 ml volume of YPD, which was incubated to an optical density at
600 nm wavelength (OD600) of ~0.2 as measured using an Evolution 60
Spectrophotometer (ThermoScientific, Waltham, MA). These cells were pelleted at
8,000×g and washed twice in Dulbecco’s Phosphate Buffered Saline (D-PBS;
LifeSciences, Oneonta, NY), then counted using a hemocytometer.
For qualitative analysis, spot assays were performed. Refreshed cells were initially
diluted to 5×103 cells/μl, and then 10-fold serially diluted three times. From each
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dilution, 2μl were spotted onto Yeast Nitrogen Base (YNB; HiMedia) plus agar
(YNB-agar) supplemented with 2% of either glucose, acetate, or ethanol. Thus,
1×104 cells, 1×103 cells, 100 cells, and 10 cells of the wild type and pdcΔ mutant
strains were each plated and were allowed to grow in an incubator at 30°C for
approximately 3 days. Images of colonies were captured using the Canon EOS
Rebel T1i camera.
For quantitative growth analysis (growth curve assay) 1×104 cells/μl were
used to inoculate YNB media supplemented with 2% of either glucose, acetate, or
ethanol, as the carbon source. Cultures were set up in each medium in triplicate in
microtiter plates. Cells were allowed to grow in a shaking incubator at 30°C for 48
hours, and their growth was monitored over time using the Epoch Multi-Volume
Microplate Reader (BioTek Instruments, Inc., Winooski, VT) to measure the OD600
at each time point.
Measurement of acetate production:
To analyze acetate production by C. neoformans, the hydroxamate assay
was performed as described previously (Fowler et al., 2012; Aceti and Ferry, 1988;
Rose et al., 1954). As detailed above, C. neoformans strains were grown overnight
in YPD media at 30°C. To refresh cells, 25 μl from each of these overnight cultures
was used to inoculate a corresponding 5 ml volume of YNB supplemented with 2%
glucose, which was incubated to an OD600 of ~0.2. Cells were counted using a
hemocytometer and the 5 ml cultures were adjusted to a concentration of 1×104
cells/μl. The 5 ml cultures were vortexed briefly to fully resuspend the cells and 1
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ml of each culture was transferred to a corresponding eppendorf tube, which was
centrifuged at 10,000×g; the recovered supernatants were transferred to fresh
tubes and frozen down at –80°C. The remaining culture volumes were incubated
at 30°C, and every 12 hours, up to and including 48 hrs, the process was repeated.
Once all supernatants were collected, the hydroxamate assay was performed on
triplicate 225 μl samples from each 1 ml of supernatant media from each strain as
described by Aceti and Ferry (1988). Briefly, 75 μl of hydroxamate reaction mix
(2.4 M hydroxylamine-HCl, pH 7.0; 0.4 M Tris pH 7.5; 80 mM MgCl2; 90 μM ATP
disodium salt hydrate) was added to each 225 μl of supernatant and the mixture
was incubated at 37°C for 5 min. Then, 5 μl of Methanosarcina thermophila acetate
kinase (purified by Dr. Cheryl Ingram-Smith) was added to a final concentration of
0.023 ng/μl, mixed to homogeneity by pipetting and incubated at 37°C for 15
minutes. Finally, the reaction was quenched using an equal volume of a stop
solution (10% trichloroacetic acid and 2.5% FeCl3 in 2 N HCl) and the absorbance
was read at 540 nm using the Epoch Multi-Volume Microplate Reader
spectrophotometer. A standard curve was prepared by performing exactly the
same protocol using known concentrations of acetate solution ranging from 0.1
mM - 2 mM instead of supernatant media.
Capsule formation assay:
Capsule production by C. neoformans was induced as previously described
(Zaragoza and Casadevall, 2004). Briefly, wild type and pdcΔ strains were grown
overnight in 2 ml Sabouraud medium (4% glucose and 1% bacto peptone, at pH
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5.6) at 30°C. The following day, cells were collected by centrifugation (8,00010,000×g) for 2 min at room temperature, washed twice with PBS (137 mM NaCl,
2.7 mM KCl, 1.5 mM KH2PO4, 8.5 mM Na2HPO4), and resuspended in 0.1x
Sabouraud medium (pH7.3). Cells were counted, diluted to 5×106 cells/ml in 2 ml
of the above 0.1x Sabouraud medium, and incubated for 24 hours at 37°C to
induce capsule formation. Capsules were observed under the Axiovert Inverted
Microscope (Carl Zeiss, Inc., Thornwood, NY) after 10 μl of each cell suspension
were mixed with 10 μl of India Ink (Becton Dickinson, NJ) to provide contrast.
Images were taken at 40x magnification and processed with Zeiss software and
Image J. At least five different fields were randomly chosen and photographed,
and 25 to 30 cells were observed.
Melanin production assay:
C. neoformans wild type and pdcΔ mutant strains were grown overnight and
refreshed the next morning in the same way as described above and then
harvested by centrifugation for 2 min at room temperature, washed twice in D-PBS,
counted using the hemocytometer. Each strain was diluted to 1×10 cells/ml and a
5

5μl volume of each strain was plated on agar-containing melanin-induction
medium (8 mg/ml KH2PO4, 2 mg/ml glucose, 2 mg/ml L-glycine, 1 μg/ml D-biotin,
1

μg/ml

thiamine,

0.92

mg/ml

MgSO4×7H2O,

and

0.4

mg/ml L-3,4-

dihydroxyphenylalanine [L-DOPA]) in order to induce melanin production (Li et al.,
2018). Plates were incubated at 30°C for 2-3 days and the imaged using the Canon
EOS Rebel T1i camera. The experiment was repeated thrice.
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Growth under hypoxia and under oxidative and nitrosative stresses:
Wild type and pdcΔ strains were grown overnight and refreshed the next
morning as described above, then harvested by centrifugation for 2 min at room
temperature, washed twice in D-PBS, counted using the hemocytometer, and
diluted to 5×103 cells/μl. Next, three 10-fold serial dilutions of cells were prepared,
and 2μl of each of these four dilutions were spotted at 1×104, 1×103, 100 and 10
cells per spot onto media that mimicked different stress conditions that the fungus
encounters during infection. To mimic hypoxia, cells were spotted onto YES-agar
(0.5% yeast extract, 2% glucose, 1.5% agar and 225 μg/mL of each of uracil,
adenine, leucine, histidine, and lysine) supplemented with 0.7 mM CoCl2 (Lee et
al., 2007). To test the effects of oxidative and nitrosative stress, cells were spotted
onto sodium succinate-adjusted YNB-agar medium (1.34 g/liter yeast nitrogen
base without amino acids, 4 g/L glucose, and 5 mM sodium succinate to adjust the
pH to 4.0, filter sterilized and mixed 1:1 with 4% agar to a final concentration of 2%
agar) supplemented with either 1 mM hydrogen peroxide (H2O2) or 1.5 mM sodium
nitrite (NaNO2), respectively, or not supplemented as control (Gerik et al., 2008).
Plates were incubated at 30°C for 2-3 days and then imaged using the Canon EOS
Rebel T1i camera. Each experiment was repeated thrice.
Growth under osmotic stress:
Fungal cells were cultured overnight, refreshed and counted the next day,
diluted, and spotted the same way as above, except that the wild type and pdcΔ
strains were grown on osmotic stress generating medium (1% yeast extract, 2%
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Bacto Peptone, 2% glucose, and 2% agar, supplemented with either 1.5 M NaCl
or 1.2 M KCl). Plates were incubated at 30°C for 3 days and then imaged using
the Canon EOS Rebel T1i camera. Each experiment (with NaCl or KCl) was
repeated three times.
SDS and Congo red assays for cell wall integrity:
Fungal cells were cultured overnight, refreshed and counted the next day,
diluted, and spotted onto plates as above, except that the wild type and pdcΔ
strains were spotted onto media with 1% yeast extract, 2% Bacto Peptone, 2%
agar, and 1% glucose supplemented with either 0.5% Congo red (SigmaAldrich/Millipore Sigma, St. Louis, MO) or 0.03% sodium dodecyl sulfate (SDS;
Calbiochem/Millipore Sigma, St. Louis, MO). Plates were incubated at 30°C for
~72 hours and then images were captured using the Canon EOS Rebel T1i
camera. Each experiment was repeated three times.
Macrophage culture:
A murine macrophage-like cell line J774A.1 (gift from Dr. Jeffrey Anker,
Clemson University), originally derived from BALB/c mouse reticulum cell sarcoma
(Fan et al.,2005), was maintained in macrophage medium (Dulbecco’s Modified
Eagle Medium [DMEM] supplemented with 10% heat-inactivated fetal bovine
serum, 1% non-essential amino acids, 1% penicillin-streptomycin, and 10%
NCTC-109 medium, Gibco Life Technologies). Cells were passaged at a 1:10 split
approximately every 5-7 days when reached 80% confluence.
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Macrophage survival assay:
At ~80% confluence, cultured macrophages were washed twice with DPBS, harvested by scraping after addition of fresh macrophage medium, and then
diluted to 1×103 cells/μl. These macrophages were transferred into three wells
each for the wild type and pdcΔ C. neoformans strains into two 96-well flat-bottom
tissue culture treated plates (Costar; Corning Inc., Corning NY), one for one-hour
co-incubation and the other for 24-hour co-incubation with fungal cells, with 100 μl
of the macrophage suspension (1×105 cells in macrophage media) added to each
well. Both plates were incubated overnight at 37˚C in the 5% CO2 incubator.
Concurrently, wild type (KN99a) and pdcΔ C. neoformans strains were
grown overnight in liquid YPD media at 30°C. The next day, the strains were
pelleted by centrifugation at 8,000×g for 1 min, washed twice with D-PBS, and
resuspended in macrophage medium. The fungal cells were then diluted to 125
cells/μl in 1 ml of macrophage media (i.e. 1.25×104 C. neoformans cells per 100
μl). To enhance macrophage phagocytosis by opsonization, the two C.
neoformans strains were each incubated for one hour at 37˚C with 1μg/ml (final
concentration) of the MAb18B7 monoclonal antibody (gift from Dr. Arturo
Casadevall, Johns Hopkins University School of Medicine) that binds to the
glucuronoxylomannan (GXM) capsule component (Casadevall et al., 1998). As
soon as the C. neoformans strains mixed with antibody were placed in the
incubator, the two plates containing macrophages were processed as follows. The
media was gently removed from each well and replaced with 100 µl macrophage

238

media containing 10 nM phorbol myristate acetate (PMA), and then both plates
were incubated at 37˚C in 5% CO2 for one hour to activate the macrophages
(Forman and Torres, 2001).
After separate one hour incubations of the macrophages and fungal cells,
the medium in each well from both 96-well macrophage plates was replaced,
without disrupting the macrophage monolayer, with a 100 µl volume of either the
wild type or pdcΔ mutant cell suspension (i.e. 1.25×104 cells), in triplicate per C.
neoformans strain, at an 8:1 macrophage to fungal cell ratio. In a third 96-well
tissue culture treated plate, as a control, 100 µl (i.e. 1.25×104 cells) per well of the
cell suspensions of C. neoformans wild type or pdcΔ strains were added, in
triplicate, in the absence of macrophages. All three plates were left at 37°C in 5%
CO2 for one hour, after which each well in the one-hour and 24-hour plates with
macrophages, but not in the control plate without macrophages, were washed
gently three times with 200 μl D-PBS to remove non-phagocytosed C. neoformans.
To the 24-hour plate, 100 μl of fresh macrophage media were added to each well,
and the plate was placed back into the 37˚C, 5% CO2 incubator for 24 hours.
To the one-hour plate, 200 µl of sterile distilled, deionized water (ddH2O)
were added to each well, and the plate was incubated at room temperature for 5
minutes to lyse the macrophages. A pipette tip was then scraped against the
bottom of the wells to lift up the adherent macrophages, and the cells suspended
in the water were pipetted up and down to disrupt and further lyse the
macrophages. The 200 µl lysate was then transferred to a microfuge tube. Again,
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200 µl of sterile ddH2O were added to each well, the wells were scraped, and the
suspensions were pipetted up and down. The additional lysates generated were
combined with the corresponding original lysates. These steps were repeated
twice more, but with 300 µl of sterile ddH2O, so that, by the end of the procedure,
each microfuge tube held 1 ml final volume of lysate. For the plate of C.
neoformans strains without macrophages, since the wells were not washed prior
to addition of sterile ddH2O, the volume of original media plus sterile ddH2O
transferred to each microfuge tube was 300 µl; then 200 µl, 200 µl, and 300 µl
volumes were used and transferred to the corresponding microfuge tube. The
same procedure that was used on the one-hour plates with macrophages was
used, without modification, to obtain macrophage lysates from the 24-hour plate
the next day. For each 96-well plate, macrophage lysis (or recovery of fungal cells
from wells without macrophages) was conducted in sets of one well per strain, in
triplicate sets, to obtain the fungal cells from the three wells per strain.
Immediately after wild type or pdcΔ mutant C. neoformans cells were
obtained from the macrophage lysates or from the fungal cell suspensions (i.e.
from the no-macrophage control plate), the cells were diluted 1:10, then again
1:2.5 for a final dilution of 1:25, or a (theoretical) maximum concentration of 500
cells/ml in a total volume of 0.5 ml. From this final dilution, 100 μl were plated on
YPD-agar plates, one plate per corresponding well from each 96-well plate,
resulting in triplicate YPD-agar plates of wild type and pdcΔ mutant cells. From the
1-hour plate, it was expected that a maximum of 50 cells from each corresponding
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well of the 96-well plates would form colonies, but, due to replication of the fungal
cells, more than this number of colonies was possible from the 24-hour plate. YPDagar plates were incubated at 30°C for ~48 hours and then colony forming units
(CFU) were counted for each plate and the percentage survival was calculated for
each strain using the following formula, in which MΦ refers to macrophages and
the CFU are the average of the individual CFU from the triplicate YPD-agar plates:
% Phagocytosis = (CFUC. neoformans with MΦ @ 1hr ÷ CFUC. neoformans without MΦ) × 100
% Survival = (CFUC. neoformans with MΦ @ 24 hrs ÷ CFUC. neoformans with MΦ @ 1 hr) × 100
C. neoformans virulence assay with invertebrate model:
To examine the virulence of mutant C. neoformans strains, the survival of
larvae of the greater wax moth, Galleria mellonella, was assayed after injection, in
parallel, with either the wild type or pdcΔ mutant C. neoformans strain; for this
assay, both strains were in an H99 strain background. For use in this assay, the
two C. neoformans strains were grown in YPD media at 30°C overnight and
refreshed the next morning by inoculation of new 2 ml cultures and incubation to
an OD600 of ~0.2. The cells from each strain were then pelleted and washed once
with sterile water and twice with D-PBS, before being resuspended in D-PBS to a
final concentration of 1×105 cells/µL. Subsequently, milky-white G. mellonella
larvae without any dark spots and weighing between 0.27 g and 0.30 g were
chosen. Ten larvae per C. neoformans strain were selected and disinfected using
alcohol wipes just prior to inoculation. Using Hamilton syringes, the ten larvae were
each injected in the bottom, left proleg with 10 µl (1×106 cells) of either the wild
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type or pdcΔ strain. To determine the level of death due solely to injection, 10 µl of
D-PBS were injected as a control into another ten larvae and death was monitored
over time. Similarly, as a negative control, the wild type C. neoformans strain (in
the H99 background) was heat-killed via incubation at 65°C for 1 hour and 1×106
of these dead cells were injected into each of another ten larvae. After all strains
and controls were injected into G. mellonella, the larvae were incubated at 37°C
and monitored daily. Death was scored based on blackened appearance
(indicative of either necrosis or complete melanization) and a lack of normal rollingover behavior. The numbers of dead larvae in each injection group were tallied
and graphed in a Kaplan-Meier survival curve.
Statistical analysis of results:
All of the graphs were prepared using GraphPad Prism. When multiple time
points were being analyzed in the experiment, the significance of the results were
determined using the analysis of variance (ANOVA) software within Prism, with
Dunnet, Sidak, or other post-test multiple comparison, as recommended by the
software, generally using one-way ANOVA to compared the wild type to the pdcΔ
strain. When only triplicate values at one time point (such as in the macrophage
survival assay, in which the relative percent survival values were first calculated
using Microsoft Excel) were analyzed, a parametric, paired, two-tailed t-test was
conducted. For Kaplan-Meier survival curves, the Gehan-Breslow-Wilcoxon test
and/or Log-Rank test was used to compare the virulence of the mutant strain to
that of the wild type strain.
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Results
Phylogenetic tree analysis:
The phylogeny of the pyruvate decarboxylase (Pdc) family was generated
with protein sequences from C. neoformans var. grubii and var. neoformans and
putative homologs from various other fungi (Figure 3.2) using MEGA X (Kumar et
al., 2001) software. The C. neoformans var. grubii Pdc was, as expected, most
closely related to that of C. neoformans var. neoformans and of Cryptococcus
gattii, and, together with a hypothetical protein from Tremella mesenterica, form a
monophyletic group (GROUP 1 in Figure 3.2) in the tree. These Pdc sequences
are next most closely related to the putative Pdc1 from Sporisorium reilianum, a
putative indolepyruvate decarboxylase from Ustilago maydis (UMAG_03994), the
Pdc sequence from Coprinopsis cinerea (CC1G_03453), and the Pdc sequence
from Phanerochaete chrysosporium (AGR57_8688), which, together, form the
monophyletic GROUP 2 in Figure 3.2. Surprisingly, the C. neoformans var. grubii
Pdc is only distantly related to Pdc proteins from a third monophyletic group
(GROUP 3 in Figure 3.2) that includes Pdc1p, Pdc5p, and Pdc6p from S.
cerevisiae and Pdc1p and Pdc4p from Schizosaccharomyces pombe, but is more
closely related to those than to the regulatory S. cerevisiae protein Pdc2p
(Hohmann, 1993; Kaiser et al., 1999) or to the related regulatory protein Pdc2p
from Candida albicans (Kaiser et al., 1999). It is therefore likely that C. neoformans
var. grubii and var. neoformans pyruvate decarboxylases have similar enzymatic
function as Pdc1p, Pdc5p, and Pdc6p from S. cerevisiae.
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Verification of PDC deletion:
The pdcΔ mutant (in the KN99a strain background) obtained from the
Madhani deletion collection (Chun and Madhani, 2010) was checked for the
replacement of PDC with a nourseothricin acetyltransferase (NAT) cassette by
PCR. The results confirmed the presence of PDC in the wild type strain (also in
the KN99a strain background) and the deletion of the gene in the pdcΔ strain
(Figure 3.3, lanes 2 and 3, respectively). No PCR product for NAT was observed
for the wild type strain, while a band of the correct size (~1600bp) was observed
for the pdcΔ strain (Figure 3.3, lanes 4 and 5, respectively).
Absence of Pdc impacts glucose-dependent growth of C. neoformans:
C. neoformans prefers glucose over other carbon sources for growth (Hu et
al., 2008; Sabiiti and May, 2012), but inside the host it encounters conditions such
as low glucose and low amino acid concentrations, which forces it to utilize acetate,
lactate, or other alternative carbon sources to survive (Hu et al., 2008; Price et al.,
2011). Therefore, the growth of the pdcΔ mutant on YNB medium supplemented
with glucose as the conventional carbon source, or with acetate or ethanol as
alternative carbon sources, was investigated. Specifically, spot assays and growth
curve analyses were performed on solid or liquid media supplemented with 2%
glucose, 2% acetate, or 2% ethanol. In the qualitative spot assay, the pdcΔ mutant
grew similarly to the wild type KN99a strain on all three media, suggesting that the
function of the Pdc enzyme is not necessary for utilization by C. neoformans of
different carbon sources (Figure 3.4). In the quantitative growth analysis, the pdcΔ
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mutant did not grow as well as the wild type strain in medium supplemented with
glucose (Figure 3.5a; P-value = 0.0011 overall), especially after 14 hours (P-value
= 0.0053, 0.0084, 0.0047, and 0.0063 at 24, 31, 38, and 48 hours, respectively).
Unlike in the colonies formed in the spot assay, in the quantitative growth assay,
the constant shaking of fungal cells grown in liquid medium tended to separated
individual cells from each other, preventing them from contributing to each other’s
growth and survival via some type of en masse metabolic compensation
mechanism; this might explain the discrepancy between the results of the two
assays. Thus, the overall results of the growth assays demonstrated that the
pyruvate decarboxylase-deficient mutant exhibited inefficient cell autonomous
utilization of glucose, but could make use of acetate or ethanol as effectively as
the wild type strain, since the two strains exhibited equivalent growth in the
corresponding media (Figure 3.5b, c).
Acetate production is reduced in the pdcΔ mutant:
Pyruvate decarboxylase is used by S. cerevisiae to convert pyruvate to
acetaldehyde, which is then be converted to acetate via an acetaldehyde
dehydrogenase (Pronk et al., 1996). In order to determine whether the C.
neoformans PDC gene is similarly involved in the production of acetate, the
amount of acetate secreted into the extracellular media by wild type and pdcΔ
strains grown on YNB supplemented with 2% glucose was measured every 12
hours. It was observed that the pdcΔ mutant could produce acetate, but at a
concentration very significantly (P-value < 0.01) lower concentration than that
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produced by the wild type KN99a strain, (Figure 3.6; P-value = 0.0035 overall, with
P-value = 0.0053 and P-value = 0.0206 at 36 and 48 hours, respectively), implying
that C. neoformans Pdc is utilized in acetate production.
Capsule formation is compromised in the pdcΔ mutant:
The C. neoformans polysaccharide capsule protects against attack by the
host immune system by downregulating inflammatory cytokines, decreasing the
levels of complement proteins, and reducing the antigen presenting capacity of
monocytes (Retini et al., 1998; Vecchiarelli et al., 2003; Vecchiarelli et al., 1995),
as well as by protecting against phagocytosis by macrophages (Panepinto et al.,
2007; Cross and Bancroft, 1995) and quenching phagocyte-produced reactive
oxygen species if the pathogen is engulfed (Zaragoza et al., 2008). To determine
whether Pdc activity is important for production of the polysaccharide capsule, cells
from wild type and pdcΔ mutant C. neoformans strains in the KN99α background
were incubated in capsule inducing medium and then stained with India Ink to
visualize capsule thickness under the microscope. Capsule thickness was reduced
in the pdcΔ mutant relative to the wild type strain (Figure 3.7), indicating that
pyruvate decarboxylase function is relevant to capsule production.
Melanization is reduced in the pdcΔ mutant:
Melanin is produced by C. neoformans, and protects the pathogen from
attack by reactive oxygen and nitrogen species produced by macrophages after
phagocytosis (Ma and May, 2009), so melanin deficient mutants of C.
neoformans are less virulent (Wang et al., 1995). Wild type and pdcΔ mutant
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cells were spotted onto plates supplemented with L-DOPA, which C. neoformans
converts to melanin using the laccase enzymes (Williamson, 1997; Li et al.,
2018). The pdcΔ mutant colonies had visibly reduced coloration as compared
with the wild type colonies, indicating that this pyruvate decarboxylase deficient
mutant had defective melanin production (Figure 3.8).
Deficiency of pyruvate decarboxlyase affects response to hypoxia:
C. neoformans causes fungal meningitis by infecting the host nervous
system and then surviving and growing under the low oxygen conditions found in
the brain (Ingavale et al., 2008; Erecińska and Silver, 2001). Thus, identifying the
enzymes used by C. neoformans to withstand hypoxia could generate therapeutic
targets. Cobalt chloride induces both the Sre1p ergosterol production pathway and
transcription of the fatty acid desaturase gene OLE1, which function in coordinating
the cellular low-oxygen response (Guzy et al 2007; Lee et al., 2007). Cells react to
CoCl2 as if they were under hypoxia (Guzy et al 2007; Lee et al., 2007). To
determine whether Pdc plays a role in the survival of the pathogen under hypoxia,
the pdcΔ mutant strain was grown in YES medium supplemented with CoCl2. The
pdcΔ mutant grew normally in YES medium under normoxic conditions (Figure
3.9a), but exhibited defective growth when subjected to the artificial hypoxia
(Figure 3.9b). This suggests that Pdc is important for survival of the pathogen
under low oxygen. However, when the pdcΔ mutant was cultured on CoCl2containing medium to which 2% acetate was added, it grew normally (Figure 3.9c).
Therefore, the observed growth defect is likely due to insufficient production of
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acetate by this pyruvate decarboxylase deficient mutant. Alternatively, Pdc
functions in a hypoxia response pathway that can be replaced by a secondary,
acetate-dependent pathway, although how this would work is uncertain.
Pyruvate decarboxylase is not required for survival under oxidative,
nitrosative, or osmotic stress
While the pathogen needs to be able to survive hypoxia after dissemination
to the brain, at a much earlier stage of infection immediately after inhalation into
the host lungs, the cryptococcal cells (or spores) must be able to survive
engulfment by alveolar macrophages, which generate and use reactive oxygen
and nitrogen species to destroy the engulfed pathogen (Hampton et al., 1998;
Vieira et al., 2002; Cox et al., 2003; Tohyama et al., 1996). To determine whether
C. neoformans Pdc activity assists in the survival of the pathogen under oxidative
or nitrosative conditions, the wild type and pdcΔ strains were grown on YNB-agar
(buffered to pH 4.0 using sodium succinate) to which 1 mM H2O2 or 1.5 mM NaNO2
was added, respectively. There was no significant difference in the growth of the
pdcΔ mutant under either oxidative (Figure 3.10a) or nitrosative (Figure 3.10b)
conditions relative to the wild type strain, indicating that Pdc plays no role in the
neutralization of oxygen or nitrogen free radicals produced by the host immune
system or in survival under oxidative or nitrosative stress.
C. neoformans is also challenged with osmotic stress inside the human
body, and produces metabolites like mannitol (Chaturvedi et al., 1996a,b) or
utilizes the HOG1 pathway (Bahn et al., 2005) to survive in high osmolarity
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environments. To assay whether Pdc has any function in the osmotic stress
response, the wild type strain and the pdcΔ mutant were grown on YPD plates
supplemented with 1.5 M NaCl and 1.2 M KCl to generate high salt conditions. It
was found that the pdcΔ mutant grew as well as the wild type strain under these
high salt conditions (Figure 3.11). This observation suggests that there is no
involvement of the Pdc enzyme in the growth of C. neoformans under osmotic
stress.
Cell wall integrity is not affected in the pdcΔ mutant:
The cell wall is an essential component that provides structure to
cryptococcal cells and that protects C. neoformans from the oxidative environment
inside the macrophages generated and used by these phagocytic cells to destroy
the pathogen (Gerik et al., 2005). The cell wall plays a role in the attachment of the
capsule to the cell membrane and harbors the laccase enzymes that produce
melanin, which is deposited in the cell wall and protects against ROS and RNS
(Baker et al., 2007; Van Dyke and Wormley, 2018). Therefore, an intact cell wall
is required for full virulence. The cell wall integrity of the pdcΔ mutant strain was
assayed by spotting decreasing concentrations of cells on media containing
sodium dodecyl sulfate (SDS) or Congo red. Congo red binds to (1,4) β-glucans
(or to the monomer, β-1,4 N-acetyl glucosamine), and thereby interferes with cell
wall construction and with attachment to the cell wall of the chitin and capsule,
while SDS that passes through gaps in the capsule, chitin, and cell wall dissolves
the plasma membrane and lyses the cells (García et al., 2015; Banks et al., 2005;
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Ram and Klis, 2006; Baker et al., 2007; Gerik et al., 2005; Wood et al., 1983).
Hence, strains with cell wall integrity defects will not survive in the presence of
either Congo red or SDS, depending which layer of capsule, cell wall, or chitin is
deficient. The growth of the pdcΔ strain was not affected by SDS (Figure 3.12b)
but was severely reduced at low cell concentrations or Congo Red (Figure 3.12c),
indicating that the Pdc enzyme does play a role in building the cell wall or
maintaining cell wall integrity, but the lack of this enzyme does not affect the
integrity to such an extent that SDS can traverse the cell wall.
Deficiency of Pdc greatly impairs survival after phagocytosis :
To investigate the contribution of Pdc in the survival of C. neoformans
against attack by host immune cells, the percentage of fungal cells surviving
engulfment by murine macrophages was assayed. Wild type and pdcΔ mutant
fungal cells were each co-incubated, in triplicate, with macrophages for 1 hour in
a 96-well plate, and the fungal cells from lysed macrophages were plated on YPD.
The relative percent phagocytosis of the mutant was determined by comparing
colony forming ability of phagocytosed fungal cells to that of non-phagocytosed
control cells and then to this ratio for wild type cells. In a parallel plate, the
macrophages were given 24 hours to destroy internalized C. neoformans cells
(after non-phagocytosed fungal cells were removed), and were then lysed.
Surviving C. neoformans cells were plated on YPD, and the number of colonies of
each strain were divided by the average number of colonies from phagocytosed
cells of that strain from the percent phagocytosis analysis. The percent
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phagocytosis of the mutant was marginally significantly increased relative to the
wild type strain (161.39% vs. 100%; P-value = 0.0293). In contrast, the percent
survival and recovery of growth capability inside the macrophages was highly
significantly reduced for the pdcΔ strain, at only 39.11% (P-value = 0.0003) relative
to the 100% normalized value for the wild type strain (Figure 3.13). These results
indicate that deficiency of the pyruvate decarboxylase enzyme does negatively
affect survival of C. neoformans inside macrophages in vitro.
The pdcΔ mutant exhibits normal virulence in the invertebrate Galleria
mellonella in vivo infection model:
Since Pdc was found to be important for the production of the capsule and
melanin, both of which are important virulence factors, and for survival in
macrophages, an in vitro assay for virulence, it was reasonable to expect a role
for Pdc in pathogenesis in vivo. Therefore, the virulence of the pdcΔ mutant
strain was assessed in the invertebrate model, the larvae of the greater wax
moth, Galleria mellonella. Fungal virulence was measured based on the number
of days required for the first larva to die and then for all of the larvae to die,
represented as a Kaplan-Meier survival curve (Figure 3.14). The two negative
control groups of larvae only started to die off on day 8, and at least some larvae
survived until day 18 at minimum. In contrast, larvae infected with wild type C.
neoformans cells started dying on day 6 post-injection and all such larvae were
dead by day 9. Similarly, larvae infected with pdcΔ mutant cells started dying on
day 6 post-injection and all larvae were dead by day 10. In fact, the survival curve
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of the pdcΔ strain-injected larvae was not statistically different from that of the
wild type H99-injected larvae, as determined using a Chi-square-based GehanBreslow-Wilcoxon test (P-value = 0.3395) or using a Log-Rank test (P-value =
0.2700), whereas the two control survival curves were statistically different from
the survival curve of the wild type injected larvae by either test (P-value < 0.0001
for both controls). The median survival of the larvae injected with pdcΔ mutant
cells was 8 days, the same as that of larvae injected with wild type C. neoformans
cells; in contrast, the median survival of larvae injected with PBS or heat-killed
C. neoformans cells were 13 and 15 days, respectively. These observations
suggest that deficiency of pyruvate decarboxylase does not affect the virulence
of C. neoformans when utilizing G. mellonella as a model, despite the effect of
this deficiency on reducing capsule size, melanin content, and even survival in
macrophages.
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Discussion
This is the first investigation of the role of Cryptococcus neoformans
pyruvate decarboxylase in the virulence of the pathogen. S. cerevisiae requires
Pdc activity for normal growth (Schmitt and Zimmermann, 1982) and has three
structural PDC genes, PDC1, PDC5, and PDC6 (Seeboth et al., 1990; Kaiser et
al., 1999; Agarwal et al., 2013). The enzyme encoded by PDC1 is the major
pyruvate decarboxylase used during fermentation (Schmitt and Zimmermann,
1982; Schmitt et al., 1983; Kellermann et al., 1986; Hohmann and Cederberg,
1990; Hohmann 1991a; Hohmann, 1993). Mutation of PDC1 decreases growth
because of excessive accumulation of pyruvate, which can slow down glycolysis
in S. cerevisiae (Schmitt and Zimmermann, 1982). Some point mutants of PDC1
are completely unable to grow on glucose-containing media under either
respiratory or fermentative conditions (Schmitt and Zimmermann, 1982; Schmitt et
al., 1983), and exhibit a cytosolic redox imbalance, as well as secrete excess
cytosolic pyruvate into the growth medium (Van Maris et al., 2004). Complete
deletion of the PDC1 gene apparently rescues growth on glucose, and the mutant
retains 60-70% of pyruvate decarboxylase activity. The total lack of Pdc1
expression causes the upregulation of expression of the PDC5 gene, which is 88%
identical to PDC1 (Seeboth et al., 1990; Agarwal et al., 2013; De Assis et al., 2013).
In short, Pdc1p appears to be the major pyruvate decarboxylase in S. cerevisiae
and the yeast uses Pdc5p instead when it cannot express Pdc1p (De Assis et al.,
2013; Muller et al., 1999; Eberhardt et al., 1999; Hohmann and Cederberg, 1990;
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Schaaff et al., 1989; Kaiser et al., 1999). A mutant in both PDC1 and PDC5 genes
has no detectable pyruvate decarboxylase activity, and cannot grow for very long
on glucose as the sole energy source, and the same is true of a triple mutant also
lacking the weakly expressed PDC6 (Flikweert et al., 1996; Hohmann, 1991b;
Kaiser et al., 1999). During fermentation, S. cerevisiae can use the Pdc activity in
the pyruvate dehydrogenase by-pass pathway to convert pyruvate to acetyl-CoA,
via acetaldehyde and acetate (Pronk et al., 1994; Remize et al., 2000), so loss of
Pdc function is expected to decrease the level of acetate, but PDC1 gene mutation
did not change the cytoplasmic acetate levels, even though it approximately
doubled the level of pyruvate (Remize et al., 2000). The normal level of acetate
may or may not result from low level expression and activity of Pdc5p or Pdc6p.
A distant relative of S. cerevisiae, Saccharomyces kluyveri, also has three
PDC genes that code for functional Pdc enzymes. (Møller et al., 2004). Another
taxonomic relative of S. cerevisiae, Kluyveromyces marxianus, has two genes
coding for Pdc enzymes, KmPDC1 and KmPDC5; deletion of KmPDC1 results in
decreased or no growth in aerobic or anaerobic conditions, respectively (Choo et
al., 2018), indicating that it encodes the major Pdc. PDC is also reported to have
homologues in several other yeast species, including in Pichia pastoris (Agarwal
et al., 2013), Scheffersomyces stipitis (Lu et al., 1998), Wickerhamomyces
anomalus (Fredlund et al., 2006) and Candida utilis (Franzblau and Sinclair, 1983),
as well as in Ogataea polymorpha (Ishchuk et al., 2008), which, along with
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Ogataea parapolymorpha, is actually a strain of the species Hansenula
polymorpha (Suh and Zhou., 2010; Ravin et al., 2013).
The fungal pathogen Candida albicans has 3 PDC genes, PDC2, PDC11
and PDC12 (Bahn et al., 2007; Kaiser et al., 1999). PDC12 likely encodes the
actual pyruvate decarboxylase. PDC11 seems to encode a functionally related
enzyme that localizes to the hyphal cell surface and that is upregulated under
hyphae-inducing conditions in a cAMP dependent manner, but which is not found
in the yeast cells themselves (Bahn et al., 2007). PDC12 is also upregulated by
the cAMP signaling pathway, but is expressed in the yeast cells (Bahn et al., 2007).
In contrast to the proteins encoded by PDC11 and PDC12, the protein encoded by
PDC2 has a regulatory role (Kaiser et al., 1999). C. albicans requires Pdc activity
to grow under hypoxic/anaerobic conditions. Pyruvate decarboxylase expression
is highly responsive to oxygen levels in C. albicans, with expression of the Pdc
apoform down-regulated in oxygen-rich environments, and upregulated in
anaerobic conditions (Tylicki et al., 2008). The maximal rate of Pdc activity in C.
albicans is reached at a much lower concentration of pyruvate than in S. cerevisiae
(Tylicki et al., 2008), indicating that the Pdc enzymes in different fungal species,
including in C. neoformans, may have different substrate affinities and enzyme
kinetics.
When the protein sequence for the single C. neoformans Pdc was analyzed
using phylogenetic software, it was found to be more closely related to the
probable

Pdc1

from

Sporisorium

reilianum,
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a

putative

indolepyruvate

decarboxylase from Ustilago maydis (UMAG_03994), the pyruvate decarboxylase
from Coprinopsis cinerea (CC1G_03453), and the pyruvate decarboxylase from
Phanerochaete chrysosporium (AGR57_8688) than to Pdc1p, Pdc5p, and Pdc6p
from S. cerevisiae or to the C. albicans proteins, making it difficult to determine the
function of the C. neoformans Pdc based on the S. cerevisiae or C. albicans
proteins. Nevertheless, the review of Pdc enzymes from the latter two model
organisms provided insight that allowed the interpretation of the results of
biochemical and cellular assays of the C. neoformans pdcΔ mutant.
As C. neoformans disseminates from the lungs, it encounters different
environments, such as those inside of macrophages, in the blood, or in the brain,
and it must adapt to utilize different available nutrients; the fungus even changes
the expression of genes important in the utilization of acetate, lactate, ethanol, or
glucose as part of adjusting to the use of alternative carbon sources (Hu et al.,
2008). Therefore, the growth of the C. neoformans pdcΔ mutant on glucose,
ethanol, or acetate as the sole carbon source was assayed. As mentioned above,
S. cerevisiae pdc1 point mutants have reduced growth on glucose while deletion
mutants grow normally by upregulating Pdc5p (Schmitt and Zimmermann, 1982;
Schmitt et al., 1983; Seeboth et al., 1990; De Assis et al., 2013; Muller et al., 1999;
Eberhardt et al., 1999; Hohmann and Cederberg, 1990; Schaaff et al., 1989; Kaiser
et al., 1999). It was therefore surprising, despite the lack of evolutionary
relatedness between the C. neoformans and S. cerevisiae enzymes, that the C.
neoformans pdcΔ mutant grew normally on solid media with glucose as the sole
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carbon source (Figure 3.4a) but displayed a growth defect in the equivalent media
in liquid form (Figure 3.5a). This indicates that, despite having only one Pdc
enzyme, C. neoformans cells deleted for the corresponding gene somehow work
together to circumvent the function of the pyruvate metabolism pathway via some
kind of compensation mechanism when grown at high density as colonies. This
mechanism appears to function only when the cells are en masse, so that, when
isolated from each other in liquid culture with constant agitation, the mutant cells
do not grow as well as wild type cells. The C. neoformans pdcΔ mutant did not
exhibit a growth defect on ethanol. Just as S. cerevisiae represses the expression
of both PDC1 and PDC5 in the presence of ethanol (Liesen et al., 1996) since it
can make acetaldehyde, and therefore acetate, from ethanol instead of from
pyruvate, C. neoformans also should not need pyruvate decarboxylase when
grown on ethanol. Likewise, if Pdc plays a role in acetate production, it should not
be necessary for growth on acetate. In support of this potential function, the pdcΔ
mutant grew normally on media containing acetate as the primary carbon source.
In addition to serving as a possible carbon source for C. neoformans,
acetate is one of the major metabolites in infected tissues (Himmelreich et
al.,2003) as well as in culture (Bubb et al., 1999; Wright et al., 2002). Based on
studies in S. cerevisiae, pyruvate produced in the cryptococcal cell by glycolysis
either could be shuttled to mitochondria to generate acetyl-CoA (via the TCA cycle)
or could be channeled into a anaerobic pathway to make acetaldehyde, which
would then be converted to acetate and acetyl-CoA via the functions of
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acetaldehyde dehydrogenase and acetyl-CoA synthetase enzymes, respectively
(Saint-Prix et al., 2004; Remize et al., 2000; Pronk et al., 1994, 1996). The latter
pathway, again, based on S. cerevisiae, is also likely to be the major source of
cytoplasmic acetate (Saint-Prix et al., 2004; Remize et al., 2000; Pronk et al., 1994,
1996). Furthermore, Hu et al. (2008) reported that C. neoformans enzymes
involved in metabolism or transport of acetate, including two acetate transporters,
acetyl-CoA

synthetase,

an

aldehyde

dehydrogenase,

and

pyruvate

decarboxylase, and are all upregulated during pulmonary infection. In order to
assess the effect of the loss of the Pdc enzyme in C. neoformans on acetate
production, the levels of acetate secreted by the wild type strain and by the pdcΔ
mutant at different time points during growth in liquid media were quantified. A
statistically significant decrease in the levels of acetate was observed in the pdcΔ
mutant relative to the wild type strain (Figure 3.6), indicating that deficiency of
pyruvate decarboxylase impaired acetate production and suggesting that Pdc
plays an important role in the generation of acetate by C. neoformans. This is
contradictory to the observation in S. cerevisiae, in which mutation of the PDC1
gene did not affect the levels of acetate (Remize et al., 2000). The reason for this
difference is likely that S. cerevisiae has at least two functioning Pdc enzymes that
can compensate for each other (De Assis et al., 2013; Muller et al., 1999;
Eberhardt et al., 1999; Hohmann and Cederberg, 1990; Schaaff et al., 1989; Kaiser
et al., 1999), while C. neoformans has only one PDC gene, loss of which severely
decreases the amount of acetate produced by C. neoformans. In combination with
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the reduced acetate secretion observed in all of the C. neoformans aldehyde
dehydrogenase mutants in the prevous chapter, the reduced levels of acetate
secreted by the pdcΔ mutant supports the notion that Pdc and the Ald enzymes
form a metabolic pathway by which a significant portion of the acetate generated
by C. neoformans is made, although each could, instead, be part of different,
parallel pathways.
Given the fact that acetate is produced by C. neoformans during in vivo
infection (Himmelreich et al.,2003), it was obviously important to investigate
whether reduced acetate levels, or reduced Pdc activity overall, could affect the
virulence of the pathogen. Therefore, the status of various virulence factors,
including capsule formation, levels of melanin, and cell wall integrity were
assayed in the C. neoformans pdcΔ mutant. Indeed, the mutant exhibited a
smaller and thinner capsule than the wild type strain (Figure 3.7). However,
whether this reduction in capsule size is deleterious for fungal infection and
survival in the host cell is actually questionable. C. neoformans spores are
generally unencapsulated as smaller size helps in passage through the airway
during inhalation (Velagapudi et al., 2009). Infection with hypocapsular strains
leads to worse clinical outcomes because of the higher possibility of passage
into the lungs (Sabiiti et al., 2014). Furthermore, at least one study showed that
hypercapsular mutants of C. neoformans were less virulent, while hypocapsular
strains were more virulent, and disseminated more effectively to the brain, in a
mouse model (Pool et al., 2013). On the other hand, completely acapsular
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mutants of C. neoformans have been shown to be avirulent (Chang and KwonChung, 1994), and cryptococci enlarge their capsules after reaching the lungs to
prevent engulfment by macrophages (Levitz and Tabuni, 1991; Xie et al., 2012;
May et al., 2016). Therefore, the lack of a proper capsule alone was not sufficient
to predict the virulence of the pdcΔ mutant.
Besides the polysaccharide capsule, the survival of C. neoformans inside
the host cells also depends on melanin. Melanin not only contributes to the
maintenance of cell wall integrity, but also accumulates at the cell wall and
neutralizes the free oxygen and nitrogen radicals produced by phagocytes
before they can reach the fungal cell membrane, thereby protecting the pathogen
from the chemical attack that is part of the immune response mounted by host
cells (Wang et al., 1995; Wang et al., 1996; McClelland et al., 2006; Steenbergen
and Casadevall, 2003). Analysis of the C. neoformans strain deficient for the Pdc
enzyme showed a reduction in the level of melanin in the cells (Figure 3.8), which
may have an impact on virulence. This decrease could be due to perturbation of
the regulation of the melanin synthesis pathway, but a limited defect in cell wall
integrity observed in the Congo red assay (Figure 3.12) could also contribute to
the similarly limited reduction in melanization, since both melanin and the
laccase enzymes that produce it are located in the C. neoformans cell wall
(Perez-Dulzaides et al., 2018; Walton et al., 2005; Zhu et al., 2001; McFadden
and Casadevall, 2001), and disruption of cell wall integrity leads to leaking out of
melanin (Perez-Dulzaides et al., 2018). It is also possible that the smaller
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capsule of the pdcΔ mutant (Figure 3.7) allowed the laccase enzyme and/or the
melanin to escape, preventing the accumulation of the latter.
Since the pdcΔ mutant had both a smaller capsule and low melanin levels,
the effect on growth of reactive oxygen and nitrogen species and of
hyperosmolarity, which should affect these "unprotected" cells more, was assayed,
but the mutants were unaffected by these stresses (Figures 3-10 and 3-11). This
was an intriguing result, since it indicated that, either the degree of reduction in
capsule size, cell wall integrity, and melanization was insufficient to increase
sensitivity to these stresses, or other factors besides the capsule and melanin were
protecting the cells from ROS/RNS-mediated cell damage or water loss. It is
possible that the accumulation of pyruvate in these pdcΔ mutant cells might have
been put to use by the cells to somehow neutralize the ROS/RNS and that the
increasing concentrations of pyruvate increased the osmolarity within the cell,
counteracting the hyperosmolarity in the media.
Just as C. neoformans cells have to be able to cope with oxidative (and
nitrosative) stress, they also have to be able to cope with the near opposite
condition, too little oxygen. C. albicans requires Pdc activity to grow under
hypoxic/anaerobic conditions (Tylicki et al., 2008). Therefore, it is possible, that
pyruvate decarboxlyase activity may also provide resistance to hypoxia stress in
C. neoformans, just as it appears to do in C. albicans. Indeed, when tested for
growth on media with cobalt chloride, which induces cells to behave as if they are
in hypoxic conditions, the pdcΔ mutant was more sensitive than the wild type strain
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(Figure 3.9b). The cobalt ion in the cobalt chloride can drive the production of ROS
via the Fenton reaction just like reduced iron (Ingavale et al., 2008); however, the
sensitivity of the pdcΔ mutant to cobalt chloride was due to its lack of ability to
respond properly to hypoxia, and not due to a sensitivity to ROS or RNS, since the
mutant grew normally on media supplemented with hydrogen peroxide or sodium
nitrite. The pdcΔ mutant also grew normally on media supplemented with CoCl2
when 2% acetate was also added to the media. This indicates that the partial
dependence of C. neoformans on Pdc for survival under hypoxia is based on the
role of pyruvate decarboxylase in acetate production, or at least, that the pathogen
needs acetate to contend with hypoxia-like conditions, and the pdcΔ mutant is
unable to make wild type levels of acetate, as demonstrated by the hydroxamate
assay.
Once it was determined that important virulence factors like melanin
production, capsule formation, and cell wall integrity were negatively affected in
the pdcΔ mutant, and that this correlated with at least one phenotype potentially
associated with reduced virulence (reduced growth under hypoxia), the next logical
step was to test whether the lack of the Pdc enzyme reduced the actual virulence
of the mutant in vitro and/or in vivo. In fact, the pdcΔ mutant did demonstrate
significantly reduced survival (and recovery) after phagocytosis relative to the wild
type strain in an assay utilizing mouse macrophages (Figure 3.13). This indicates
that, while the smaller capsule, reduced cell wall integrity, and decreased
melanization observed in the mutant did not affect the response to ROS/RNS, they
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did affect the ability to survive the other types of attacks mounted by the
macrophages after engulfment. Thus, deficiency of pyruvate decarboxylase
activity did reduce C. neoformans virulence in vitro.
Nevertheless, the effects on virulence of deletion of a gene are best
determined using an in vivo assay. Other C. neoformans mutants with defective
melanin production have reduced virulence in the in vivo Galleria mellonela
infection model (Firacative et al., 2014). Therefore, since the pdcΔ mutant strain
had reduced melanization in addition to reduced survival after macrophage
engulfment, it was expected to have reduced virulence when injected into G.
mellonela larvae. However, pdcΔ mutant cells killed the larvae just as effectively
as C. neoformans wild type cells. This discrepancy may be due to differences in
genetic background between the strains used in the larval assay and those used
in the other assays; unlike in the other assays, in which the mutant and wild type
strain were from the KN99α background, in the G. mellonella survival assay, the
strains used were in the H99α background. The H99α background strains were
used in the in vivo assay because the KN99α strains had not yet been obtained
when the larvae were available. On the other hand, this strain difference should
have minimal effect on the assay results, since the KN99α background strain is
derived from the H99 background strain. Even if differences in genetic background
played no role in the dissimilarity between the virulence of the pdcΔ mutant as
measured by the in vitro macrophage assay and that measured by the in vivo
Galleria survival curve assay, the apparently contradictory results are not that
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surprising. Work by Bouklas et al. (2015) shows that phagocytosis and killing by
murine macrophages does not necessarily correlate with virulence in Galleria;
instead, the results of assays in which killing by macrophages was used to assess
virulence are moderately similar to the results obtained from a murine infection
model. This suggests that the Galleria model works well for testing some virulence
factors but it does not consistently show a correlation with a murine model for many
other virulence factors. Since this is the case, and since a murine model of infection
is much more likely to demonstrate the effects on virulence in humans of mutations
in C. neoformans genes, it is recommended that the pdcΔ mutant be tested for
virulence in a mouse pulmonary infection or cryptococcal meningitis model.
Overall, this study shows that Pdc is an important metabolic enzyme in C.
neoformans that can regulate synthesis of the capsule and the level of melanin in
fungal cells, as well as the ability to grow in hypoxic conditions in an acetatedependent manner, but that might or might not influence the virulence of the
pathogen.
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Potential future experiments
The current results point to a role for the PDC gene in acetate production,
since it is now clear that the lack of the Pdc enzyme caused reduced growth under
hypoxia-mimicking conditions in an acetate-dependent manner, based on the
rescue of normal growth via supplementation with acetate. However, the
importance of this putative role and of normal acetate levels to phenotypes
associated with virulence needs to be investigated further by the addition of
acetate to capsule induction and melanin induction media, and to the Congo red
containing media in order to uncover whether the capsule formation, melanization,
and cell wall integrity phenotypes are due to insufficient acetate production by the
mutant. Likewise, culturing the wild type and pdcΔ mutant strains in media
containing acetate prior to using them in the macrophage survival assay will reveal
whether the mutant is less able to counteract the destruction of the fungal cells in
the phagolysosome because it cannot produce enough acetate.
While the pdcΔ mutant had reduced survival when engulfed by murine
macrophages, it exhibited normal virulence in the Galleria mellonella in vivo assay.
However, the mutant (and wild type) strain used in the G. mellonella assay was in
the H99α background, and was the KN99α background strain used in other
assays, so the G. mellonella assay result should be confirmed with wild type and
pdcΔ mutant strains in the KN99α background. If the mutant still does not exhibit
reduced virulence in the larvae, and therefore contradicts the macrophage survival
assay result, then this might indicate an issue with the use of an invertebrate
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infection model. In other words, the use of mammalian organisms as an in vivo
infection model would better match the use of murine macrophages, which are part
of the vertebrate immune system, than the use of insect larvae, which have
macrophage-like cells, but not actual macrophages (Arvanitis et al., 2013; Tsai et
al., 2016). So, further testing of the virulence of the pdcΔ mutant should be
undertaken using murine or zebrafish infection models involving injection or
inhalation of C. neoformans. In particular, it is recommended that the pdcΔ mutant
be tested for virulence in a mouse pulmonary infection or cryptococcal meningitis
model. Since oxygen levels in the brain are lower than in many parts of the body
after infection (Erecińska and Silver, 2001; Kronstad et al., 2012; Chang et al.,
2007), cryptococcal dissemination and the development of cryptococcal meningitis
requires C. neoformans to be able to grow under low oxygen. Therefore, the pdcΔ
mutant, which exhibited a growth defect under hypoxia-mimicking conditions, is
expected to be less virulent than the wild type pathogen in a mouse infection
model.
Furthermore, the expression of various virulence-related and metabolic
genes in the pdcΔ mutant could be analyzed after the C. neoformans are used in
the infection of the mice. Hu et al. (2008) showed that levels of the mRNA encoding
Pdc are upregulated in C. neoformans recovered from the lungs of mice from a
pulmonary infection model. Therefore, the levels of the C. neoformans PDC mRNA
could be determined by quantitative PCR after the fungal cells are grown under
physiological conditions, under various stress conditions, or in or on different
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carbon sources (i.e. glucose, acetate, or ethanol) to shed light onto the regulation
of Pdc (mRNA) expression in Cryptococcus, and the level of expression of PDC in
wild type cells, and of stress-response and metabolic genes in the wild type and
pdcΔ mutant strains, could be determined after the fungal cells infect mouse lungs
or brain tissue.
Finally, growth analysis of two double mutants should be undertaken. The
first, a pdcΔ, ackΔ double mutant has been generated to determine whether the
two corresponding enzymes function in a single pathway or in parallel pathways in
acetate production; this double mutant is in the process of characterization.
Likewise, since both the ald29Δ and pdcΔ mutants exhibited a growth defect under
hypoxia-mimicking conditions, and both recovered normal growth when provided
acetate, it is possible that the corresponding enzymes work in a single acetate
production pathway. Generation of a pdcΔ, ald29Δ double mutant and analysis of
the growth of this second double mutant, in this case versus that of each single
mutant and of the wild type strain on media with CoCl2 or with CoCl2 and acetate,
would determine whether the two enzymes work in series or in parallel pathways.
If they function in the same pathway, the double mutant phenotype should be no
worse than that of either single mutant, while, if they operate in parallel, the double
mutant should be completely unable to grow on cobalt chloride supplemented
media, unless acetate is provided. Analysis of the phenotype of the double mutant
versus each single mutant (and wild type) strain in other assays, such as the
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hydroxamate assay for acetate production, should confirm the findings of the
hypoxic growth assay.
All of these experiments would further the understanding of the role of
pyruvate decarboxylase in C. neoformans growth and virulence, completing the
work begun here.
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Table 3.1: Information about the gene/enzyme deficient in the pdcΔ mutant
strains used in this study.
Gene

PDC

Enzyme name†

Pyruvate
decarboxylase

Identification
Number†

Chromosome†

CNAG_04659

10

Predicted
Location‡
Cytoplasmic

† The official enzyme name and identification number, as well as the chromosomal
location of the corresponding PDC gene was obtained from the Fungi Database,
https://fungidb.org/fungidb/app/record/gene/CNAG_04659.
‡ The predicted mitochondrial or cytoplasmic cellular location of the protein was
determined

using

the

MitoFates

website

bin/top.cgi; (Fukasawa et al., 2015).
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Figure 3.1: Various metabolic pathways utilized by C. neoformans to harness
energy and invade the host immune system. Glucose, ethanol, and acetate can
be used as sources of carbon by C. neoformans. Under anaerobic conditions,
glucose is likely converted to acetate by the action of pyruvate decarboxylase
(Pdc) and acetaldehyde dehydrogenase enzymes. Ethanol in the cells is converted
via alcohol dehydrogenase to acetaldehyde, which is then likely converted to
acetate via acetaldehyde dehydrogenase.
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Figure 3.2: Phylogenetic tree analysis shows evolutionary relatedness of
Cryptococcus neoformans pyruvate decarboxylase enzymes to those of
other fungal species. The protein sequences of cryptococcal pyruvate
decarboxylase (Pdc) enzymes and potential homologues from other fungal
species were analyzed using Molecular Evolutionary Genetics Analysis (MEGAX)
software to build a phylogenetic tree. The Pdc enzymes from C. neoformans var
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grubii and C. neoformans var neoformans were most similar to each other and
then to the homologue from C. gattii, and, as a group, were next most closely
related to enzymes from Sporisorium reilianum, Ustilago maydis, Coprinopsis
cinerea, and Phanerochaete chrysosporium. The cryptococcal proteins were only
distantly related to the enzymatic proteins Pdc1p, Pdc5p, and Pdc6p from
Saccharomyces cerevisiae, but these were more closely related than were
regulatory proteins like Pdc2p from S. cerevisiae or from Candida albicans.
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Figure 3.3: Verification of the deletion of PDC in the corresponding mutant.
PCR primers specific for the pyruvate decarboxylase gene (3 and 4 above) and for
the NAT gene conferring resistance to the nourseothricin (NTC) antibiotic (107 and
108) were used to confirm the replacement of PDC with the NAT cassette in the
pdc mutant (pdcD) obtained from the Madhani lab at UCSF. The presence of a
band representing PDC from the wild type DNA (WT; lane 2, yellow asterisk), but
not from the mutant DNA (pdcD; lane 3), corroborated the deletion of PDC in the
mutant. The presence of the NAT gene in the pdcΔ mutant (lane 4, yellow asterisk,
~1600 bp), but not in the wild type strain (lane 5), also confirmed that insertional
mutagenesis had occurred.
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Figure 3.4: No qualitative difference in growth using glucose, acetate, or
ethanol as the carbon source was observed between wild type and pdcΔ
mutant strains. Four 10-fold serial dilutions (2 µl of 5000, 500, 50, and 5 cells/µl)
of the pdc mutant strain (pdcD), and of the wild type (WT) strain of C. neoformans
(both in a KN99α strain background) were spotted from left to right on YNB-agar
plates supplemented with (a) 2% glucose, (b) 2% acetate, or (c) 2% ethanol. The
pdcΔ mutant strain exhibited normal growth (relative to the wild type strain) on all
three media.
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Figure 3.5: Quantification of the impact of deletion of PDC on growth in liquid
media with various carbon sources. Growth curves for the wild type strain and
for the pyruvate decarboxylase deficient strain (pdcD) of C. neoformans (both in a
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KN99a strain background) were generated over a 48-hour time course in media
supplemented with (a) 2% glucose, (b) 2% acetate, or (c) 2% ethanol as the
primary carbon source. The pdcΔ mutant displayed a very statistically significant
(** P-value < 0.01) reduced growth rate in glucose, but not in acetate or ethanol.
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Figure 3.6: The pdcΔ mutant produced significantly less acetate than the wild
type strain. A time course analysis over 48 hours revealed that the pdc mutant
strain (pdcD) produced less acetate, than the wild type (WT) strain (both in the
KN99a background). This difference was very statistically significant (** P-value <
0.01).
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Figure 3.7: The PDC gene plays an important role in capsule formation. Cells
from the pdc mutant (pdcD) and wild type strain (in the KN99a background) were
cultured in capsule-inducing medium, stained with India Ink, and observed under
a Zeiss microscope at 40x magnification. A white line indicates the width of the
capsule (the layer of secreted polysaccharides outside the cell wall, appearing as
a grey zone),in the wild type strain. The capsule of the pyruvate decarboxylase
deficient mutant is clearly reduced in width.
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Figure 3.8: The pdcΔ mutant produces less melanin than the wild type strain.
Wild type and pdc mutant strains (pdcD) in a KN99a strain background were grown
in a spot assay on plates supplemented with L-DOPA, the substrate converted to
a brown melanin-like pigment by laccase enzymes (Williamson, 1997; Li et al.,
2018). The pdcΔ mutant accumulate less of the pigment and was lighter in color.
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Figure 3.9: The pdcΔ mutant grew poorly under hypoxic conditions. A spot
assay mimicking growth under low oxygen, in which cobalt chloride induces cells
to act metabolically as if they were growing in hypoxia, was conducted. The wild
type strain (WT, in the KN99a background) and the pyruvate decarboxylase
mutant (pdcD, also in the KN99a background) were grown on a) YES-agar media
lacking CoCl2 as the normoxic control, in which the pdcΔ mutant grew normally, or
b) YES-agar media supplemented with 0.7 mM CoCl2, (0.7 mM CoCl2; Hypoxia
mimic), in which the pdcΔ mutant exhibited a growth defect, indicative of an
abnormal response to hypoxia. c) This growth defect was reversed when media
with CoCl2 were supplemented with acetate (0.7 mM CoCl2 + 2% Acetate).
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Figure 3.10: The pdcΔ mutant grew normally under oxidative and nitrosative
stresses. The wild type and pdc mutant strains (pdcD), both in the KN99a
background, were grown on a) YNB-agar media (buffered to pH 4.0 with sodium
succinate) either not supplemented (Control) or supplemented with 1mM H2O2 to
assess sensitivity of the mutant to oxidative stress, or b) on sodium succinate
buffered YNB-agar media not supplemented (Control) or supplemented with
1.5mM NaNO2 to assess sensitivity of the mutant to nitrosative stress. Growth of
the pdcΔ mutant was normal (comparable to wild type) under both stress
conditions.
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Figure 3.11: The pdcΔ mutant grew normally under high salt conditions. Wild
type and pyruvate decarboxylase mutant (pdcD) strains (both in a KN99a
background) were grown on a) YPD-agar alone as control, b) YPD-agar
supplemented with 1.5 M NaCl, or c) YPD-agar supplemented with 1.2 M KCl in
order to induce osmotic stress via the excess sodium or potassium chloride. The
pdcΔ mutant grew normally relative to the wild type strain under all of these
conditions.
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Figure 3.12: The pdcΔ mutant had abnormal cell wall and capsule integrity.
Wild type and pyruvate decarboxylase mutant (pdcD) strains (in a KN99a
background) were grown on a) YPD-agar alone as control, b) YPD-agar
supplemented with 0.03% sodium dodecyl sulfate (SDS), which can disrupt the cell
membrane, or c) YPD-agar supplemented with 0.5% Congo red, which can disrupt
the cell wall production and integrity by binding to components of the cell wall and
chitin layers. The pdcΔ mutant was not sensitive to SDS, but the deficiency of the
pyruvate decarboxylase enzyme did affect survival of cells spotted at low density
on Congo red media, indicating that Pdc is required for full cell wall integrity.
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Figure 3.13: Percent survival of wild type and pdcΔ mutant C. neoformans
cells after engulfment by macrophages in an in vitro assay. The pdcΔ mutant
exhibits reduced survival and recovery (*** P-value < 0.001) after phagocytosis by
macrophages than the wild type KN99α strain.
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Figure 3.14: Galleria mellonella survival assay. The survival of Galleria
mellonella larvae was analyzed after injection with the pdc mutant (pdcD; blue
line) or wild type (WT; black line) strains of C. neoformans, in the H99
background, or, as control for death of the larvae due to injection-related
damage or excessive immune response to fungal infection, with phosphate
buffered saline (PBS; dotted black line) or heat-killed H99 wild type strain
(Dead H99; dashed black line), respectively. Here, the survival percentages,
over time, of the larvae after injection with one million cells of the appropriate
type are graphed as Kaplan-Meier survival curves. The survival curves of the
pdcΔ and wild type strain-injected larvae were not statistically different, as
determined via either a Gehan-Breslow-Wilcoxon test (P-value = 0.3395) or a
Log-Rank test (P-value = 0.2700), while the survival curves for the two
negative controls were statistically different (from the wild type survival curves)
by either test (P-value < 0.0001 for both controls).
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CHAPTER FOUR

USE OF A GENETIC SCREEN TO IDENTIFY ACETATE UTILIZATION GENES
IN C. NEOFORMANS
Mufida Ammar, Hanan Al Mousa, Nitya Muppala, Erin Mihealsick, and
Kerry Smith
Department of Genetics and Biochemistry, Clemson University, Clemson, South
Carolina, USA

Abstract
Cryptococcus neoformans is an opportunistic fungal pathogen that can adapt to
use different carbon sources as needed. Additionally, it can produce and utilize
acetate, ethanol, or other alternate carbon sources whenever there is insufficient
glucose in the environment. The ability to use alternative carbon sources can be
studied to develop drugs against the relevant pathways. In this study, a global
screening approach was used to identify genes required for growth of the pathogen
when provided with acetate or glucose as the only carbon source. A total of 3,936
distinct strains from two gene-knockout libraries were screened for their ability to
grow on acetate-containing medium. In total, 41 individual mutants failed to grow
on either glucose- or acetate- containing medium. Of these, 12 failed to grow on
medium containing glucose as the only carbon source, 15 mutants failed to grow
on medium with acetate as the only carbon source, and 14 failed to grow on both
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of these media. The corresponding genes were categorized, as far as possible,
based on the pathways to which they belong. Many of these genes are involved in
gluconeogenesis, arginine biosynthesis, or mitochondrial transport. Some of these
genes have known homologues in other fungal species, like Saccharomyces
cerevisiae, Aspergillus nidulans, Candida albicans, and Neurospora crassa, and
the roles of these homologues have been studied with respect to acetate
utilization. However, some of the genes identified in this screening are novel and
have not been previously studied in the context of acetate utilization pathways.
Herein, the C. neoformans genes identified by this screen for growth on acetate as
an alternate carbon source, and, taking insights from other fungal species, the
possible roles of some of these genes, are presented.

300

Introduction
Cryptococcus neoformans is an opportunistic, invasive pathogen that often
disseminates to the central nervous system (CNS) and is the most frequent cause
of human fungal meningitis (Lin and Heitman, 2006). It causes significant annual
global mortality (Park et al., 2009, Pappas, 2001; Lui et al., 2006; Franzot et al.,
1999; Dromer et al., 1996; Tortorano et al., 1997; Powderly, 1993). This fungus
mainly

affects

HIV/AIDS

patients,

transplant

recipients

who

are

immunosuppressed to prevent immune-mediated graft rejection, and other
immunocompromised individuals (Hull and Heitman, 2002). When C. neoformans
cells enter the lungs, alveolar macrophages attempt to phagocytose the fungal
cells and kill them, or at least sequester them into granulomas (Rohatgi and
Pirofski, 2015; Vecchiarelli et al., 1994a,b; Mitchell and Friedman, 1972;
McQuiston and Williamson, 2012; Sabiiti and May, 2012). If phagocytosis occurs
and the pathogen is trafficked into the macrophage phagolysosome, a low pH
environment, hydrolytic enzymes, antimicrobial peptides, and toxic free radicals
are used to try to destroy the pathogen (Hampton et al., 1998; Vieira et al., 2002;
Cox et al., 2003; Tohyama et al., 1996; Ma and May, 2009) and to break apart
pathogen proteins into peptides for presentation to T cells in order to activate the
adaptive immune response (Vecchiarelli et al., 1994a). In preparation for immune
attack, C. neoformans increases the production and use of a capsule and of
melanin to prevent phagocytosis, or if phagocytosed, to counteract the reactive
oxygen species (i.e. free radicals) and modulate pH, thereby blocking the initial
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steps of immune activation by macrophages (Wang et al., 1995; Mednick et al.,
2005; Shoham and Levitz, 2005; Tucker and Casadevall, 2002; Zaragoza et al.,
2008; De Leon-Rodriguez et al., 2018; Rohatgi and Pirofski, 2015). This, along
with other virulence factors, including the ability to grow at the host body
temperature of 37°C and the use of degradative enzymes, allows the pathogen to
survive and spread inside the host (Coelho et al., 2014; Casadevall et al., 2000;
Kronstad et al., 2011; Ma and May, 2009).
Metabolic adaptability and flexibility are important attributes for fungal
pathogens to successfully infect and cause disease. Although carbon metabolism
is critical for virulence in C. neoformans (Price et al., 2011), very little is known
about which carbon sources are utilized during infection. Lung alveolar
macrophages, which present a first line of host defense against C. neoformans
infection (Feldmesser et al., 2000; Feldmesser et al., 2001), provide a glucoseand amino acid-poor environment {Barelle et al., 2006; Lorenz et al., 2004), and
nonpreferred carbon sources such as lactate and acetate are likely important early
in establishment of a pulmonary infection (Price et al., 2011).
To identify C. neoformans genes not previously known to be important in
acetate utilization, strains from two gene knockout libraries were screened for the
ability to utilize acetate as the sole carbon source. From this screen, 26 genes
were identified that encode proteins necessary for growth on acetate as a sole
carbon source. Some of these genes, like those encoding acetyl-CoA synthetase
and phosphoenolpyruvate carboxy kinase, were previously identified in other
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fungal species like S. cerevisiae, Aspergillus nidulans, and Neurospora crassa,
(Apirion, 1965; Sealy-Lewis, 1994; Flavell and Fincham, 1968a; Schüller, 2003) or
even in C. neoformans itself (Hu et al., 2008), as important acetate utilization
enzymes, thereby verifying the sensitivity of the assay, while others have been
identified as important in acetate metabolism in C. neoformans for the first time.
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Materials and methods
Strains
Two libraries of C. neoformans strains produced in 2015 and 2017 by the
Madhani laboratory at the University of California San Francisco (UCSF) (Chun
and Madhani, 2010; NIH R01AI100272), were obtained from the Fungal Genetic
Stock Center.
Screening of single-deletion strains from the libraries via spot assays
Thawed 96-well plates with strains from the original knockout libraries were
used to produce duplicate 96-well plates by inoculating corresponding wells
containing 100 μl YPD with 2 μl from each of the wells of the original plates. The
yeast in these duplicate plates were allowed to grow overnight at 30°C with
constant shaking. The following day, cells from each well were refreshed by
inoculating a corresponding well of 100 μl fresh YPD media in new 96-well plates
(second duplicate plates) with 2 μl of the overnight culture. After a 3 hr incubation,
2.5 μl of cells from each well were spotted onto corresponding locations on each
of two YNB-agar plates, one supplemented with 2% glucose and the other
supplemented with 2% acetate. After a ~48-hour incubation at 30°C, the glucose
or acetate supplemented plates were imaged using a Canon EOS Rebel T1i
camera. The identity of the genes mutated in strains that showed growth inhibition
in either test condition were recorded.
For the strains that did not grow on either glucose or acetate supplemented
YNB-agar, the corresponding well in the duplicate plate #2 was assessed under a
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light microscope under 20x magnification to ensure that there were cells in the
wells. If no cells were observed, the same well in duplicate plate #1 was also
checked. If neither duplicate plate had cells, the original stock was re-thawed, a
small volume of cells from the corresponding mutant strain was plated onto YPDagar media, and a glycerol stock was generated to add to the original library stock.
Once cells from the strains that did not grow on glucose or acetate supplemented
media were obtained from either of the two duplicate plates or, if necessary, from
the original stock, they were grown on YPD media and then plated once again on
glucose or acetate supplemented YNB-agar to attempt to replicate the original
result.
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Results
Previous reports suggest that acetate is a key carbon source for the survival
of C. neoformans and other fungal pathogens at early stages of infection (Hu et
al., 2008; Bubb et al., 1999; Wright et al., 2002; Himmelreich et al., 2001, 2003;
De Sousa Lima et al., 2014; Baeza et al., 2017). Thus, obtaining a global overview
of which fungal genes are involved in the synthesis, utilization, or transport of
acetate in cryptococcal cells is potentially of both scientific and medical
importance. Therefore, a library 3,936 distinct C. neoformans knockout strains,
each produced by deletion within the open reading frame of the corresponding
genes via insertional mutagenesis, was screened by spotting each individual strain
on YNB-agar plates supplemented with either glucose or acetate as the sole
carbon source. The growth of each of the mutant strains was assayed after
incubating the plates for 48 hours at 30°C. The majority of the deletion mutants
grew normally in the presence of either carbon source. However, some mutants
were found to be compromised in their ability to utilize glucose and/or acetate as
the sole carbon source, and grew poorly or not at all in the corresponding medium.
Representative glucose and acetate supplemented plates are shown in Figures 41a and 4-1b, respectively. Some strains, like the deletion mutant for SWR1Complex protein 4 (CNAG_02020), had an unusual phenotype of growth into
seemingly more dense, slightly larger, creamy-white colonies on media with either
glucose or acetate as the sole carbon source, or on both media (Figure 4.1 c).

306

Further analysis of these mutants is beyond the scope of this screen, but may be
undertaken at a later date.
Mutants that failed to grow were plated from the original library stock onto YPDagar media to provide nutrient-rich growth conditions, and then the strains on these
plates were transferred to YNB-agar plates supplemented with either glucose or
acetate to confirm that the growth defect observed was both verifiable and
dependent on the requirement to use a specific carbon source, not a general
growth defect. In total, 12 deletion mutants failed to grow on media supplemented
with glucose (Table 4.1), another 15 deletion mutants failed to grow on media
containing acetate as the only carbon source (Table 4.2), and 14 deletion mutants
failed to grow on glucose or acetate as the only carbon source (Table 4.3). The
strains that failed to grow on glucose-containing medium included those mutant for
genes encoding ste20 protein kinase (CNAG_00405), the V-type H+-transporting
ATPase subunit AC39 (CNAG_00448), chitin deacetylase 2 (CNAG_01230), and
the calcium sensor and enzyme regulator calmodulin (CNAG_01557), the latter of
which plays a role in many cell functions, including thermotolerance (Kraus et al.,
2005).
The strains that failed to grow on medium containing acetate as the sole
carbon source included mutants with defects in genes encoding glucose-6phosphate isomerase (CNAG_03916), which is important for melanin and capsule
production, as well as in cell wall integrity and stress resistance (Zhang et al.,
2015), fructose-1,6-bisphosphatase I (CNAG_00057), and phosphoenolpyruvate
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carboxykinase (CNAG_04217), all of which function in gluconeogenesis (Hynes et
al., 2002; Zhang et al., 2015). A mutant for the gene encoding acetyl-CoA
synthetase (CNAG_00797), which converts acetate to acetyl-CoA that can be used
for multiple purposes, including gluconeogenesis (Hu et al., 2008), was also unable
to grow on the acetate supplemented, glucose-free medium. Two members of the
solute carrier family 25, a mitochondrial carnitine/acylcarnitine transporter
(CNAG_00499) and a mitochondrial citrate transporter (CNAG_02288), as well as
two carnitine acetyltransferases (CNAG_00537 and CNAG_06551), also failed to
grow on acetate-containing medium. Mutant strains that grew on neither acetatesupplemented nor glucose supplemented media included those deleted for the
mitochondrial

amino-acid

acetyltransferase

(CNAG_02826),

carbamoyl-

phosphate synthase arginine-specific large chain (CNAG_06112), ornithine
carbamoyltransferase

(CNAG_02812),

and

argininosuccinate

lyase

(CNAG_02825), all of which function in arginine biosynthesis (Rhodes and
Howard, 1980), as well as the large subunit of a carbamoyl-phosphate synthase
(CNAG_07373) that functions in other biosynthesis pathways.
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Discussion
Acetate is a two-carbon metabolite that plays a significant role in energy
production in fungal pathogens after conversion to acetyl-CoA, especially after
infection. The acetyl-CoA can be channeled into the tricarboxylic acid cycle, the
glyoxylate cycle, or the gluconeogenesis pathway (Hu et al., 2008). A genetic
screen for growth on two different carbon sources, glucose and acetate, was
performed on an array of C. neoformans deletion mutants to uncover enzymes (or
other proteins) not previously characterized as contributing to the growth of the
pathogen when acetate is the only available carbon source. In total, 41 mutants
were identified that failed to grow on media with either glucose or acetate as the
only carbon source. Of these, 12 failed to grow on medium with glucose as the
only source of carbon, another 15 did not grow on medium containing acetate as
the sole carbon source, and 14 did not grow on either medium.
Analysis of the mutants identified several genes that play a central or
secondary role in the metabolism of acetate in the fungus. These mutants can be
divided into three categories based on the types of pathways affected by the
corresponding protein deficiencies. Those that could not grow with glucose as the
only carbon source but could grow on acetate probably have a more general
glucose utilization defect and will not be discussed further. Those deletion mutants
that could not grow with acetate as the sole carbon source but could grow on
glucose are likely to be deficient in either the conversion of acetate to acetyl groupcontaining molecules used in various critical cellular functions or in the import of
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these molecules (but not of glucose-derived alternatives) into the mitochondria for
use in cellular respiration to produce ATP. Finally, those mutants that were able to
grow on neither glucose nor acetate as the sole carbon source likely have a defect
in either a metabolic pathway that combines acetyl group-containing molecules
with biological derivatives of glucose or in (the downstream part of) a pathway by
which acetate is utilized after it is derived from glucose or obtained from the
environment.
Of the mutants that failed to grow on acetate (but that grew on glucose),
some have not been previously identified, demonstrating the value of this screen.
Among the proteins identified with predicted function, most were either
mitochondrial transporters or enzymes in acetate or acetyl-CoA metabolic
pathways, namely acetyl-CoA synthesis and gluconeogenesis, as determined
based on the reported functions of homologues in other fungal species like S.
cerevisiae, N. crassa, and A. nidulans (Apirion, 1965; Sealy-Lewis, 1994; Flavell
and Fincham, 1968a; Schüller, 2003). For these, possible explanations for the
inability of the corresponding C. neoformans mutant to grow on acetate as the sole
carbon source are discussed below.
Detection of an acs1 mutant validates the sensitivity of the screen
A growth defect on acetate supplemented, but not glucose supplemented,
media was observed for the C. neoformans acs1 mutant. ACS1 (CNAG_00797)
encodes acetyl-CoA synthetase, which generates acetyl-CoA from acetate
(Schüller, 2003; Hu et al., 2008). Acetyl-CoA synthetase mutants of A. nidulans
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(facA) (Apirion, 1965; Sealy-Lewis, 1994), in N. crassa (acu-5)(Flavell and
Fincham, 1968a), and S. cerevisiae (acs1) (De Virgilio et al., 1992) also fail to grow
on media containing acetate as the only carbon source. More importantly, a C.
neoformans acs1 deletion mutant has been previously described as being unable
to grow on acetate (Hu et al., 2008), so the identification of the acs1 mutant from
the Madhani library verified the sensitivity of the screen used in the present study.
Furthermore, acetyl-CoA synthetase is upregulated in C. neoformans isolated from
pulmonary tissue obtained from a mouse infection model and acs1 loss of function
mutants have reduced growth and virulence in this model (Hu et al., 2008),
indicating that the library screening is capable of uncovering other genes that may
connect acetate metabolism with C. neoformans virulence. Supporting these
findings, acs1 has been shown to be a possible drug target (Koselny et al., 2016a,
2016b).
Mitochondrial transporters are necessary for growth of C. neoformans on
acetate
The screening also demonstrated that a mutant that is deficient in solute
carrier family 25 member 20/29 (AcuH; CNAG_00499), also known as
mitochondrial

carnitine/acylcarnitine

transporter

(or

mitochondrial

carnitine/acylcarnitine carrier) was unable to grow on media containing acetate as
the only carbon source. The equivalent S. cerevisiae carnitine/acylcarnitine carrier
Crc1p, is located in the mitochondria, presumably in the inner mitochondrial
membrane like the mammalian homologue, and exchanges carnitine present in
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the mitochondrial matrix with acylcarnitine present in the cytosol (Indiveri et al.,
1990, 1994; Swiegers et al., 2001; Palmieri et al., 1999a; Van Roermund et al.,
1995). In S. cerevisiae and other fungi, acetyl-CoA first produced by β-oxidation in
peroxisomes is converted by peroxisomal carnitine acetyltransferase to
acetylcarnitine, which is exchanged with cytosolic carnitine, possibly by a predicted
peroxisomal

membrane-bound

transporter

similar

to

the

mitochondrial

carnitine/acylcarnitine transporter (Van Roermund et al., 1995; Elgersma et al.,
1995; Swiegers et al., 2001; Palmieri et al., 2006). In S. cerevisiae, the cytosolic
acetylcarnitine is then imported into the mitochondria in exchange for the
mitochondrial carnitine (Van Roermund et al., 1995; Elgersma et al., 1995; Palmieri
et al., 1999a). In multiple fungi, including S. cerevisiae, a mitochondrial carnitine
acetyltransferase then reverses the conversion, producing acetyl-CoA and
carnitine from acetylcarnitine, and the acetyl-CoA is released into the mitochondrial
matrix for use in the TCA cycle (Strijbis et al., 2010; Swiegers et al., 2001; Stemple
et al., 1998; Kohlhaw and Tan-Wilson, 1977). The modification of carnitine to
acylcarnitines (especially to acetylcarnitine) is one of the few ways, if not the only
way, by which acetyl-CoA from the peroxisomes or produced from acetate in the
cytoplasm can enter the mitochondria, at least in S. cerevisiae, since mitochondrial
and peroxisomal membranes have very low permeability or are impermeable to
acetyl-CoA (Swiegers et al., 2001; Kohlhaw and Tan-Wilson, 1977; Van Roermund
et al., 1995; Elgersma et al., 1995; Todd et al., 1997; Palmieri et al., 1999a). This
S. cerevisiae peroxisome-cytosol-mitochondria carnitine/acylcarnitine exchange
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process is expected to be similar in C. neoformans, in which the mitochondrial
import of acetylcarnitine most likely occurs via solute carrier family 25 member
20/29.
This similarity extends to the use of carnitine O-acetyltransferases, and C.
neoformans mutants lacking either of two carnitine O-acetyltransferases,
CNAG_00537 or CNAG_06551, were unable to grow on media supplemented with
acetate as the sole carbon source in the current screen. Both S. cerevisiae and C.
albicans have three carnitine acetyltransferases, two in the cytoplasm and one that
can localize to either the mitochondria or peroxisome (Strijbis and Distel, 2010;
Strijbis et al., 2010). A third carnitine O-acetyltransferase, CNAG_05042, does
exist in C. neoformans, but the Madhani laboratory was unable to produce a
deletion mutant of the corresponding gene. Just like loss of the Cat2
peroxisomal/mitochondrial carnitine acetyltransferase in C. albicans precludes
growth on acetate or ethanol (Strijbis et al., 2008), single C. neoformans mutants
of either CNAG_00537 or CNAG_06551 were unable to grow on acetate,
indicating that each of these enzymes plays a unique, non-redundant, and critical
role in acetate utilization in C. neoformans. In A. nidulans, there are two carnitine
acetyltransferases, FacC and AcuJ, the first of which is in the cytoplasm, while the
second contains both peroxisomal and mitochondrial targeting sequences (Hynes
et al., 2011; Stemple et al., 1998), much like the Cat2 enzyme in C. albicans or S.
cerevisiae (Elgersma et al., 1995; Strijbis and Distel, 2010). While the location of
the three carnitine acetyltransferases in C. neoformans is uncertain, CNAG_06551
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is the most similar in amino acid sequence to A. nidulans FacC, indicating that it
may be the cytoplasmic carnitine acetyltransferase.
In addition to having at least one similar carnitine acetyltransferase to C.
neoformans, A. nidulans also has the overall acetyl-CoA/carnitine/acylcarnitine
shuttling pathway (Hynes et al., 2011; Stemple et al., 1998). A carnitine
transporter, encoded by acuH, has been identified in A. nidulans and lack of a
functional version of this transporter results in loss of growth on media containing
acetate as the only carbon source (De Lucas et al., 1999; Armitt et al., 1976). Toxic
accumulation of acetyl-CoA in the cytosol has been observed in the A. nidulans
acuH mutant cultured on acetate and is the probable cause of the growth defect;
it could also be the reason for the defect in growth of the C. neoformans
CNAG_00499 (acuH) mutant (Armitt et al., 1976; De Lucas et al., 1997, 1999,
2008; Martínez et al., 2007). Another possible reason for the inability of the C.
neoformans mutant to grow on acetate could be insufficient levels of acetyl-CoA in
the mitochondria for continuous use in the TCA cycle (Strijbis et al., 2010; Stemple
et al., 1998; Kohlhaw and Tan-Wilson, 1977).
A C. neoformans mutant deficient for another solute carrier family 25
member, solute carrier family 25 member 1 protein (AcuL; CNAG_02288),
exhibited complete growth failure on medium with acetate as the sole carbon
source. The S. cerevisiae homologue to AcuL is referred to as the succinatefumarate carrier or succinate-fumarate antiporter (Sfc1p/Sfa), and it functions in a
pathway that allows yeast to use acetate in the generation of ATP or to undergo
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gluconeogenesis when acetate is the sole carbon source (Palmieri et al., 1997,
2000). While succinate can be formed by succinyl-CoA synthetase in the
mitochondrial TCA cycle, it is also made by isocitrate lyase in the glyoxylate cycle
in the cytoplasm (Przybyla-Zawislak, et al., 1998; Schüller, 2003). In fungi such as
S. cerevisiae and in plants, the glyoxylate cycle utilizes a combination of enzymes
in the cytosol, peroxisomes, and mitochondria, so the products of theses enzymes
need to be transported between these compartments (Kunze et al., 2006; Flipphi
et al., 2014). In particular, S. cerevisiae uses Sfc1p (or the dicarboxylate carrier,
Dic1p, both of which are localized in the mitochondrial inner membrane) to transfer
succinate produced in the cytoplasm into the mitochondria (Flipphi et al., 2014;
Palmieri et al., 1999b, 2000; Lançar-Benba et al., 1996). Since Sfc1p (also called
Acr1p) is an antiporter, it couples mitochondrial succinate import with export of
fumarate into the cytoplasm by a strict counter-exchange mechanism (Palmieri et
al., 1997) that makes the fumarate available for use in the cytoplasm. Fumarate is
converted to malate and then to oxaloacetate which is used as a substrate for
gluconeogenesis or is joined with acetyl-CoA in the TCA cycle after import into the
mitochondria (Palmieri et al., 1997, 1999b; Flipphi et al., 2014). Reduction in the
levels of succinate and oxaloacetate in mitochondria (the latter due to lack of
fumarate in the cytoplasm) due to absence of the Sfc1p antiporter can hinder the
TCA cycle and therefore usage of acetyl-CoA, which may accumulate in the
mitochondria and in the cytoplasm. Acetyl-CoA toxicity has been described in A.
nidulans acuL mutants grown on acetate (Armitt et al., 1976; De Lucas et al.,
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1997,1999, 2008; Martínez et al., 2007). This toxicity may explain the findings that
S. cerevisiae acr1 or dic1 mutants, as well as the A. nidulans acuL mutant cannot
grow on either ethanol or acetate as the sole carbon source (Palmieri et al., 1997,
1999a; Fernández et al., 1994; Flipphi et al., 2014), corroborating the equivalent
severe phenotype of the C. neoformans sfc1 mutant observed in the present
screen. Given that the lack of export of fumarate to the cytoplasm can lead to toxic
acetyl-CoA accumulation, it is noteworthy that Sfc1 actually plays multiple roles
during growth on ethanol or acetate; not only is it required for the mitochondrial
succinate-fumarate antiport, but Sfc1/Acr1 also regulates the expression of Acs1
(Palmieri 1997, 2000). SFC1 expression is itself upregulated in C. neoformans
during infection in a mouse model (Hu et al., 2008).
Interestingly, the induction of SFC1/ACR1 expression is co-regulated with
that of the genes encoding isocitrate lyase and malate synthase of the glyoxylate
cycle and phosphoenolpyruvate carboxykinase and fructose-1,6-bisphosphatase
of the gluconeogenesis pathway (Bojunga et al., 1998; Redruello et al., 1999).
Mutations

in

phosphoenolpyruvate

carboxykinase

and

fructose-1,6-

bisphosphatase have been shown here and in the published literature to prevent
or reduce growth on acetate of C. neoformans or other fungal species, including
A. nidulans, C. albicans, N. crassa and S. cerevisiae (Rude et al., 2002, Flavell
and Fincham, 1968a; Armitt et al., 1976; Lorenz and Fink, 2001; Hynes et al.,
2002).
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The gluconeogenesis pathway is important for C. neoformans growth on
acetate
Two

mutants

from

the

Madhani

libraries,

one

deficient

for

phosphoenolpyruvate carboxykinase (Pck1; CNAG_04217), and the other for
fructose-1,6-bisphosphatase I (Fbp1; CNAG_00057), were unable to grow on
acetate as the sole carbon source. In many fungal species, including A. nidulans
and C. neoformans, Pck1 converts oxaloacetate produced in the TCA cycle to
phosphoenolpyruvate in the cytoplasm. This allows the fungi to undergo
gluconeogenesis and thereby grow on carbon sources that are processed into
TCA cycle intermediates used to produce the oxaloacetate (Hynes et al., 2002).
Similarly, Fbp1 converts fructose-1,6-bisphosphate to fructose-6-phosphate and is
important for growth of fungi on all carbon sources that can only (or optimally) be
utilized via gluconeogenesis (Hynes et al., 2002). A. nidulans acuF and acuG
mutants lacking Pck1 and Fbp1 activity, respectively, fail to grow on media
containing acetate as the sole carbon source (Armitt et al., 1976), just like the C.
neoformans mutants in this study. Of importance, Pck1 activity was highly induced,
and expression of the PCK1 gene was increased, in C. neoformans cells recovered
from infected mouse brain or lung (Price et al., 2011; Hu et al., 2008; Fan et al.,
2005). Furthermore, lack of PCK1 in C. neoformans leads to impaired virulence in
a murine inhalation model, even though it does not affect the persistence of the
pathogen or its ability to disseminate to the brain in a rabbit cryptococcosis model
(Panepinto et al., 2005; Price et al., 2011). Both PCK1 and FBP1 are upregulated
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in C. neoformans after phagocytosis by macrophages (Derengowski et al., 2013).
Together, these findings suggests that enzyme of gluconeogenesis, especially
Pck1 and Fbp1, play an important role in the utilization of acetate as a carbon
source and therefore, potentially, growth of the pathogen during infection, by
converting two-carbon compounds (such as acetate) and intermediates of the TCA
cycle to glucose, to allow continuous energy production even when glucose (or
other hexoses) are not available. It is uncertain why gluconeogenesis is required
for growth on acetate when TCA cycle intermediates such as oxaloacetate, or even
acetyl-CoA, could be used to generate ATP via the TCA cycle itself, but it is clear
that this is, in fact, the case.
In further support of this idea, a mutant that was deficient in glucose-6phosphate isomerase (CNAG_03916), which converts glucose-6-phosphate to
fructose-6-phosphate and vice-versa in glycolysis and gluconeogenesis,
respectively, also exhibited a growth defect in this screen on acetate as the sole
carbon source. A similar result was observed in another study (Zhang et al., 2015),
in which a mutant of glucose-6-phosphate isomerase (also known as
phosphoglucoisomerase) that retains only 1.9% of the original enzyme activity due
to insertional disruption of the promoter has reduced growth on media where
acetate is the only carbon source. Surprisingly, just like the leaky mutant in Zhang
et al. (2015), the mutant tested in the current screen, which is expected to entirely
lack glucose-6-phosphate isomerase, was able to grow when provided with
glucose as the sole carbon source, even though, without this enzyme, the
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glycolysis pathway should not function. It is possible that C. neoformans is able to
bypass glycolysis using the pentose phosphate pathway when deficient in glucose6-phosphate isomerase, much like Trichoderma reesei (Limón et al., 2011), even
though this does not occur in S. cerevisiae (Sierkstra et al., 1993; Heux et al.,
2008). Just like the glucose-6-phosphate isomerase mutant, a mutant deficient for
transketolase (CNAG_06172) in the pentose phosphate pathway, is able to grow
on the glucose-only medium in this screen, but this is not surprising, since it can
utilize the glycolysis pathway. To test the hypothesis that the mutant lacking
glucose-6-phosphate isomerase grew on glucose because it used the pentose
phosphate pathway, one can generate a double mutant deficient in both
CNAG_03916 and CNAG_06172 and test its ability to utilize glucose as the sole
carbon source.
While

glucose-6-phosphate

isomerase

is

employed

in

both

gluconeogenesis and glycolysis, Pck1 and Fbp1 are used only in gluconeogenesis,
and, in fact, are regulated such that they cannot be used when glucose is present.
In S. cerevisiae, Pck1 activity is repressed and degradation of the enzyme is
induced in the presence of glucose (Burlini et al., 1989; Haarasilta and Oura,
1975). Similarly, FBP1 is induced in the presence of non-glucose carbon sources,
and its expression is repressed, while the corresponding enzyme is degraded via
a ubiquitination-mediated pathway, in the presence of glucose (Giardina et al.,
2012; Gancedo, 1971; Holzer, 1989; Schork et al., 1995; Schüle et al., 2000).
Thus, overall, these results reflect the importance of the gluconeogenesis pathway
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in the growth of C. neoformans when provided with acetate as the sole carbon
source.
The essential amino acid arginine is necessary for growth of C. neoformans
in vitro
Several of the mutants that were detected in this screen as being unable to
grow on both medium supplemented with glucose-only and that supplemented with
acetate-only were knocked out for genes encoding enzymes in the arginine
biosynthetic pathway. It is not surprising that these mutants were unable to survive,
since as an amino acid, arginine is necessary for the production of many proteins
with physiological and biochemical functions in the cell.
The arginine biosynthesis pathway in S. cerevisiae and other fungi
combines several enzymatic reactions to form L-citrulline from ornithine and
carbamoyl phosphate, and then converts the citrulline to arginine via a series of
steps (Jauniaux, et al., 1978). The process could be considered to begin in the
mitochondria, where amino acid acetyltransferase, also known as Nacetylglutamate synthase, reacts L-glutamic acid with acetyl-CoA to form N-acetyl
L-glutamic acid, which is then converted via three intermediates into L-ornithine
(Jauniaux, et al., 1978). In parallel and possibly in the cytoplasm, depending on
the species of fungus, carbamoyl phosphate synthetase, in particular the large
subunit of an arginine-pathway-specific carbamoyl phosphate synthetase,
catalyses the formation of carbamoyl phosphate from ammonia, bicarbonate, and
ATP (Price et al., 1978; Jauniaux, et al., 1978). The carbamoyl from the carbamoyl

320

phosphate is then transferred to the L-ornithine, in a reaction catalyzed by ornithine
carbamoyltransferase, to form L-citrulline (Price et al., 1978; Jauniaux, et al.,
1978). Argininosuccinate synthase converts the L-citrulline into argininosuccinate,
which is turned into arginine by argininosuccinate lyase (Jauniaux, et al., 1978).
Thus, C. neoformans mutants that were deficient for amino acid
acetyltransferase (CNAG_02826), the arginine-specific carbamoyl phosphate
synthetase large subunit (CNAG_06112), or ornithine carbamoyltransferase
(CNAG_02812) failed to grow on media containing either glucose or acetate as the
carbon source because these mutants were unable to make L-ornithine, carbamoyl
phosphate, or, citrulline, respectively. Without the ability to produce citrulline, these
mutants were unable to make arginine, and were therefore unable to grow at all,
regardless of the carbon source provided. These mutants, when grown on media
with acetate or glucose as the carbon source but supplemented with arginine, grew
normally (H. Al Mousa personal comunication), indicating that the lack of arginine
was, in fact, the reason for the original lack of growth. In contrast, a mutant lacking
the non-specific carbamoyl-phosphatase synthase (CNAG_07373), which
primarily plays a role in synthesis of pyrimidines, was unable to grow even when
provided with arginine (H. Al mousa personal comunication), since it was unable
to make the pyrimidines needed for DNA and RNA synthesis. This also means that
the (vast majority of) carbamoyl phosphate made by CNAG_06112 is used to
produce

citrulline,

and

is

therefore

unavailable

(possibly

due

to

compartmentalization of the enzymes and products of the arginine pathway) to
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make sufficient pyrimidines for survival of the CNAG_07373-deficient mutant. The
reverse is also apparently true, since the mutant deficient in CNAG_06112 is
unable to make (sufficient) arginine from the carbamoyl phosphate produced by
CNAG_07373 to survive without arginine supplementation. The inability to produce
arginine does reduce virulence in other pathogenic fungal species. For example, it
reduces or eliminates the penetration by Colletotrichum higginsianum of its (plant)
host and the pathogenicity of Fusarium oxysporum, a melon fungus (Huser et al.,
2009), as well as the pathogenicity of Magnaporthe oryzae, a fungus that infects
rice plants (Liu et al., 2016). Similarly, inability to produce arginine reduces the
virulence of C. neoformans in a mouse infection model, although an
arginosuccinate lyase mutant is able to regain virulence, presumably by obtaining
arginine from the host (Rhodes and Howard, 1980).
Other acetate utilization enzymes function in diverse pathways
Other C. neoformans mutants that failed to grow on acetate as the only
carbon source included those deficient in 8-Amino-7-oxononanoate synthase
(CNAG_00236), cytosine deaminase (CNAG_00613), a 53 kDa brg1-associated
factor (CNAG_04048), a HAL protein kinase (HRK1; CNAG_00745), and a
AGC/AKT protein kinase (YPK1; CNAG_04678). The identification of two kinases
is of interest. Hrk1 functions downstream, as well as independently, of the high
osmolarity glycerol response (HOG) pathway, which controls the stress response
to a hypertonic environment through regulation of ergosterol biosynthesis and of
expression of virulence factors in C. neoformans (Kim et al., 2011; Bahn and Jung,

322

2013). There are homologous proteins in S. cerevisiae (Rck1/2) and in
Schizosaccharomyces pombe (Srk1) to C. neoformans Hrk1 (Kim et al., 2011),
and inhibition of ergosterol biosynthesis enzymes with drugs results in toxic stress
and disrupts membrane integrity in S. cerevisiae (Lee et al., 2012). The expression
of HRK1 depends on the central protein in the HOG pathway, a mitogen activated
protein kinase (MAPK) called Hog1, but an hrk1, hog1Δ double mutant is even
more sensitive to hyperosmolarity than the hog1Δ mutant alone (Kim et al., 2011;
Bahn and Jung, 2013) and than an hrk1Δ only C. neoformans mutant, which was
not sensitive to osmolar stress (Lee et al., 2016). Hrk1 is not required for capsule
biosynthesis, and is dispensable for C. neoformans virulence, but the protein does
appear to be involved in melanin biosynthesis (Kim et al., 2011; Lee et al., 2016),
although its role may be minor (Liu et al., 2008). Hrk1 also appears to be involved
in metabolite transport (Liu et al., 2008). Furthermore, deficiency of this kinase
confers sensitivity to sodium dodecylsulfate (SDS) in one hrk1Δ mutant, indicative
of a cell wall or cell membrane integrity defect (Liu et al., 2008); however, this
defect is not observed in another C. neoformans hrk1Δ mutant (Lee et al., 2016).
A recent study in Komagataella phaffii (previously Pichia pastoris) found
that an hrk1 mutant is sensitive to the cytoplasmic acidity generated by entry of
acetate into the cell (Xu et al., 2019). Moreover, in S. cerevisiae, expression of an
Hrk1 protein, which regulates a membrane bound ATPase-associated proton
pump in response to glucose metabolism changes, protected the yeast from this
acetate-induced acidity (Mira et al., 2010). The identification, in the present screen,
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of a C. neoformans hrk1Δ mutant among those unable to grow on acetate is in line
with these findings in other species, and indicates that this screen was able to
successfully detect genes involved in acetate-related processes beyond those
functioning only in acetate utilization.
The other protein kinase detected in this screen, Ypk1, is a member of the
AGC kinase (protein kinases A, G or C) family and therefore likely plays a role in
cell survival, growth, and proliferation (Lee et al., 2012). C. neoformans Ypk1
shares 55% identity with S. cerevisiae Ypk1 and 69% identity with S. pombe Gad8,
suggesting that these proteins are homologues (Lee et al., 2012). Just like the C.
neoformans hrk1Δ mutant, the C. neoformans ypk1Δ mutant also exhibits
sensitivity to inhibition of ergosterol (or other lipid) biosynthesis, which correlates
with a similar phenotype in S. cerevisiae ypk1 mutants (Kim et al., 2011; Lee et al.,
2012; Lee et al., 2016). In C. neoformans, a kinase-dead mutant exhibits the same
sensitivity to inhibition of ergosterol biosynthesis as the deletion mutant (Lee et al.,
2012). The C. neoformans ypk1Δ mutant also demonstrates similarity to the hrk1Δ
mutant in that it has a melanin production defect (Kim et al., 2011; Lee et al., 2012;
Lee et al., 2016). However, the C. neoformans ypk1 mutant has been reported to
have several other phenotypes as well (Lee et al., 2012; Lee et al., 2016). It has a
mild general growth defect and a mild temperature sensitivity, sensitivity to osmolar
and oxidative stresses, and sensitivity to Congo red, Calcofluor white, and SDS,
indicative of loss of cell wall and/or cell membrane integrity (Lee et al., 2016). In
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contrast to Hrk1, Ypk1 plays a role in C. neoformans virulence, since the ypk1Δ
mutant exhibits reduced virulence in mice (Lee et al., 2012).
Comparison to previously published screening results
This screen identified some of the proteins important for acetate utilization,
including acetyl-CoA synthetase (Acs1; CNAG_00797), Phosphoenolpyruvate
carboxykinase (Pck1; CNAG_04217) and fructose-1,6-bisphophatase (Fbp1;
CNAG_00057), and acetate transporters like the acetylcarnitine transporter (AcuH;
CNAG_00499) and the succinate-fumarate antiporter (AcuL; CNAG_02288).
However, previously published, alternate screening assays in other fungal species
and in C. neoformans identified some acetate utilization mutants that were not
detected in this screen. Thorough analysis of the literature indicated five possible
reasons for the failure to identify previously recognized acetate utilization mutants
and their corresponding genes in this screen. First, some published screens
detected mutants only when the fungus was grown for screening at a different
temperature than that used in this screening. For example, Hu et al. (2008)
identified a mutant for Snf1 (CNAG_06552; a serine/threonine protein kinase also
known as CAMK/CAMKL/AMPK protein kinase) that grows normally on glucose,
acetate, and sucrose media at 30°C but at 37°C has reduced growth on media with
sucrose and ethanol and exhibits a severe growth defect on acetate as the sole
carbon source. This Snf1 protein kinase regulates the growth of fungi by
modulating gluconeogenesis and alternative carbon source utilization pathways
(Celenza and Carlson, 1986) and functions, in part, as a regulator of Acs1, which
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converts acetate to acetyl-CoA in yeast (Young et al., 2003). C. neoformans cells
grown on low glucose or acetate media have high levels of Snf1 mRNA, although
cells recovered from infected mouse lung do not (Hu et al., 2008). This suggests
that although Snf1 is not necessary for virulence, it is required for cryptococcal
growth under stress, such as when glucose is not available and acetate is the sole
carbon source, or, possibly, under higher temperatures, explaining the finding that
the Madhani library mutant did not exhibit growth defects in the current screen
because all mutants were grown at 30°C.
The second potential reason is the difference in the carbon source
concentrations used in the screening. For instance, an acetate transporter mutant,
ady2Δ, was determined in the Smith lab to have an extreme growth defect in media
supplemented with 0.2% acetate but was able to grow normally in 2% acetate
(Kisirkoi, 2017). The equivalent mutant from the Madhani (combined) library,
deleted for the gene designated CNAG_05678, was also able to grow at the 2%
acetate concentration used in the current screen, meaning that the growth defect
was suppressed at the higher acetate concentration. This presumably because
acetate at higher concentrations is able to diffuse adequately across the
membrane to support growth in the absence of Ady2 (Kisirkoi, 2017). The current
screening result supports this hypothesis.
The third potential reason for differences between the current screen in C.
neoformans and screens of other fungal species is that there may be multiple
protein isoforms encoded by paralogous genes or other functionally redundant
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proteins in C. neoformans. In the present screen, a C. neoformans mutant lacking
a NAD+ specific malate dehydrogenase (CNAG_03266) grew normally on both
acetate and glucose supplemented media, but this enzyme has previously been
shown to be important for acetate utilization in other fungal species. For instance,
an acetate-inducible NAD+-specific malate dehydrogenase mutant in N. crassa
(acu-13) failed to utilize acetate as the sole carbon source and demonstrated a
growth defect on 40 mM acetate (Owen et al., 1992). However, a search of the C.
neoformans genome via the FungiDB website (https://fungidb.org/fungidb/)
revealed the presence of a second malate dehydrogenase gene (CNAG_03225)
located elsewhere in the same chromosome but coding for a similar protein (with
56.51% identity by Clustal Omega analysis) that likely compensates for the
absence of the first enzyme and thereby masks the effect of the loss of the first
protein. Unfortunately, a double mutant of CNAG_03266 and CNAG_03225 was
not available for analysis.
The fourth reason is that the two libraries used in this screen do not cover
the entire genome, so knockout mutants for many of the genes identified as critical
for acetate utilization in other screens were unavailable for testing. There are
~6500 intron-rich genes in total in the C. neoformans genome (Loftus et al., 2005),
but using the Madhani libraries it was only possible to screen 3936 of these genes.
One of the important proteins encoded by a gene missing from the libraries is
isocitrate lyase (CNAG_05303), a key enzyme of the glyoxylate cycle, which, in S.
cerevisiae, is encoded by ICL1 (Fernández et al., 1992; Fernandez et al., 1993;
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Schüller, 2003). In S. cerevisiae, the glyoxylate cycle permits and is essentially
required for yeast to grow on two-carbon molecules like ethanol or acetate as the
sole carbon source. Acetyl-CoA produced from acetate that is not used in the
tricarboxylic acid (TCA) cycle is fed into the glyoxylate cycle (Schüller, 2003;
Lorenz and Fink, 2001; Fernández et al., 1992). Mutations in S. cerevisiae ICL1
and in homologues of this gene in A. nidulans (acuD), N. crassa (acu-3), and C.
albicans (ICL1), as well as C. neoformans, caused defects in acetate utilization
and in the growth of the fungi in acetate-containing media (Armitt et al., 1976;
Flavell and Fincham, 1968a, Idnurm et al., 2007). C. neoformans cells grown on
acetate as the sole carbon source and those recovered from a rabbit infection
model both upregulate ICL1 transcription (Rude et al., 2002). However, while C.
albicans icl1 deletion mutants have clearly diminished virulence in mice (Lorenz
and Fink, 2001), S. cerevisiae icl1 deletion mutants have only slightly reduced
virulence in a mouse infection model (Goldstein and McCusker, 2001; Rude et al.,
2002), and C. neoformans icl1 mutants exhibited no difference from wild type cells
in growth inside macrophages, nor in virulence in mouse inhalation-based and
rabbit meningeal infection models (Rude et al., 2002). Hence, isocitrate lyase
seems to be critical for acetate utilization and growth on acetate-containing media,
and perhaps enhances virulence, but is not required for pathogenesis, especially
in C. neoformans (Idnurm et al., 2007; Hu et al., 2008). Thus, while it is extremely
important to be able screen mutants for genes such as ICL1 that are not available
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in the Madhani libraries, some of the acetate utilization defective mutants that were
missed in the current screen may not themselves be of critical importance.
The fifth and final reason for the failure to identify genes in the current
screen that in other species are important for growth on acetate is the absence of
homologues of these genes in C. neoformans. Proteins like acetyl-CoA hydrolase,
which is required for growth of N. crassa on acetate (Owen et al., 1992), and A.
nidulans facB, a master transcriptional regulator of genes involved in acetate
utilization, including genes encoding acetyl-CoA synthetase, isocitrate lyase,
malate synthase, and phosphoenolpyruvate carboxykinase, (Todd et al.,. 1997;
Apirion, 1965; Armitt et al., 1976; Hynes, 1977; Kelly and Hynes, 1982), do not
have corresponding homologues in the C. neoformans genome. A. nidulans and
N. crassa are from the phylum Ascomycota and evolved separately from C.
neoformans of the phylum Basidiomycota, so it is not surprising that they harbor
several genetic differences from C. neoformans.
Although some acetate utilization mutants identified in other screens were
not detected in this screen, several C. neoformans enzymes previously known to
function in pathways related to the use or transport of acetate as well as some
proteins that have not previously been linked to acetate utilization were identified
in this screen. C. neoformans may employ these enzymes to enhance growth and
virulence after infection, such as in the host central nervous system. This study
opens up new avenues for both fundamental research and drug discovery to
understand and treat cryptococcal meningitis. Larger scale screenings, as
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described by Motaung (2018), may provide yet more target proteins for the
development of therapeutic pharmaceuticals to treat and reduce the lethality of C.
neoformans-driven cryptococcal meningitis.
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Summary and Conclusions
The ability to utilize alternate carbon sources provides C. neoformans with
survival advantages inside the host system, especially in organs like the brain
where glucose levels are low (Polacheck et al., 1982; Zhu and Williamson, 2004).
Targeting this ability to switch between carbon sources for drug development can
open up new avenues for treatment of meningitis caused by cryptococcal infection.
This study a global screen to discover genes that are important for acetate
utilization and presumably would be important for targeting cryptococcal infections
in the human brain. Fourteen genes that were important for acetate utilization by
C. neoformans were identified that have homologues in other fungal species. Most
of these genes belong to the gluconeogenesis pathway, mitochondrial membrane
transport pathways, or the arginine biosynthesis pathway. Further characterization
of the remaining genes, deleted in mutants not previously characterized as having
a growth defect on acetate, will be required to determine their exact role in acetate
utilization.
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Table 4.1: Mutants from the Madhani laboratory C. neoformans strain
libraries that were unable to grow on media with glucose as the only carbon
source.
Identifier
CNAG_00405
CNAG_00448
CNAG_00458
CNAG_00461
CNAG_01230
CNAG_01487
CNAG_01557
CNAG_02066
CNAG_02588
CNAG_03168
CNAG_05668
CNAG_06230

Protein description
Ste/ste20/ysk protein kinase
V-type H+-transporting ATPase subunit AC39
hypothetical protein
Protein kinase C substrate 80K-H
Chitin deacetylase 2
hypothetical protein
Calmodulin
hypothetical protein
Avenacinase
Sulfite reductase (NADPH) flavoprotein alpha-component
hypothetical protein
hypothetical protein
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Table 4.2: Mutants from the Madhani laboratory C. neoformans strain
libraries that were unable to grow on media with acetate as the only carbon
source.
Identifier
CNAG_00057
CNAG_00236
CNAG_00403
CNAG_00499
CNAG_00537
CNAG_00613
CNAG_00745
CNAG_00797
CNAG_02288
CNAG_03916
CNAG_04048
CNAG_04217
CNAG_04290
CNAG_04678
CNAG_06551

Protein description
Fructose-1,6-bisphosphatase I
8-Amino-7-oxononanoate synthase
mitochondrial protein
Solute carrier family 25 (Mitochondrial carnitine/acylcarnitine
transporter), member 20/29; Carnitine/acyl-carnitine carrier;
AcuH
Carnitine O-acetyltransferase
Cytosine deaminase
HAL protein kinase
Acetyl-CoA synthetase
Solute carrier family 25 (Mitochondrial citrate transporter),
member 1; Mitochondrial succinate-fumarate anti-porter; sfa;
acuL
Glucose-6-phosphate isomerase
53 kDa brg1-associated factor b
Phosphoenolpyruvate carboxykinase (ATP)
hypothetical protein
AGC/AKT protein kinase
Carnitine O-acetyltransferase
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Table 4.3: Mutants from the Madhani laboratory C. neoformans strain
libraries that failed to grow on glucose and on acetate, each as the only
carbon source.
Identifier
Protein description
CNAG_00734 Dihydroorotase, homodimeric type, dihydroorotase,
homodimeric type, variant
CNAG_02795 Phosphoribosyl glycinamide formyl transferase
CNAG_02812 Ornithine carbamoyltransferase
CNAG_02825 Argininosuccinate lyase
CNAG_02826 Amino-acid acetyltransferase, mitochondrial
CNAG_02853 Amido phosphoribosyl transferase
CNAG_03174 4'-phosphopantetheinyl transferase
CNAG_04196 Actin binding protein
CNAG_04647 Glutathione synthetase
CNAG_05074 hypothetical protein
CNAG_05445 Smooth muscle cell associated protein-1 isoform 2
CNAG_06112 Carbamoyl-phosphate synthase arginine-specific large chain
CNAG_06314 Phosphoribosylamine-glycine ligase
CNAG_07373 Carbamoyl-phosphate synthase, large subunit
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Figure 4.1: Representative plates of Madhani library strains screened for
growth on a) glucose or b) acetate as the only carbon source. Strains that did
not grow on original plates (circled) and that were re-tested are shown below each
plate. c) Some strains, like the strain mutant for SWR1-Complex protein 4
(CNAG_02020), had an odd phenotype; they grew into seemingly more dense,
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slightly larger, creamy-white colonies on media with either glucose (top, circled) or
acetate (middle, circled) as the sole carbon source, or on both media. This
phenotype was also visible when the CNAG_02020-deficient mutant was re-grown
on acetate as the sole carbon source (bottom).
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APPENDIX
This section contains supplementary material for Chapters Two and Three
Given the small capsules of aldΔ mutants, and, in particular, the loss of cell
wall integrity in the Congo red assay, extremely low melanization, and sensitivity
to reactive oxygen species (ROS) and reactive nitrogen species (RNS) of the
ald69Δ mutant, quantification of the extent of membrane damage due to uptake of
ROS seemed likely to be informative. Similarly, since the pdcΔ mutant exhibited a
smaller than normal capsule, reduced melanization, and loss of cell wall integrity
in the Congo red assay, even though it did not demonstrate sensitivity to ROS or
RNS, determining the level of ROS-mediated membrane damage also was likely
to be informative.
Method: Flow cytometry analysis of oxidative stress and cellular integrity
The concentration of ROS generated by treatment of cells with hydrogen
peroxide as well as the level of ROS-induced cell wall/membrane damage in wild
type and mutant C. neoformans strains were measured using a procedure modified
from Peng et al., 2018. Colonies of C. neoformans wild type and mutant strains
grown on YPD-agar media were transferred to 2ml YPD liquid medium and
incubated overnight at 30°C with constant shaking. Cells were centrifuged at
5000×g for 5 min and resuspended in 850 μl YPD medium. For each strain, the
cell suspension was diluted in YNB medium (adjusted to pH 4.0 with sodium
succinate) to a final OD600 of ~0.2 before cells were counted using a
hemocytometer and the concentration was corrected to ~1×104 cells/μl. The cell
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suspension of each strain was aliquoted into six tubes at 2 ml per tube, and either
H2O2 to a final concentration of 5 mM, or sterile water as control, was added to
three pairs of tubes each. The cultures were incubated at 30°C for 3 hours with
constant shaking. Next, cells were harvested by centrifugation at 5000×g for 5 min,
washed with 1X Dulbecco’s Phosphate-Buffered Saline without calcium and
magnesium (D-PBS w/o Ca2+, Mg2+;Corning Inc., Corning, NY), resuspended in DPBS w/o Ca2+, Mg2+ supplemented with 20 μM 2′,7′ dichlorofluorescin diacetate
(H2DCFDA; Sigma), and then transferred to fresh microfuge tubes, which were
immediately covered with aluminum foil. The tubes were incubated for 20 min at
30°C with constant shaking, after which cells were centrifuged again at 5000×g for
5 min., washed with D-PBS w/o Ca2+, Mg2+, and then resuspended in 1 ml D-PBS
w/o Ca2+, Mg2+ supplemented with 5 μg/ml propidium iodide (PI; Sigma). The tubes
were covered again with aluminum foil and incubated for 40 min at 30°C with
constant shaking. After this final incubation, cells were centrifuged one more time
at 5000×g for 5 min, washed and then resuspended in 1 ml D-PBS w/o Ca2+, Mg2+,
and sonicated (Q500 Sonicator, Qsonica) with 20% output strength for 5 seconds
to ensure a single-cell suspension. Fluorescence was detected by flow cytometry
with the Accuri C6 flow cytometer (BD Biosciences, San Jose, CA). The H2DCFDA
was expected to react with ROS to form 2',7'-dichlorofluorescein (DCF), which was
detected and quantified via the FITC-A channel (533/30 nm), while the PI that
entered cells through gaps in the cell wall and membrane was detected and
quantified via the PerCP-A channel (670 nm).
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Results
It was considered informative to determine, quantitatively, whether oxidative
stress and the introduction of ROS caused increased cell wall and membrane
damage in aldehyde dehydrogenase mutants, or whether they were able to
compensate by neutralizing the ROS or repairing their membranes. To establish
which was true for each mutant, biological triplicates of the wild type and ald mutant
strains, as well as of the pdcΔ mutant, were treated with hydrogen peroxide, or
not, as control, and then stained with a compound that converts to a green
fluorescent dye upon reacting with ROS, as well as with propidium iodide (PI), a
red fluorescent molecule to which the cell membrane is impermeable. The intensity
of fluorescence of the two dyes in the triplicate samples of wild type or mutant cells
was quantified by flow cytometry. The intensity of the green fluorescence was
assumed to be roughly indicative of the amount of ROS inside the cell. Cells with
a high intensity of PI fluorescence were considered to have lost capsule, cell wall,
and/or cell membrane integrity (referred to as "membrane damage" hereafter),
allowing entry of the PI. Only the PI intensity of cells with high ROS was quantified.
Of the ald mutants, only the ald78Δ mutant exhibited a statistically significant
difference in the amount of ROS taken into the cell compared with the wild type
strain (Supplementary Figure 2.1a; P-value = 0.0269). Strangely, the ald78Δ
mutant has less ROS than the wild type strain. Similarly, none of the ald mutants
exhibited increased membrane damage in cells with high ROS, in the sense that
the cells of the wild type strain with high ROS had the highest membrane damage
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of all strains, but not significantly so (Supplementary Figure 2.1b). The pdcΔ
mutant appeared to be resistant to ROS uptake and membrane damage relative
to the wild type cells (Supplementary Figure 3.1a and 3-1b, respectively), but the
results were not statistically significant, indicating that lack of Pdc did not affect
response to ROS in this assay. It is worth noting that there was a moderate amount
of sample-to-sample variation in ROS and PI intensity measurements of several
strains, making these results susceptible to error. Thus, it is difficult to conclude
with certainty that the mutants were resistant to ROS and/or able to repair their
membrane damage, but, tentatively, this appears to be the case.
Overall conclusions and future directions
The quantification of uptake of reactive oxygen species (produced from hydrogen
peroxide) and of the unrepaired membrane damage resulting from the associated
chemical attack on membrane lipids is a useful endeavor. It suggests how the wild
type and mutant strains might respond within the phagolysosome of macrophages
after engulfment. However, the current results are mostly not significant because
of high sample-to-sample variation in signal intensity within each wild type or
mutant strain. Thus, the experiment needs to be repeated after the technique is
further optimized. Additionally, conducting the experiment with sodium nitrite to
generate reactive nitrogen species may also be informative, especially since
sodium nitrite is more stable than hydrogen peroxide, and since the chemical
attack on pathogens that occurs in phagolysosomes of macrophages primarily
utilizes reactive nitrogen species (Tohyama et al., 1996; Maffei et al., 2004).
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Quantifying the extent of unrepaired ROS- or RNS-induced membrane damage of
the pyruvate decarboxylase deficient mutant of C. neoformans or of mutants
deficient in each of the aldehyde dehydrogenases should illuminate the role of
these enzymes, and, potentially, of acetate production, in the neutralization of
reactive oxygen and nitrogen species and/or in repair of membrane, cell wall, and
capsule damage.
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Appendix Figure 2.1: Effect of hydrogen peroxide treatment on reactive
oxygen species (ROS) content and membrane damage. a) Change in ROS with
H2O2. * significant, P-value < 0.05, b) Change in membrane damage (and,
presumably, loss of cell wall and capsule integrity), based on propidium iodide (PI)
entry into cells, with H2O2.
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Appendix Figure 3.1: Effect of hydrogen peroxide treatment on reactive
oxygen species content and membrane damage on wild type and pdcΔ
mutant strains of C. neoformans. a) Change in reactive oxygen species (ROS)
content with H2O2. b) Change in membrane damage, based on propidium iodide
(PI) entry into cells, with H2O2. While it appears that the mutant had decreased
ROS uptake and membrane damage relative to the wild type cells, the results were
not statistically significant.
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